Publications published since 2000 from OUS - Department of Haematology

693 publications found

Publications 2020

  1. Andresen MS, Stavik B, Sletten M, Tinholt M, Sandset PM, Iversen N, Skretting G (2020)
    Indirect regulation of TFPI-2 expression by miR-494 in breast cancer cells
    Sci Rep, 10 (1), 4036
    DOI 10.1038/s41598-020-61018-x, PubMed 32132611
  2. Bazarbachi A, Bug G, Baron F, Brissot E, Ciceri F, Dalle IA, Döhner H, Esteve J, Floisand Y, Giebel S, Gilleece M, Gorin NC, Jabbour E, Aljurf M, Kantarjian H, Kharfan-Dabaja M, Labopin M, Lanza F, Malard F, Peric Z, Prebet T, Ravandi F, Ruggeri A, Sanz J, Schmid C et al. (2020)
    Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Haematologica, 105 (6), 1507-1516
    DOI 10.3324/haematol.2019.243410, PubMed 32241850
  3. Berentsen S, Malecka A, Randen U, Tjønnfjord GE (2020)
    Cold agglutinin disease: where do we stand, and where are we going?
    Clin Adv Hematol Oncol, 18 (1), 35-44
    PubMed 32511221
  4. Blomkvist AW, Zadig P, Christoffersen S, Kaushal S, Nordengen E, Shanmugarajah I, Ghanima W (2020)
    Rettelse: Hjemmebehandling ved lungeembolisme
    Tidsskr Nor Laegeforen, 140 (4)
    DOI 10.4045/tidsskr.20.0116, PubMed 32192270
  5. Caglayan S, Hashim A, Cieslar-Pobuda A, Jensen V, Behringer S, Talug B, Chu DT, Pecquet C, Rogne M, Brech A, Brorson SH, Nagelhus EA, Hannibal L, Boschi A, Taskén K, Staerk J (2020)
    Optic Atrophy 1 Controls Human Neuronal Development by Preventing Aberrant Nuclear DNA Methylation
    iScience, 23 (6), 101154
    DOI 10.1016/j.isci.2020.101154, PubMed 32450518
  6. Derolf Å, Juliusson G, Benson L, Fløisand Y, Lazarevic V, Antunovic P, Möllgård L, Lehmann S, Uggla B, Wahlin A, Höglund M, Deneberg S (2020)
    Decreasing early mortality in acute myeloid leukaemia in Sweden 1997-2014: improving performance status is a major contributing factor
    Br J Haematol, 188 (1), 187-191
    DOI 10.1111/bjh.16265, PubMed 31863470
  7. Divito SJ, Aasebo AT, Matos TR, Hsieh PC, Collin M, Elco CP, O'Malley JT, Bækkevold ES, Reims HM, Gedde-Dahl T, Hagerstrom M, Hilaire J, Lian JW, Milford EL, Pinkus GS, Ho VT, Soiffer RJ, Kim HT, Mihm MC, Ritz J, Guleria I, Cutler CS, Clark R, Jahnsen FL, Kupper TS (2020)
    Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host-disease
    J Clin Invest (in press)
    DOI 10.1172/JCI129965, PubMed 32516138
  8. Dusingizimana T, Weber JL, Ramilan T, Iversen PO, Brough L (2020)
    A qualitative analysis of infant and young child feeding practices in rural Rwanda
    Public Health Nutr, 1-10 (in press)
    DOI 10.1017/S1368980020001081, PubMed 32611464
  9. Fronas SG, Dahm AEA, Wik HS, Jørgensen CT, Gleditsch J, Raouf N, Holst R, Klok FA, Ghanima W (2020)
    Safety and feasibility of rivaroxaban in deferred workup of patients with suspected deep vein thrombosis
    Blood Adv, 4 (11), 2468-2476
    DOI 10.1182/bloodadvances.2020001556, PubMed 32502267
  10. Godolphin PJ, Bath PM, Partlett C, Berge E, Brown MM, Eliasziw M, Sandset PM, Serena J, Montgomery AA (2020)
    Outcome assessment by central adjudicators in randomised stroke trials: Simulation of differential and non-differential misclassification
    Eur. Stroke J., 2396987320910047
  11. Gorkom BL, Holme PA, Joch C, Rogosch T, Feussner A, McKeand W, Roberts J, van Heerde W (2020)
    Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency
    Hematology, 25 (1), 17-25
    DOI 10.1080/16078454.2019.1700329, PubMed 31852380
  12. Grønvold B, Ali MM, Remberger M, Mattsson J, Egeland T, Lundin KU, Myhre AE, Abrahamsen IW, Heldal D, Dybedal I, Tjønnfjord GE, Fløisand Y, Gedde-Dahl T (2020)
    HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation
    Bone Marrow Transplant
    DOI 10.1038/s41409-020-0827-3, PubMed 32054997
  13. Hetland G, Tangen JM, Mahmood F, Mirlashari MR, Nissen-Meyer LSH, Nentwich I, Therkelsen SP, Tjønnfjord GE, Johnson E (2020)
    Antitumor, Anti-Inflammatory and Antiallergic Effects of Agaricus blazei Mushroom Extract and the Related Medicinal Basidiomycetes Mushrooms, Hericium erinaceus and Grifolafrondosa: A Review of Preclinical and Clinical Studies
    Nutrients, 12 (5)
    DOI 10.3390/nu12051339, PubMed 32397163
  14. Iversen PO, Atukunda P, Kort R, Ueland PM, Westerberg AC, Muhoozi GKM (2020)
    No associations between microbiota signalling substances and cognitive, language and motor development among three-year-old rural Ugandan children
    Acta Paediatr
    DOI 10.1111/apa.15330, PubMed 32347570
  15. Iversen PO, Sioud M (2020)
    Harnessing the Antiviral-Type Responses Induced by Immunostimulatory siRNAs for Cancer Immunotherapy
    Methods Mol Biol, 2115, 281-287
    DOI 10.1007/978-1-0716-0290-4_16, PubMed 32006407
  16. Kaiser M, Beksaç M, Gulbrandsen N, Schjesvold F, Hájek R, Moreau P, de Arriba de la Fuente F, Mateos MV, West S, Spencer A, Rajkumar SV, Suryanarayan K, Czorniak M, Li C, Teng Z, Labotka R, Dimopoulos MA (2020)
    Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma
    Ann Hematol (in press)
    DOI 10.1007/s00277-020-04149-5, PubMed 32613281
  17. Kara E, Nielsen NV, Eggertsdottir B, Thiede B, Kanse SM, Løset GÅ (2020)
    Design and Characterization of a New pVII Combinatorial Phage Display Peptide Library for Protease Substrate Mining Using Factor VII Activating Protease (FSAP) as Model
    Chembiochem, 21 (13), 1875-1884
    DOI 10.1002/cbic.201900705, PubMed 32180321
  18. Kempton CL, Makris M, Holme PA (2020)
    Management of comorbidities in haemophilia
    DOI 10.1111/hae.14013, PubMed 32476243
  19. Lenartova A, Johannesen TB, Tjønnfjord GE (2020)
    Chronic lymphocytic leukemia and secondary hematological malignancies: A nation-wide cancer registry study
    Eur J Haematol, 104 (6), 546-553
    DOI 10.1111/ejh.13396, PubMed 32058605
  20. Małecka A, Delabie J, Østlie I, Tierens A, Randen U, Berentsen S, Tjønnfjord GE, Trøen G (2020)
    Cold agglutinin-associated B-cell lymphoproliferative disease shows highly recurrent gains of chromosome 3 and 12 or 18
    Blood Adv, 4 (6), 993-996
    DOI 10.1182/bloodadvances.2020001608, PubMed 32168377
  21. Mpinganzima C, Haaland A, Holm AGV, Thein SL, Tjønnfjord GE, Iversen PO (2020)
    Two Consecutive Episodes of Severe Delayed Hemolytic Transfusion Reaction in a Sickle Cell Disease Patient
    Case Rep Hematol, 2020, 2765012
    DOI 10.1155/2020/2765012, PubMed 32351743
  22. Mwaiswelo RO, Mawala W, Iversen PO, de Montalembert M, Luzzatto L, Makani J (2020)
    Sickle cell disease and malaria: decreased exposure and asplenia can modulate the risk from Plasmodium falciparum
    Malar J, 19 (1), 165
    DOI 10.1186/s12936-020-03212-w, PubMed 32334583
  23. Pope MK, Ghanima W, Atar D (2020)
    Intensification of antithrombotic therapy for chronic atherosclerosis
    Tidsskr Nor Laegeforen, 140 (10)
    DOI 10.4045/tidsskr.20.0066, PubMed 32602309
  24. Qvigstad C, Sørensen LQ, Tait RC, de Moerloose P, Holme PA, ADVANCE Working Group (2020)
    Macroscopic hematuria as a risk factor for hypertension in ageing people with hemophilia and a family history of hypertension
    Medicine (Baltimore), 99 (9), e19339
    DOI 10.1097/MD.0000000000019339, PubMed 32118768
  25. Qvigstad C, Tait RC, de Moerloose P, Holme PA, ADVANCE Working Group (2020)
    Hematuria in aging men with hemophilia: Association with factor prophylaxis
    Res Pract Thromb Haemost, 4 (2), 309-317
    DOI 10.1002/rth2.12298, PubMed 32110762
  26. Schjesvold F (2020)
    Evolution of diagnostic workup and treatment for multiple myeloma 2013 - 2019
    Eur J Haematol (in press)
    DOI 10.1111/ejh.13464, PubMed 32557833
  27. Schjesvold F, Goldschmidt H, Maisnar V, Spicka I, Abildgaard N, Rowlings P, Cain L, Romanus D, Suryanarayan K, Rajkumar V, Odom D, Gnanasakthy A, Dimopoulos M (2020)
    Quality of life is maintained with ixazomib maintenance in post-transplant newly diagnosed multiple myeloma: The TOURMALINE-MM3 trial
    Eur J Haematol, 104 (5), 443-458
    DOI 10.1111/ejh.13379, PubMed 31880006
  28. Schjesvold F, Robak P, Pour L, Aschan J, Sonneveld P (2020)
    OCEAN: a randomized Phase III study of melflufen + dexamethasone to treat relapsed refractory multiple myeloma
    Future Oncol, 16 (11), 631-641
    DOI 10.2217/fon-2020-0024, PubMed 32141766
  29. Schjesvold FH, Richardson PG, Facon T, Alegre A, Spencer A, Jurczyszyn A, Sunami K, Frenzel L, Min CK, Guillonneau S, Lin PL, Le-Guennec S, Campana F, van de Velde H, Bensfia S, Bringhen S (2020)
    Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis
    Haematologica (in press)
    DOI 10.3324/haematol.2020.253450, PubMed 32586908
  30. Spyridonidis A, Labopin M, Savani BN, Niittyvuopio R, Blaise D, Craddock C, Socié G, Platzbecker U, Beelen D, Milpied N, Cornelissen JJ, Ganser A, Huynh A, Griskevicius L, Giebel S, Aljurf M, Brissot E, Malard F, Esteve J, Peric Z, Baron F, Ruggeri A, Schmid C, Gilleece M, Gorin NC et al. (2020)
    Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients
    Bone Marrow Transplant, 55 (6), 1213
    DOI 10.1038/s41409-020-0835-3, PubMed 32144364
  31. Spyridonidis A, Labopin M, Savani BN, Niittyvuopio R, Blaise D, Craddock C, Socié G, Platzbecker U, Beelen D, Milpied N, Cornelissen JJ, Ganser A, Huynh A, Griskevicius L, Giebel S, Aljurf M, Brissot E, Malard F, Esteve J, Peric Z, Baron F, Ruggeri A, Schmid C, Gilleece M, Gorin NC et al. (2020)
    Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients
    Bone Marrow Transplant, 55 (6), 1114-1125
    DOI 10.1038/s41409-020-0803-y, PubMed 31996792
  32. Thorsen L, Haugnes HS, Fosså SD, Brydøy M, Tandstad T, Wisløff T, Gjerset GM, Edvardsen E, Larsen KO, Sandset PM, Henriksson CE, Raastad T, Negaard HFS (2020)
    Thromboembolic events after high-intensity training during cisplatin-based chemotherapy for testicular cancer: Case reports and review of the literature
    Int J Cancer (in press)
    DOI 10.1002/ijc.33151, PubMed 32525564
  33. Tjønnfjord E, Holme PA, Darne B, Khelif A, Waage A, Michel M, Ben Romdhan N, Ghanima W (2020)
    Long-term outcomes of patients treated with rituximab as second-line treatment for adult immune thrombocytopenia - Follow-up of the RITP study
    Br J Haematol
    DOI 10.1111/bjh.16672, PubMed 32342497
  34. Wacoo AP, Atukunda P, Muhoozi G, Braster M, Wagner M, Broek TJVD, Sybesma W, Westerberg AC, Iversen PO, Kort R (2020)
    Aflatoxins: Occurrence, Exposure, and Binding to Lactobacillus Species from the Gut Microbiota of Rural Ugandan Children
    Microorganisms, 8 (3)
    DOI 10.3390/microorganisms8030347, PubMed 32121365
  35. Wang J, Chatzidimitriou E, Wood L, Hasanalieva G, Markelou E, Iversen PO, Seal C, Baranski M, Vigar V, Ernst L, Willson A, Thapa M, Barkla BJ, Leifert C, Rempelos L (2020)
    Effect of wheat species (Triticum aestivum vs T. spelta), farming system (organic vs conventional) and flour type (wholegrain vs white) on composition of wheat flour - Results of a retail survey in the UK and Germany - 2. Antioxidant activity, and phenolic and mineral content
    Food Chem X, 6, 100091
    DOI 10.1016/j.fochx.2020.100091, PubMed 32420543
  36. Wang J, Hasanalieva G, Wood L, Markellou E, Iversen PO, Bernhoft A, Seal C, Baranski M, Vigar V, Ernst L, Willson A, Barkla BJ, Leifert C, Rempelos L (2020)
    Effect of wheat species (Triticum aestivum vs T. spelta), farming system (organic vs conventional) and flour type (wholegrain vs white) on composition of wheat flour; results of a retail survey in the UK and Germany - 1. Mycotoxin content
    Food Chem, 327, 127011
    DOI 10.1016/j.foodchem.2020.127011, PubMed 32438263
  37. Weum Abrahamsen I, Grønvold BC, Inderberg EM, Mensali N, Mattsson J, Gedde-Dahl T (2020)
    Posttransplantation Lymphoproliferative Disease Treated by Retransplantation
    Case Reports Immunol, 2020, 9403123
    DOI 10.1155/2020/9403123, PubMed 32158568
  38. Ziyenda Katenga-Kaunda L, Iversen PO, Holmboe-Ottesen G, Fjeld H, Mdala I, Kamudoni PR (2020)
    Dietary intake and processes of behaviour change in a nutrition education intervention for pregnant women in rural Malawi: a cluster-randomised controlled trial
    Public Health Nutr, 1-10 (in press)
    DOI 10.1017/S1368980020000294, PubMed 32419688

Publications 2019

  1. Andersen E, Chollet ME, Baroni M, Pinotti M, Bernardi F, Skarpen E, Sandset PM, Skretting G (2019)
    The effect of the chemical chaperone 4-phenylbutyrate on secretion and activity of the p.Q160R missense variant of coagulation factor FVII
    Cell Biosci, 9, 69
    DOI 10.1186/s13578-019-0333-8, PubMed 31467667
  2. Andersen MF, Holme PA, Tjønnfjord GE (2019)
    Surgical procedures in patients with severe haemophilia 1997–2014
    Tidsskr Nor Laegeforen, 139 (8)
    DOI 10.4045/tidsskr.18.0592, PubMed 31062561
  3. Andersen MLF, Holme PA, Tjonnfjord GE (2019)
    Surgical intervention in patients with severe bleeding disorder 1997-2014
    Tidsskr. Nor. Laegeforen., 139 (8), 709-712
  4. Attal M, Richardson PG, Rajkumar SV, San-Miguel J, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang JS, Minarik J, Cavo M, Prince HM, Macé S, Corzo KP, Campana F, Le-Guennec S, Dubin F, Anderson KC, ICARIA-MM study group (2019)
    Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
    Lancet, 394 (10214), 2096-2107
    DOI 10.1016/S0140-6736(19)32556-5, PubMed 31735560
  5. Atukunda P, Muhoozi GKM, van den Broek TJ, Kort R, Diep LM, Kaaya AN, Iversen PO, Westerberg AC (2019)
    Child development, growth and microbiota: follow-up of a randomized education trial in Uganda
    J Glob Health, 9 (1), 010431
    DOI 10.7189/jogh-09-010431, PubMed 31131103
  6. Atukunda P, Muhoozi GKM, Westerberg AC, Iversen PO (2019)
    Nutrition, Hygiene and Stimulation Education for Impoverished Mothers in Rural Uganda: Effect on Maternal Depression Symptoms and Their Associations to Child Development Outcomes
    Nutrients, 11 (7)
    DOI 10.3390/nu11071561, PubMed 31373314
  7. Baliakas P, Tesi B, Wartiovaara-Kautto U, Stray-Pedersen AR, Friis LS, Dybedal I, Hovland R, Jahnukainen K, Raaschou-Jensen K, Ljungman P, Rustad CF, Lautrup CK, Kilpivaara O, Kittang AO, Gr Nbæk K, Cammenga J, Hellström-Lindberg E, Andersen MK (2019)
    Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up
    Hemasphere, 3 (6), e321
    DOI 10.1097/HS9.0000000000000321, PubMed 31976490
  8. Beitland S, Wimmer H, Lorentsen T, Jacobsen D, Draegni T, Brunborg C, Kløw NE, Sandset PM, Sunde K (2019)
    Venous thromboembolism in the critically ill: A prospective observational study of occurrence, risk factors and outcome
    Acta Anaesthesiol Scand, 63 (5), 630-638
    DOI 10.1111/aas.13316, PubMed 30623406
  9. Berentsen S, Röth A, Randen U, Jilma B, Tjønnfjord GE (2019)
    Cold agglutinin disease: current challenges and future prospects
    J Blood Med, 10, 93-103
    DOI 10.2147/JBM.S177621, PubMed 31114413
  10. Birgegard G, Samuelsson J, Ahlstrand E, Ejerblad E, Enevold C, Ghanima W, Hasselbalch H, Nielsen CH, Knutsen H, Pedersen OB, Sørensen A, Andreasson B (2019)
    Inflammatory functional iron deficiency common in myelofibrosis, contributes to anaemia and impairs quality of life. From the Nordic MPN study Group
    Eur J Haematol, 102 (3), 235-240
    DOI 10.1111/ejh.13198, PubMed 30472746
  11. Blakstad EW, Korpela K, Lee S, Nakstad B, Moltu SJ, Strømmen K, Rønnestad AE, Brække K, Iversen PO, de Vos WM, Drevon CA (2019)
    Enhanced nutrient supply and intestinal microbiota development in very low birth weight infants
    Pediatr Res, 86 (3), 323-332
    DOI 10.1038/s41390-019-0412-x, PubMed 31086354
  12. Blomkvist AW, Zadig P, Christoffersen S, Kaushal S, Nordengen E, Shanmugarajah I, Ghanima W (2019)
    Home treatment for pulmonary embolism
    Tidsskr Nor Laegeforen, 139 (18)
    DOI 10.4045/tidsskr.19.0115, PubMed 31823570
  13. Chellappa S, Kushekhar K, Munthe LA, Tjønnfjord GE, Aandahl EM, Okkenhaug K, Taskén K (2019)
    The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function
    J Immunol, 202 (5), 1397-1405
    DOI 10.4049/jimmunol.1701703, PubMed 30692213
  14. Chowdary P, Carcao M, Holme PA, Jiménez-Yuste V, Lentz SR, Møss J, Poulsen LH, Shen C, Tosetto A, Wheeler A, Santagostino E (2019)
    Fixed doses of N8-GP prophylaxis maintain moderate-to-mild factor VIII levels in the majority of patients with severe hemophilia A
    Res Pract Thromb Haemost, 3 (3), 542-554
    DOI 10.1002/rth2.12220, PubMed 31294338
  15. Cooper N, Ghanima W (2019)
    Immune Thrombocytopenia
    N Engl J Med, 381 (10), 945-955
    DOI 10.1056/NEJMcp1810479, PubMed 31483965
  16. Cremers EMP, de Witte T, de Wreede L, Eikema DJ, Koster L, van Biezen A, Finke J, Socié G, Beelen D, Maertens J, Nagler A, Kobbe G, Ziagkos D, Itälä-Remes M, Gedde-Dahl T, Sierra J, Niederwieser D, Ljungman P, Beguin Y, Ozkurt ZN, Anagnostopoulos A, Jindra P, Robin M, Kröger N (2019)
    A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation.
    Leuk Lymphoma, 60 (10), 2404-2414
    DOI 10.1080/10428194.2019.1594215, PubMed 30997844
  17. Curry N, Albayrak C, Escobar M, Andre Holme P, Kearney S, Klamroth R, Misgav M, Négrier C, Wheeler A, Santagostino E, Shima M, Landorph A, Tønder SM, Lentz SR (2019)
    Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial)
    Haemophilia, 25 (3), 373-381
    DOI 10.1111/hae.13712, PubMed 30817066
  18. Dahm AEA, Jacobsen EM, Wik HS, Jacobsen AF, Mollnes TE, Kanse SM, Sandset PM (2019)
    Elevated Complement C3 and C4 Levels are Associated with Postnatal Pregnancy-Related Venous Thrombosis
    Thromb Haemost, 119 (9), 1481-1488
    DOI 10.1055/s-0039-1692426, PubMed 31254974
  19. Eilertsen AL, Dahm AEA, Høibraaten E, Lofthus CM, Mowinckel MC, Sandset PM (2019)
    Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment
    Blood Coagul Fibrinolysis, 30 (1), 17-23
    DOI 10.1097/MBC.0000000000000784, PubMed 30507711
  20. El-Serafi I, Loy O, Zhao Y, Oerther S, Mattsson J (2019)
    Pre-formulation investigations for establishing a protocol for treosulfan handling and activation
    Pharm Dev Technol, 24 (5), 639-648
    DOI 10.1080/10837450.2018.1551903, PubMed 30474459
  21. Engeseth M, Enden T, Andersen MH, Sandset PM, Wik HS (2019)
    Does the Villalta scale capture the essence of postthrombotic syndrome? A qualitative study of patient experience and expert opinion
    J Thromb Haemost, 17 (10), 1707-1714
    DOI 10.1111/jth.14557, PubMed 31265193
  22. Engeseth M, Enden T, Sandset PM, Wik HS (2019)
    Limitations of the Villalta scale in diagnosing post-thrombotic syndrome
    Thromb Res, 184, 62-66
    DOI 10.1016/j.thromres.2019.10.018, PubMed 31707153
  23. Gamage TH, Lengle E, Gunnes G, Pullisaar H, Holmgren A, Reseland JE, Merckoll E, Corti S, Mizobuchi M, Morales RJ, Tsiokas L, Tjønnfjord GE, Lacruz RS, Lyngstadaas SP, Misceo D, Frengen E (2019)
    STIM1 R304W in mice causes subgingival hair growth and an increased fraction of trabecular bone
    Cell Calcium, 85, 102110
    DOI 10.1016/j.ceca.2019.102110, PubMed 31785581
  24. Garabet L, Ghanima W, Hellum M, Sandset PM, Bussel JB, Tran H, Henriksson CE (2019)
    Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists
    Platelets, 31 (3), 322-328
    DOI 10.1080/09537104.2019.1639655, PubMed 31280643
  25. Garabet L, Ghanima W, Rangberg A, Teruel-Montoya R, Martinez C, Lozano ML, Nystrand CF, Bussel JB, Sandset PM, Jonassen CM (2019)
    Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists
    Platelets, 31 (2), 198-205
    DOI 10.1080/09537104.2019.1585527, PubMed 30885035
  26. Garabet L, Henriksson CE, Lozano ML, Ghanima W, Bussel J, Brodin E, Fernández-Pérez MP, Martínez C, González-Conejero R, Mowinckel MC, Sandset PM (2019)
    Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists
    Thromb Res, 185, 119-124
    DOI 10.1016/j.thromres.2019.11.031, PubMed 31805421
  27. Gilleece MH, Labopin M, Savani BN, Yakoub-Agha I, Socié G, Gedde-Dahl T, Blaise D, Byrne JL, Craddock C, Cornelissen JJ, Arcese W, Forcade E, Crawley C, Polge E, Mohty M, Nagler A (2019)
    Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT
    Leukemia, 34 (1), 87-99
    DOI 10.1038/s41375-019-0527-4, PubMed 31363160
  28. Godolphin PJ, Bath PM, Algra A, Berge E, Brown MM, Chalmers J, Duley L, Eliasziw M, Gregson J, Greving JP, Hankey GJ, Hosomi N, Johnston SC, Patsko E, Ranta A, Sandset PM, Serena J, Weimar C, Montgomery AA, Knipp SC, Giugliano RP, Bonati LH, Nagai Y, Matsumoto M, Barnett HJM et al. (2019)
    Outcome Assessment by Central Adjudicators Versus Site Investigators in Stroke Trials: A Systematic Review and Meta-Analysis
    Stroke, 50 (8), 2187-2196
  29. Gregersen I, Høibraaten E, Holven KB, Løvdahl L, Ueland T, Mowinckel MC, Dahl TB, Aukrust P, Halvorsen B, Sandset PM (2019)
    Effect of hormone replacement therapy on atherogenic lipid profile in postmenopausal women
    Thromb Res, 184, 1-7
    DOI 10.1016/j.thromres.2019.10.005, PubMed 31677448
  30. Halaburda K, Labopin M, Mailhol A, Socié G, Craddock C, Aljurf M, Beelen D, Cornelissen JJ, Bourhis JH, Labussière-Wallet H, Blaise D, Gedde-Dahl T, Gilleece M, Yakoub-Agha I, Mufti G, Esteve J, Mohty M, Nagler A (2019)
    Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Haematologica, 105 (6), 1723-1730
    DOI 10.3324/haematol.2019.222810, PubMed 31439677
  31. Hillengass J, Usmani S, Rajkumar SV, Durie BGM, Mateos MV, Lonial S, Joao C, Anderson KC, García-Sanz R, Riva E, Du J, van de Donk N, Berdeja JG, Terpos E, Zamagni E, Kyle RA, San Miguel J, Goldschmidt H, Giralt S, Kumar S, Raje N, Ludwig H, Ocio E, Schots R, Einsele H et al. (2019)
    International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
    Lancet Oncol, 20 (6), e302-e312
    DOI 10.1016/S1470-2045(19)30309-2, PubMed 31162104
  32. Johansen S, Helgeland L, Vetti N, Dybedal I, Reikvam H (2019)
    A man in his 70s with back pain, abdominal pain and rash
    Tidsskr. Nor. Laegeforen., 139 (15), 1477-1481
  33. Johansen S, Helgeland L, Vetti N, Dybedal I, Reikvam H (2019)
    A man in his seventies with back pain, gastrointestinal symptoms and rash
    Tidsskr Nor Laegeforen, 139 (15)
    DOI 10.4045/tidsskr.18.0819, PubMed 31642632
  34. Jønsson V, Awan H, Jones ND, Johannesen TB, Steig BÁ, Andosdottir G, Tjønnfjord GE (2019)
    Inheritance of Susceptibility to Malignant Blood Disorders
    Sci Rep, 9 (1), 2444
    DOI 10.1038/s41598-019-38879-y, PubMed 30792429
  35. Kristoffersen AH, Jacobsen EM, Varsi K, Henriksson CE (2019)
    Analysis of lupus anticoagulant during ongoing anti coagulation treatment
    Tidsskr. Nor. Laegeforen., 139 (15), 1491
  36. Lalezari S, Reding MT, Pabinger I, Holme PA, Negrier C, Chalasani P, Shin HJ, Wang M, Tseneklidou-Stoeter D, Maas Enriquez M (2019)
    BAY 94-9027 prophylaxis is efficacious and well tolerated for up to >5 years with extended dosing intervals: PROTECT VIII extension interim results
    Haemophilia, 25 (6), 1011-1019
    DOI 10.1111/hae.13853, PubMed 31621991
  37. Lenartova A, Randen U, Johannesen TB, Tjønnfjord GE (2019)
    Richter syndrome epidemiology in a large population based chronic lymphocytic leukemia cohort from Norway
    Cancer Epidemiol, 60, 128-133
    DOI 10.1016/j.canep.2019.04.002, PubMed 30986631
  38. Lien K, Johansen B, Veierød MB, Haslestad AS, Bøhn SK, Melsom MN, Kardel KR, Iversen PO (2019)
    Abnormal blood lactate accumulation during repeated exercise testing in myalgic encephalomyelitis/chronic fatigue syndrome
    Physiol Rep, 7 (11), e14138
    DOI 10.14814/phy2.14138, PubMed 31161646
  39. Ljungkvist M, Strandberg K, Berntorp E, Chaireti R, Holme PA, Larsen OH, Lassila R, Jouppila A, Szanto T, Zetterberg E (2019)
    Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram: A Nordic study
    Haemophilia, 25 (2), 334-342
    DOI 10.1111/hae.13640, PubMed 30715788
  40. Luhr M, Torgersen ML, Szalai P, Hashim A, Brech A, Staerk J, Engedal N (2019)
    The kinase PERK and the transcription factor ATF4 play distinct and essential roles in autophagy resulting from tunicamycin-induced ER stress
    J Biol Chem, 294 (20), 8197-8217
    DOI 10.1074/jbc.RA118.002829, PubMed 30926605
  41. Mateos MV, Blacklock H, Schjesvold F, Oriol A, Simpson D, George A, Goldschmidt H, Larocca A, Chanan-Khan A, Sherbenou D, Avivi I, Benyamini N, Iida S, Matsumoto M, Suzuki K, Ribrag V, Usmani SZ, Jagannath S, Ocio EM, Rodriguez-Otero P, San Miguel J, Kher U, Farooqui M, Liao J, Marinello P et al. (2019)
    Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
    Lancet Haematol, 6 (9), e459-e469
    DOI 10.1016/S2352-3026(19)30110-3, PubMed 31327687
  42. Nielsen NV, Roedel E, Manna D, Etscheid M, Morth JP, Kanse SM (2019)
    Characterization of the enzymatic activity of the serine protease domain of Factor VII activating protease (FSAP)
    Sci Rep, 9 (1), 18990
    DOI 10.1038/s41598-019-55531-x, PubMed 31831842
  43. Passweg JR, Labopin M, Christopeit M, Cornelissen J, Pabst T, Socié G, Russel N, Yakoub-Agha I, Blaise D, Gedde-Dahl T, Labussière-Wallet H, Malladi R, Forcade E, Maury S, Polge E, Lanza F, Gorin NC, Mohty M, Nagler A (2019)
    Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
    Biol Blood Marrow Transplant, 26 (4), 659-664
    DOI 10.1016/j.bbmt.2019.11.021, PubMed 31759159
  44. Richardson PG, Oriol A, Beksac M, Liberati AM, Galli M, Schjesvold F, Lindsay J, Weisel K, White D, Facon T, San Miguel J, Sunami K, O'Gorman P, Sonneveld P, Robak P, Semochkin S, Schey S, Yu X, Doerr T, Bensmaine A, Biyukov T, Peluso T, Zaki M, Anderson K, Dimopoulos M et al. (2019)
    Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
    Lancet Oncol, 20 (6), 781-794
    DOI 10.1016/S1470-2045(19)30152-4, PubMed 31097405
  45. Rukundo PM, Rukooko B, Andreassen BA, Iversen PO (2019)
    Housing, water and sanitation implications on food insecurity and diet diversity in landslide affected communities: A cross-sectional survey of two districts in Uganda
    Clin Nutr ESPEN, 33, 47-56
    DOI 10.1016/j.clnesp.2019.07.010, PubMed 31451275
  46. Rut W, Nielsen NV, Czarna J, Poreba M, Kanse SM, Drag M (2019)
    Fluorescent activity-based probe for the selective detection of Factor VII activating protease (FSAP) in human plasma
    Thromb Res, 182, 124-132
    DOI 10.1016/j.thromres.2019.08.016, PubMed 31479940
  47. Sandset PM (2019)
    Inflammation, infection and coagulation disorders
    Hemasphere, 3 2, 88
  48. Sandset PM, Dahm AEA (2019)
    Is venous thromboembolism a problem in patients with cancer in palliative care?
    Lancet Haematol, 6 (2), e61-e62
    DOI 10.1016/S2352-3026(18)30218-7, PubMed 30709433
  49. Savikj M, Kostovski E, Lundell LS, Iversen PO, Massart J, Widegren U (2019)
    Altered oxidative stress and antioxidant defence in skeletal muscle during the first year following spinal cord injury
    Physiol Rep, 7 (16), e14218
    DOI 10.14814/phy2.14218, PubMed 31456346
  50. Schultz NH, Holme PA, Henriksson CE, Mowinckel MC, Sandset PM, Bratseth V, Jacobsen EM (2019)
    The influence of rivaroxaban on markers of fibrinolysis and endothelial cell activation/injury in patients with venous thrombosis
    Thromb Res, 177, 154-156
    DOI 10.1016/j.thromres.2019.03.010, PubMed 30903875
  51. Sioud M, Pettersen S, Ailte I, Fløisand Y (2019)
    Targeted Killing of Monocytes/Macrophages and Myeloid Leukemia Cells with Pro-Apoptotic Peptides
    Cancers (Basel), 11 (8)
    DOI 10.3390/cancers11081088, PubMed 31370273
  52. Skretting G, Andersen E, Myklebust CF, Sandset PM, Tinholt M, Iversen N, Stavik B (2019)
    Transcription factor FOXP3: A repressor of the TFPI gene?
    J Cell Biochem, 120 (8), 12924-12936
    DOI 10.1002/jcb.28563, PubMed 30861202
  53. Skånland SS, Cremaschi A, Bendiksen H, Hermansen JU, Thimiri Govinda Raj DB, Munthe LA, Tjønnfjord GE, Taskén K (2019)
    An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL
    Leukemia, 34 (2), 478-487
    DOI 10.1038/s41375-019-0569-7, PubMed 31471562
  54. Skaarud KJ, Veierød MB, Lergenmuller S, Bye A, Iversen PO, Tjønnfjord GE (2019)
    Body weight, body composition and survival after 1 year: follow-up of a nutritional intervention trial in allo-HSCT recipients
    Bone Marrow Transplant, 54 (12), 2102-2109
    DOI 10.1038/s41409-019-0638-6, PubMed 31455897
  55. Søraas A, Matsuyama M, de Lima M, Wald D, Buechner J, Gedde-Dahl T, Søraas CL, Chen B, Ferrucci L, Dahl JA, Horvath S, Matsuyama S (2019)
    Epigenetic age is a cell-intrinsic property in transplanted human hematopoietic cells
    Aging Cell, 18 (2), e12897
    DOI 10.1111/acel.12897, PubMed 30712319
  56. Saad A, Lamb L, Wang T, Hemmer MT, Spellman S, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Agrawal V, Aljurf M, Beitinjaneh AM, Bhatt VR, Buchbinder D, Byrne M, Cahn JY, Cairo M, Castillo P, Chhabra S, Diaz MA, Farhan S, Floisand Y, Frangoul HA, Gadalla SM, Gajewski J et al. (2019)
    Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation
    Biol Blood Marrow Transplant, 25 (9), 1875-1883
    DOI 10.1016/j.bbmt.2019.05.007, PubMed 31085303
  57. Thomas AM, Gerogianni A, McAdam MB, Fløisand Y, Lau C, Espevik T, Nilsson PH, Mollnes TE, Barratt-Due A (2019)
    Complement Component C5 and TLR Molecule CD14 Mediate Heme-Induced Thromboinflammation in Human Blood
    J Immunol, 203 (6), 1571-1578
    DOI 10.4049/jimmunol.1900047, PubMed 31413105
  58. Torkildsen S, Gorunova L, Heim S, Tjønnfjord GE, Spetalen S, Risberg B, Tran HTT, Panagopoulos I (2019)
    Molecular Genetic Characterization of Acute Myeloid Leukemia With Trisomy 4 as the Sole Chromosome Abnormality
    Cancer Genomics Proteomics, 16 (3), 175-178
    DOI 10.21873/cgp.20123, PubMed 31018948
  59. Usmani SZ, Schjesvold F, Oriol A, Karlin L, Cavo M, Rifkin RM, Yimer HA, LeBlanc R, Takezako N, McCroskey RD, Lim ABM, Suzuki K, Kosugi H, Grigoriadis G, Avivi I, Facon T, Jagannath S, Lonial S, Ghori RU, Farooqui MZH, Marinello P, San-Miguel J, KEYNOTE-185 Investigators (2019)
    Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
    Lancet Haematol, 6 (9), e448-e458
    DOI 10.1016/S2352-3026(19)30109-7, PubMed 31327689
  60. Wiktor-Jedrzejczak W, Drozd-Sokolowska J, Eikema DJ, Hoek J, Potter M, Wulf G, Sellner L, Ljungman P, Chevallier P, Volin L, Koc Y, Martin S, Bunjes D, Rovira M, Itälä-Remes M, Foá R, Deconinck E, Gedde-Dahl T, Cornelissen J, Collin M, Brecht A, Patel A, de Groot M, Reményi P, Nagler A et al. (2019)
    EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)
    Bone Marrow Transplant, 54 (9), 1391-1398
    DOI 10.1038/s41409-019-0448-x, PubMed 30664723
  61. Zhang B, Ayuda-Durán P, Piechaczyk L, Fløisand Y, Safont MM, Karlsen IT, Fandalyuk Z, Tadele D, van Mierlo P, Rowe AD, Robertson JM, Gjertsen BT, McCormack E, Enserink JM (2019)
    GRP94 rewires and buffers the FLT3-ITD signaling network and promotes survival of acute myeloid leukemic stem cells
    Haematologica, 104 (5), e229
    DOI 10.3324/haematol.2019.220533, PubMed 31040234

Publications 2018

  1. Andersen E, Chollet ME, Myklebust CF, Pinotti M, Bernardi F, Chuansumrit A, Skarpen E, Sandset PM, Skretting G (2018)
    Activation of Endoplasmic Reticulum Stress and Unfolded Protein Response in Congenital Factor VII Deficiency
    Thromb Haemost, 118 (4), 664-675
    DOI 10.1055/s-0038-1637690, PubMed 29618153
  2. Bhamra JS, Iversen PO, Titze TK, Tjønnfjord GE, Akkök ÇA (2018)
    A Case of Posttransfusion Purpura with Severe Refractory Thrombocytopenia but No Cutaneous Manifestations
    Case Rep Hematol, 2018, 8187659
    DOI 10.1155/2018/8187659, PubMed 30510818
  3. Bruserud Ø, Melve GK, Gedde-Dahl T, Tvedt THA (2018)
    Immunological heterogeneity of healthy peripheral blood stem cell donors - preharvesting donor characteristics, additional heterogeneity induced by granulocyte colony-stimulating factor and possible importance for outcome after allotransplantation
    Expert Rev Hematol, 11 (10), 757-759
    DOI 10.1080/17474086.2018.1511420, PubMed 30126308
  4. Chortatos A, Iversen PO, Haugen M, Eberhard-Gran M, Bjelland EK, Veierød MB (2018)
    Nausea and vomiting in pregnancy - association with pelvic girdle pain during pregnancy and 4-6 months post-partum
    BMC Pregnancy Childbirth, 18 (1), 137
    DOI 10.1186/s12884-018-1764-7, PubMed 29739355
  5. Danylesko I, Bukauskas A, Paulson M, Peceliunas V, Gedde-Dahl D Y T, Shimoni A, Shouval R, Griskevicius L, Floisand Y, Nagler A (2018)
    Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease
    Bone Marrow Transplant, 54 (7), 987-993
    DOI 10.1038/s41409-018-0364-5, PubMed 30356163
  6. Diep PP, Melberg HO, Brinch L, Buechner J, Fløisand Y, Gedde-Dahl T, Loge JH, Tjønnfjord GE, Ruud E (2018)
    Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway
    Bone Marrow Transplant, 53 (5), 657-660
    DOI 10.1038/s41409-018-0091-y, PubMed 29358600
  7. Dimopoulos MA, Gay F, Schjesvold F, Beksac M, Hajek R, Weisel KC, Goldschmidt H, Maisnar V, Moreau P, Min CK, Pluta A, Chng WJ, Kaiser M, Zweegman S, Mateos MV, Spencer A, Iida S, Morgan G, Suryanarayan K, Teng Z, Skacel T, Palumbo A, Dash AB, Gupta N, Labotka R et al. (2018)
    Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
    Lancet, 393 (10168), 253-264
    DOI 10.1016/S0140-6736(18)33003-4, PubMed 30545780
  8. Enden T, Bernklev T, Jelsness-Jorgensen LP, Amdal CD (2018)
    Patients know their own health best
    Tidsskr. Nor. Laegeforen., 138 (8), 716-718
  9. Etscheid M, Subramaniam S, Lochnit G, Zabczyk M, Undas A, Lang IM, Hanschmann KM, Kanse SM (2018)
    Altered structure and function of fibrinogen after cleavage by Factor VII Activating Protease (FSAP)
    Biochim Biophys Acta Mol Basis Dis, 1864 (10), 3397-3406
    DOI 10.1016/j.bbadis.2018.07.030, PubMed 30076961
  10. Fevang B, Fagerli UM, Sorte H, Aarset H, Hov H, Langmyr M, Keil TM, Bjørge E, Aukrust P, Stray-Pedersen A, Gedde-Dahl T (2018)
    Runaway Train: A Leaky Radiosensitive SCID with Skin Lesions and Multiple Lymphomas
    Case Reports Immunol, 2018, 2053716
    DOI 10.1155/2018/2053716, PubMed 29888014
  11. Fløisand Y, Lazarevic VL, Maertens J, Mattsson J, Shah NN, Zachée P, Taylor A, Akbari M, Quadri S, Parfionovas A, Chen YB (2018)
    Safety and Effectiveness of Vedolizumab in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease: A Retrospective Record Review
    Biol Blood Marrow Transplant, 25 (4), 720-727
    DOI 10.1016/j.bbmt.2018.11.013, PubMed 30468919
  12. Fronas SG, Wik HS, Dahm AEA, Jørgensen CT, Gleditsch J, Raouf N, Klok FA, Ghanima W (2018)
    Safety of D-dimer testing as a stand-alone test for the exclusion of deep vein thrombosis as compared with other strategies
    J Thromb Haemost, 16 (12), 2471-2481
    DOI 10.1111/jth.14314, PubMed 30303610
  13. Gamage TH, Gunnes G, Lee RH, Louch WE, Holmgren A, Bruton JD, Lengle E, Kolstad TRS, Revold T, Amundsen SS, Dalen KT, Holme PA, Tjønnfjord GE, Christensen G, Westerblad H, Klungland A, Bergmeier W, Misceo D, Frengen E (2018)
    STIM1 R304W causes muscle degeneration and impaired platelet activation in mice
    Cell Calcium, 76, 87-100
    DOI 10.1016/j.ceca.2018.10.001, PubMed 30390422
  14. Gravensteen IK, Jacobsen EM, Sandset PM, Helgadottir LB, Rådestad I, Sandvik L, Ekeberg Ø (2018)
    Anxiety, depression and relationship satisfaction in the pregnancy following stillbirth and after the birth of a live-born baby: a prospective study
    BMC Pregnancy Childbirth, 18 (1), 41
    DOI 10.1186/s12884-018-1666-8, PubMed 29361916
  15. Habberstad AH, Tran HTT, Randen U, Spetalen S, Dybedal I, Tjønnfjord GE, Dahm AEA (2018)
    Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report
    J Med Case Rep, 12 (1), 105
    DOI 10.1186/s13256-018-1663-6, PubMed 29685167
  16. Hermansen JU, Tjønnfjord GE, Munthe LA, Taskén K, Skånland SS (2018)
    Cryopreservation of primary B cells minimally influences their signaling responses
    Sci Rep, 8 (1), 17651
    DOI 10.1038/s41598-018-36121-9, PubMed 30518828
  17. Holme PA, Tjønnfjord GE (2018)
    Continuous infusion of simoctocog alfa in haemophilia A patients undergoing surgeries
    Haemophilia, 25 (1), 54-59
    DOI 10.1111/hae.13625, PubMed 30394617
  18. Hope S, Nordstrom M, Retterstol K, Iversen PO, Kolset SO (2018)
    The right to a health promoting diet for people with intellectual disabilities
    Tidsskr. Nor. Laegeforen., 138 (2), 122-123
  19. Kolset SO, Nordstrøm M, Hope S, Retterstøl K, Iversen PO (2018)
    Securing rights and nutritional health for persons with intellectual disabilities - a pressing challenge
    Food Nutr Res, 62
    DOI 10.29219/fnr.v62.1268, PubMed 29899685
  20. Korpela K, Blakstad EW, Moltu SJ, Strømmen K, Nakstad B, Rønnestad AE, Brække K, Iversen PO, Drevon CA, de Vos W (2018)
    Intestinal microbiota development and gestational age in preterm neonates
    Sci Rep, 8 (1), 2453
    DOI 10.1038/s41598-018-20827-x, PubMed 29410448
  21. Kostovski E, Frigato E, Savikj M, Dahm A, Sandset PM, Mowinckel MC, Skretting G, Østerud B, Bertolucci C, Iversen PO (2018)
    Normalization of disrupted clock gene expression in males with tetraplegia: a crossover randomized placebo-controlled trial of melatonin supplementation
    Spinal Cord, 56 (11), 1076-1083
    DOI 10.1038/s41393-018-0176-x, PubMed 29985456
  22. Kverneland M, Molteberg E, Iversen PO, Veierød MB, Taubøll E, Selmer KK, Nakken KO (2018)
    Effect of modified Atkins diet in adults with drug-resistant focal epilepsy: A randomized clinical trial
    Epilepsia, 59 (8), 1567-1576
    DOI 10.1111/epi.14457, PubMed 29901816
  23. Lindgren M, Samuelsson J, Nilsson L, Knutsen H, Ghanima W, Westin J, Johansson PL, Andréasson B (2018)
    Genetic variation in IL28B (IFNL3) and response to interferon-alpha treatment in myeloproliferative neoplasms
    Eur J Haematol, 100 (5), 419-425
    DOI 10.1111/ejh.13034, PubMed 29369421
  24. Lorentino F, Labopin M, Bernardi M, Ciceri F, Socié G, Cornelissen JJ, Esteve J, Ruggeri A, Volin L, Yacoub-Agha I, Craddock C, Passweg J, Blaise D, Gedde-Dahl T, Poiani M, Fegueux N, Mohty M, Nagler A, Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2018)
    Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission
    Am J Hematol, 93 (10), 1236-1244
    DOI 10.1002/ajh.25231, PubMed 30058714
  25. Lundell LS, Savikj M, Kostovski E, Iversen PO, Zierath JR, Krook A, Chibalin AV, Widegren U (2018)
    Protein translation, proteolysis and autophagy in human skeletal muscle atrophy after spinal cord injury
    Acta Physiol (Oxf), 223 (3), e13051
    DOI 10.1111/apha.13051, PubMed 29423932
  26. McLornan DP, Szydlo R, Robin M, van Biezen A, Koster L, Blok HJP, Van Lint MT, Finke J, Vitek A, Carlson K, Griskevicius L, Holler E, Itälä-Remes M, Schaap M, Socié G, Bay JO, Beguin Y, Bruno B, Cornelissen JJ, Gedde-Dahl T, Ljungman P, Rubio MT, Yakoub-Agha I, Klyuchnikov E, Olavarria E et al. (2018)
    Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT
    Br J Haematol, 182 (3), 418-422
    DOI 10.1111/bjh.15407, PubMed 29808926
  27. Muhoozi GKM, Atukunda P, Skaare AB, Willumsen T, Diep LM, Westerberg AC, Iversen PO (2018)
    Effects of nutrition and hygiene education on oral health and growth among toddlers in rural Uganda: follow-up of a cluster-randomised controlled trial
    Trop Med Int Health, 23 (4), 391-404
    DOI 10.1111/tmi.13036, PubMed 29381827
  28. Myhrvold IK, Cremaschi A, Hermansen JU, Tjønnfjord GE, Munthe LA, Taskén K, Skånland SS (2018)
    Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia
    Oncotarget, 9 (10), 9273-9284
    DOI 10.18632/oncotarget.23949, PubMed 29507689
  29. Nahalomo A, Iversen PO, Rukundo PM, Kaaya A, Kikafunda J, Eide WB, Marais M, Wamala E, Kabahenda M (2018)
    Realization of the right to adequate food and the nutritional status of land evictees: a case for mothers/caregivers and their children in rural Central Uganda
    BMC Int Health Hum Rights, 18 (1), 21
    DOI 10.1186/s12914-018-0162-6, PubMed 29793472
  30. Navarro-Fernández J, Eugenia de la Morena-Barrio M, Martínez-Alonso E, Dybedal I, Toderici M, Bohdan N, Miñano A, Heimdal K, Abildgaard U, Martínez-Menárguez JÁ, Corral J, Vicente V (2018)
    Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family
    Oncotarget, 9 (69), 33202-33214
    DOI 10.18632/oncotarget.26059, PubMed 30237862
  31. Nesvold MB, Jensen JL, Hove LH, Singh PB, Young A, Palm Ø, Andersen LF, Carlsen MH, Iversen PO (2018)
    Dietary Intake, Body Composition, and Oral Health Parameters among Female Patients with Primary Sjögren's Syndrome
    Nutrients, 10 (7)
    DOI 10.3390/nu10070866, PubMed 29973575
  32. Ngari MM, Iversen PO, Thitiri J, Mwalekwa L, Timbwa M, Fegan GW, Berkley JA (2018)
    Linear growth following complicated severe malnutrition: 1-year follow-up cohort of Kenyan children
    Arch Dis Child, 104 (3), 229-235
    DOI 10.1136/archdischild-2018-315641, PubMed 30266874
  33. Ngari MM, Mwalekwa L, Timbwa M, Hamid F, Ali R, Iversen PO, Fegan GW, Berkley JA (2018)
    Changes in susceptibility to life-threatening infections after treatment for complicated severe malnutrition in Kenya
    Am J Clin Nutr, 107 (4), 626-634
    DOI 10.1093/ajcn/nqy007, PubMed 29635501
  34. Olsson M, Stanne TM, Pedersen A, Lorentzen E, Kara E, Martinez-Palacian A, Rønnow Sand NP, Jacobsen AF, Sandset PM, Sidelmann JJ, Engström G, Melander O, Kanse SM, Jern C (2018)
    Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity
    J Thromb Haemost, 16 (10), 2024-2034
    DOI 10.1111/jth.14258, PubMed 30070759
  35. Panagopoulos I, Gorunova L, Jacobsen EM, Andersen K, Micci F, Heim S (2018)
    RUNX1-PDCD6 fusion resulting from a novel t(5;21)(p15;q22) chromosome translocation in myelodysplastic syndrome secondary to chronic lymphocytic leukemia
    PLoS One, 13 (4), e0196181
    DOI 10.1371/journal.pone.0196181, PubMed 29672642
  36. Pathak M, Diep PP, Lai X, Brinch L, Ruud E, Drolsum L (2018)
    Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation
    Bone Marrow Transplant, 53 (7), 863-872
    DOI 10.1038/s41409-018-0090-z, PubMed 29382955
  37. Qvigstad C, Tait RC, Rauchensteiner S, Berntorp E, de Moerloose P, Schutgens RE, Holme PA, ADVANCE Working Group (2018)
    The elevated prevalence of risk factors for chronic liver disease among ageing people with hemophilia and implications for treatment
    Medicine (Baltimore), 97 (39), e12551
    DOI 10.1097/MD.0000000000012551, PubMed 30278553
  38. Reikvam H, Skavland J, Gullaksen SE, Hovland R, Gedde-Dahl T, Bruserud Ø, Gjertsen BT (2018)
    Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation
    Case Rep Hematol, 2018, 2045985
    DOI 10.1155/2018/2045985, PubMed 30345125
  39. Rogne M, Svaerd O, Madsen-Østerbye J, Hashim A, Tjønnfjord GE, Staerk J (2018)
    Cytokinesis arrest and multiple centrosomes in B cell chronic lymphocytic leukaemia
    J Cell Mol Med, 22 (5), 2846-2855
    DOI 10.1111/jcmm.13579, PubMed 29516674
  40. Sacco S, Merki-Feld GS, Ægidius KL, Bitzer J, Canonico M, Gantenbein AR, Kurth T, Lampl C, Lidegaard Ø, Anne MacGregor E, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Paemeleire K, Sandset PM, Terwindt GM, Vetvik KG, Martelletti P, European Headache Federation (EHF), the European Society of Contraception and Reproductive Health (ESCRH) (2018)
    Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)
    J Headache Pain, 19 (1), 76
    DOI 10.1186/s10194-018-0896-5, PubMed 30171365
  41. Sacco S, Merki-Feld GS, Ægidius KL, Bitzer J, Canonico M, Kurth T, Lampl C, Lidegaard Ø, Anne MacGregor E, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Sandset PM, Martelletti P, European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC) (2018)
    Correction to: Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
    J Headache Pain, 19 (1), 81
    DOI 10.1186/s10194-018-0912-9, PubMed 30203397
  42. Savikj M, Ruby MA, Kostovski E, Iversen PO, Zierath JR, Krook A, Widegren U (2018)
    Retained differentiation capacity of human skeletal muscle satellite cells from spinal cord-injured individuals
    Physiol Rep, 6 (12), e13739
    DOI 10.14814/phy2.13739, PubMed 29906337
  43. Schultz NH, Holme PA, Bjørnsen S, Henriksson CE, Sandset PM, Jacobsen EM (2018)
    The impact of rivaroxaban on primary hemostasis in patients with venous thrombosis
    Platelets, 31 (1), 43-47
    DOI 10.1080/09537104.2018.1557618, PubMed 30569801
  44. Schultz NH, Lundblad R, Holme PA (2018)
    Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series
    J Med Case Rep, 12 (1), 138
    DOI 10.1186/s13256-018-1660-9, PubMed 29764497
  45. Schwab C, Gabrysch A, Olbrich P, Patiño V, Warnatz K, Wolff D, Hoshino A, Kobayashi M, Imai K, Takagi M, Dybedal I, Haddock JA, Sansom DM, Lucena JM, Seidl M, Schmitt-Graeff A, Reiser V, Emmerich F, Frede N, Bulashevska A, Salzer U, Schubert D, Hayakawa S, Okada S, Kanariou M et al. (2018)
    Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects
    J Allergy Clin Immunol, 142 (6), 1932-1946
    DOI 10.1016/j.jaci.2018.02.055, PubMed 29729943
  46. Shapiro AD, Nakar C, Parker JM, Albert GR, Moran JE, Thibaudeau K, Thukral N, Hardesty BM, Laurin P, Sandset PM (2018)
    Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency
    Blood, 131 (12), 1301-1310
    DOI 10.1182/blood-2017-09-806729, PubMed 29321155
  47. Sioud M, Westby P, Vasovic V, Fløisand Y, Peng Q (2018)
    Development of a new high-affinity human antibody with antitumor activity against solid and blood malignancies
    FASEB J, 32 (9), 5063-5077
    DOI 10.1096/fj.201701544R, PubMed 29913558
  48. Skaarud KJ, Hjermstad MJ, Bye A, Veierød MB, Gudmundstuen AM, Lundin KEA, Distante S, Brinch L, Tjønnfjord GE, Iversen PO (2018)
    Effects of individualized nutrition after allogeneic hematopoietic stem cell transplantation following myeloablative conditioning; a randomized controlled trial
    Clin Nutr ESPEN, 28, 59-66
    DOI 10.1016/j.clnesp.2018.08.002, PubMed 30390894
  49. Subramaniam S, Kanse SM, Kothari H, Reinhardt C, Fletcher C (2018)
    Post-transcriptional, post-translational and pharmacological regulation of tissue factor pathway inhibitor
    Blood Coagul Fibrinolysis, 29 (8), 668-682
    DOI 10.1097/MBC.0000000000000775, PubMed 30439766
  50. Tangen JM, Tjønnfjord GE, Gulbrandsen N, Gedde-Dahl T, Stormorken E, Anderson K, Vo CD, Schjesvold FH, For Oslo Myeloma Center (2018)
    Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001-2010: a retrospective, population based analysis
    BMC Cancer, 18 (1), 801
    DOI 10.1186/s12885-018-4722-x, PubMed 30089450
  51. Tavoly M, Wik HS, Sirnes PA, Jelsness-Jørgensen LP, Ghanima JP, Klok FA, Sandset PM, Ghanima W (2018)
    The impact of post-pulmonary embolism syndrome and its possible determinants
    Thromb Res, 171, 84-91
    DOI 10.1016/j.thromres.2018.09.048, PubMed 30267974
  52. Tinholt M, Garred Ø, Borgen E, Beraki E, Schlichting E, Kristensen V, Sahlberg KK, Iversen N (2018)
    Subtype-specific clinical and prognostic relevance of tumor-expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study
    J Thromb Haemost, 16 (7), 1347-1356
    DOI 10.1111/jth.14151, PubMed 29766637
  53. Tulstrup M, Grosjean M, Nielsen SN, Grell K, Wolthers BO, Wegener PS, Jonsson OG, Lund B, Harila-Saari A, Abrahamsson J, Vaitkeviciene G, Pruunsild K, Toft N, Holm M, Hulegårdh E, Liestøl S, Griskevicius L, Punab M, Wang J, Carroll WL, Zhang Z, Dalgaard MD, Gupta R, Nersting J, Schmiegelow K (2018)
    NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia
    Leukemia, 32 (12), 2527-2535
    DOI 10.1038/s41375-018-0245-3, PubMed 30201983
  54. Utne KK, Dahm A, Wik HS, Jelsness-Jørgensen LP, Sandset PM, Ghanima W (2018)
    Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome
    Thromb Res, 163, 6-11
    DOI 10.1016/j.thromres.2018.01.013, PubMed 29324334
  55. Zhang B, Durán PA, Piechaczyk L, Fløisand Y, Safont MMS, Karlsen IT, Fandalyuk Z, Tadele D, Mierlo PV, Rowe AD, Robertson JM, Gjertsen BT, McCormack E, Enserink JM, Bjørn Tore Gjertsen Group, Emmet McCormack Group (2018)
    GRP94 rewires and buffers the FLT3-ITD signaling network and promotes survival of acute myeloid leukemic stem cells
    Haematologica (in press) (Retracted)
    DOI 10.3324/haematol.2018.189399, PubMed 29748445

Publications 2017

  1. Andresen MS, Ali HO, Myklebust CF, Sandset PM, Stavik B, Iversen N, Skretting G (2017)
    Estrogen induced expression of tissue factor pathway inhibitor-2 in MCF7 cells involves lysine-specific demethylase 1
    Mol Cell Endocrinol, 443, 80-88
    DOI 10.1016/j.mce.2017.01.016, PubMed 28088469
  2. Berentsen S, Randen U, Oksman M, Birgens H, Tvedt THA, Dalgaard J, Galteland E, Haukås E, Brudevold R, Sørbø JH, Næss IA, Malecka A, Tjønnfjord GE (2017)
    Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial
    Blood, 130 (4), 537-541
    DOI 10.1182/blood-2017-04-778175, PubMed 28533306
  3. Berntorp E, Dargaud Y, Hart D, Lobet S, Mancuso ME, d'Oiron R, Perry D, Pollard D, van den Berg M, Blatný J, Chambost H, Doria AS, Holme PA, Kaczmarek R, Mantovani L, McLaughlin P, Nanayakkara L, Petrini P, Sannié T, Laane E, Maia R, Dettoraki A, Farrell A, Halimeh S, Raza S et al. (2017)
    The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany
    Eur J Haematol, 98 Suppl 85, 1-15
    DOI 10.1111/ejh.12828, PubMed 28101938
  4. Byskov K, Boettger T, Ruehle PF, Nielsen NV, Etscheid M, Kanse SM (2017)
    Factor VII activating protease (FSAP) regulates the expression of inflammatory genes in vascular smooth muscle and endothelial cells
    Atherosclerosis, 265, 133-139
    DOI 10.1016/j.atherosclerosis.2017.08.029, PubMed 28881271
  5. Canaani J, Beohou E, Labopin M, Socié G, Huynh A, Volin L, Cornelissen J, Milpied N, Gedde-Dahl T, Deconinck E, Fegueux N, Blaise D, Mohty M, Nagler A (2017)
    Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT
    Am J Hematol, 92 (4), 344-350
    DOI 10.1002/ajh.24640, PubMed 28052366
  6. Canaani J, Labopin M, Socié G, Nihtinen A, Huynh A, Cornelissen J, Deconinck E, Gedde-Dahl T, Forcade E, Chevallier P, Bourhis JH, Blaise D, Mohty M, Nagler A (2017)
    Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT
    Am J Hematol, 92 (7), 653-659
    DOI 10.1002/ajh.24737, PubMed 28370339
  7. Chollet ME, Andersen E, Skarpen E, Myklebust CF, Koehler C, Morth JP, Chuansumrit A, Pinotti M, Bernardi F, Thiede B, Sandset PM, Skretting G (2017)
    Factor VII deficiency: Unveiling the cellular and molecular mechanisms underlying three model alterations of the enzyme catalytic domain
    Biochim Biophys Acta Mol Basis Dis, 1864 (3), 660-667
    DOI 10.1016/j.bbadis.2017.12.016, PubMed 29246447
  8. Cui XY, Skretting G, Tinholt M, Stavik B, Dahm AEA, Sahlberg KK, Kanse S, Iversen N, Sandset PM (2017)
    A novel hypoxia response element regulates oxygen-related repression of tissue factor pathway inhibitor in the breast cancer cell line MCF-7
    Thromb Res, 157, 111-116
    DOI 10.1016/j.thromres.2017.07.013, PubMed 28734156
  9. Espada S, Stavik B, Holm S, Sagen EL, Bjerkeli V, Skjelland M, Dahl TB, Espevik T, Kanse S, Sandset PM, Skretting G, Halvorsen B (2017)
    Tissue factor pathway inhibitor attenuates ER stress-induced inflammation in human M2-polarized macrophages
    Biochem Biophys Res Commun, 491 (2), 442-448
    DOI 10.1016/j.bbrc.2017.07.070, PubMed 28712870
  10. Garabet L, Ghanima W, Monceyron Jonassen C, Skov V, Holst R, Mowinckel MC, C Hasselbalch H, A Kruse T, Thomassen M, Liebman H, Bussel JB, Sandset PM (2017)
    Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia
    Platelets, 30 (2), 206-212
    DOI 10.1080/09537104.2017.1394451, PubMed 29215956
  11. Ghanima W, Wik HS, Tavoly M, Enden T, Jelsness-Jørgensen LP (2017)
    Late consequences of venous thromboembolism: Measuring quality of life after deep vein thrombosis and pulmonary embolism
    Thromb Res, 164, 170-176
    DOI 10.1016/j.thromres.2017.07.025, PubMed 28760416
  12. Gjevestad GO, Ottestad I, Biong AS, Iversen PO, Retterstøl K, Raastad T, Skålhegg BS, Ulven SM, Holven KB (2017)
    Consumption of protein-enriched milk has minor effects on inflammation in older adults-A 12-week double-blind randomized controlled trial
    Mech Ageing Dev, 162, 1-8
    DOI 10.1016/j.mad.2017.01.011, PubMed 28163108
  13. Grasso S, Neumann A, Lang IM, Etscheid M, von Köckritz-Blickwede M, Kanse SM (2017)
    Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs)
    Thromb Res, 161, 36-42
    DOI 10.1016/j.thromres.2017.11.012, PubMed 29178989
  14. Gravensteen IK (2017)
    Author's reply re: Healthcare utilisation, induced labour and caesarean section in the pregnancy after stillbirth: a prospective study
    BJOG, 125 (1), 92
    DOI 10.1111/1471-0528.14787, PubMed 28791796
  15. Gravensteen IK, Jacobsen EM, Sandset PM, Helgadottir LB, Rådestad I, Sandvik L, Ekeberg Ø (2017)
    Healthcare utilisation, induced labour and caesarean section in the pregnancy after stillbirth: a prospective study
    BJOG, 125 (2), 202-210
    DOI 10.1111/1471-0528.14750, PubMed 28516500
  16. Gullaksen SE, Skavland J, Gavasso S, Tosevski V, Warzocha K, Dumrese C, Ferrant A, Gedde-Dahl T, Hellmann A, Janssen J, Labar B, Lang A, Majeed W, Mihaylov G, Stentoft J, Stenke L, Thaler J, Thielen N, Verhoef G, Voglova J, Ossenkoppele G, Hochhaus A, Hjorth-Hansen H, Mustjoki S, Sopper S et al. (2017)
    Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib
    Haematologica, 102 (8), 1361-1367
    DOI 10.3324/haematol.2017.167080, PubMed 28522574
  17. Gustavsen A, Skattum L, Bergseth G, Lorentzen B, Floisand Y, Bosnes V, Mollnes TE, Barratt-Due A (2017)
    Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome: A case report
    Medicine (Baltimore), 96 (11), e6338
    DOI 10.1097/MD.0000000000006338, PubMed 28296762
  18. Herold J, Nowak S, Kostin S, Daniel JM, Francke A, Subramaniam S, Braun-Dullaeus RC, Kanse SM (2017)
    Factor VII activating protease (FSAP) influences vascular remodeling in the mouse hind limb ischemia model
    Am J Transl Res, 9 (6), 3084-3095
    PubMed 28670395
  19. Holme PA, Tjønnfjord GE, Batorova A (2017)
    Continuous infusion of coagulation factor concentrates during intensive treatment
    Haemophilia, 24 (1), 24-32
    DOI 10.1111/hae.13331, PubMed 28873263
  20. Klohe K, Prazeres da Costa C, Lien N, Holmboe-Ottesen G, Rychlik M, Haavardsson I, Stordalen G, Singh S, Engebretsen I, Iversen PO, Winkler AS (2017)
    Nutrition – A global challenge for health
    Tidsskr Nor Laegeforen, 137 (23-24)
    DOI 10.4045/tidsskr.17.0679, PubMed 29231665
  21. Komperød MJ, Sommer C, Mellin-Olsen T, Iversen PO, Røseth AG, Valeur J (2017)
    Persistent symptoms in patients with Crohn's disease in remission: An exploratory study on the role of diet
    Scand J Gastroenterol, 53 (5), 573-578
    DOI 10.1080/00365521.2017.1397736, PubMed 29168412
  22. Krishnan K, Jusufovic M, Sandset PM, Sandset EC (2017)
    Antiplatelet Therapy in Noncardioembolic Stroke: A Review of Current Evidence
    Semin Neurol, 37 (3), 366-375
    DOI 10.1055/s-0037-1603469, PubMed 28759917
  23. Lazarevic VL, Labopin M, Depei W, Yakoub-Agha I, Huynh A, Ljungman P, Schaap N, Cornelissen JJ, Maillard N, Pioltelli P, Gedde-Dahl T, Lenhoff S, Houhou M, Esteve J, Mohty M, Nagler A (2017)
    Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)
    Am J Hematol, 93 (1), 31-39
    DOI 10.1002/ajh.24928, PubMed 28971504
  24. Małecka A, Trøen G, Tierens A, Østlie I, Małecki J, Randen U, Wang J, Berentsen S, Tjønnfjord GE, Delabie JMA (2017)
    Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease
    Br J Haematol, 183 (5), 838-842
    DOI 10.1111/bjh.15063, PubMed 29265349
  25. Muhoozi GKM, Atukunda P, Diep LM, Mwadime R, Kaaya AN, Skaare AB, Willumsen T, Westerberg AC, Iversen PO (2017)
    Nutrition, hygiene, and stimulation education to improve growth, cognitive, language, and motor development among infants in Uganda: A cluster-randomized trial
    Matern Child Nutr, 14 (2), e12527
    DOI 10.1111/mcn.12527, PubMed 28925580
  26. Ngari MM, Thitiri J, Mwalekwa L, Timbwa M, Iversen PO, Fegan GW, Berkley JA (2017)
    The impact of rickets on growth and morbidity during recovery among children with complicated severe acute malnutrition in Kenya: A cohort study
    Matern Child Nutr, 14 (2), e12569
    DOI 10.1111/mcn.12569, PubMed 29178404
  27. Olsen MB, Hildrestrand GA, Scheffler K, Vinge LE, Alfsnes K, Palibrk V, Wang J, Neurauter CG, Luna L, Johansen J, Øgaard JDS, Ohm IK, Slupphaug G, Kuśnierczyk A, Fiane AE, Brorson SH, Zhang L, Gullestad L, Louch WE, Iversen PO, Østlie I, Klungland A, Christensen G, Sjaastad I, Sætrom P et al. (2017)
    NEIL3-Dependent Regulation of Cardiac Fibroblast Proliferation Prevents Myocardial Rupture
    Cell Rep, 18 (1), 82-92
    DOI 10.1016/j.celrep.2016.12.009, PubMed 28052262
  28. Osooli M, Steen Carlsson K, Baghaei F, Holmström M, Rauchensteiner S, Holme PA, Hvitfeldt L, Astermark J, Berntorp E (2017)
    The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA register
    Haemophilia, 23 (3), e180-e187
    DOI 10.1111/hae.13231, PubMed 28393468
  29. Ottestad I, Løvstad AT, Gjevestad GO, Hamarsland H, Šaltytė Benth J, Andersen LF, Bye A, Biong AS, Retterstøl K, Iversen PO, Raastad T, Ulven SM, Holven KB (2017)
    Intake of a Protein-Enriched Milk and Effects on Muscle Mass and Strength. A 12-Week Randomized Placebo Controlled Trial among Community-Dwelling Older Adults
    J Nutr Health Aging, 21 (10), 1160-1169
    DOI 10.1007/s12603-016-0856-1, PubMed 29188875
  30. Pahnke S, Larfors G, Axdorph-Nygell U, Fischer-Nielsen A, Haastrup E, Heldal D, Itälä-Remes M, Johansson JE, Kauppila M, Lenhoff S, Ljungman P, Niittyvuopio R, Sandstedt A, Hägglund H (2017)
    Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors
    J Clin Apher, 33 (3), 226-235
    DOI 10.1002/jca.21576, PubMed 28833474
  31. Panagopoulos I, Gorunova L, Torkildsen S, Tierens A, Heim S, Micci F (2017)
    FAM53B truncation caused by t(10;19)(q26;q13) chromosome translocation in acute lymphoblastic leukemia
    Oncol Lett, 13 (4), 2216-2220
    DOI 10.3892/ol.2017.5705, PubMed 28454383
  32. Panagopoulos I, Gorunova L, Torkildsen S, Tjønnfjord GE, Micci F, Heim S (2017)
    DEK-NUP214-Fusion Identified by RNA-Sequencing of an Acute Myeloid Leukemia with t(9;12)(q34;q15)
    Cancer Genomics Proteomics, 14 (6), 437-443
    DOI 10.21873/cgp.20053, PubMed 29109093
  33. Prebensen C, Trøseid M, Ueland T, Dahm A, Sandset PM, Aaberge I, Waalen K, Dyrhol-Riise AM, Taskén K, Kvale D (2017)
    Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial
    PLoS One, 12 (5), e0176527
    DOI 10.1371/journal.pone.0176527, PubMed 28464042
  34. Retterstøl K, Narverud I, Selmer R, Berge KE, Osnes IV, Ulven SM, Halvorsen B, Aukrust P, Holven KB, Iversen PO (2017)
    Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics
    Lipids Health Dis, 16 (1), 115
    DOI 10.1186/s12944-017-0511-9, PubMed 28606150
  35. Ringdén O, Labopin M, Sadeghi B, Mailhol A, Beelen D, Fløisand Y, Ghavamzadeh A, Finke J, Ehninger G, Volin L, Socié G, Kröger N, Stuhler G, Ganser A, Schmid C, Giebel S, Mohty M, Nagler A (2017)
    What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?
    J Intern Med, 283 (2), 166-177
    DOI 10.1111/joim.12695, PubMed 29027756
  36. Robin M, Porcher R, Zinke-Cerwenka W, van Biezen A, Volin L, Mufti G, Craddock C, Finke J, Richard C, Passweg J, Peniket A, Maertens J, Sucak G, Gedde-Dahl T, Vitek A, Nagler A, Blaise D, Beelen D, Maillard N, Schwerdtfeger R, de Witte T, Kroger N (2017)
    Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT
    Bone Marrow Transplant, 52 (7), 1081
    DOI 10.1038/bmt.2017.86, PubMed 28677682
  37. Rørholt M, Ghanima W, Farkas DK, Nørgaard M (2017)
    Risk of cardiovascular events and pulmonary hypertension following splenectomy - a Danish population-based cohort study from 1996-2012
    Haematologica, 102 (8), 1333-1341
    DOI 10.3324/haematol.2016.157008, PubMed 28572164
  38. Sacco S, Merki-Feld GS, Ægidius KL, Bitzer J, Canonico M, Kurth T, Lampl C, Lidegaard Ø, Anne MacGregor E, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Sandset PM, Martelletti P, European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC) (2017)
    Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
    J Headache Pain, 18 (1), 108
    DOI 10.1186/s10194-017-0815-1, PubMed 29086160
  39. Sagedal S, Sandvik L, Klingenberg O, Sandset PM (2017)
    β-Thromboglobulin may not reflect platelet activation during haemodialysis with the HeprAN membrane
    Scand J Clin Lab Invest, 77 (8), 679-684
    DOI 10.1080/00365513.2017.1397288, PubMed 29117741
  40. Schultz NH, Tran HTT, Bjørnsen S, Henriksson CE, Sandset PM, Holme PA (2017)
    The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII in apixaban-treated patients in vitro
    Res Pract Thromb Haemost, 1 (1), 49-56
    DOI 10.1002/rth2.12015, PubMed 30046673
  41. Schultz NH, Tran HTT, Bjørnsen S, Henriksson CE, Sandset PM, Holme PA (2017)
    The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
    Thromb J, 15, 6
    DOI 10.1186/s12959-017-0129-1, PubMed 28239301
  42. Server A, Bargalló N, Fløisand Y, Sponheim J, Graus F, Hald JK (2017)
    Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation
    Neuroradiology, 59 (2), 105-126
    DOI 10.1007/s00234-017-1804-4, PubMed 28255902
  43. Sperling C, Maitz MF, Grasso S, Werner C, Kanse SM (2017)
    A Positively Charged Surface Triggers Coagulation Activation Through Factor VII Activating Protease (FSAP)
    ACS Appl Mater Interfaces, 9 (46), 40107-40116
    DOI 10.1021/acsami.7b14281, PubMed 29091393
  44. Stavik B, Holm S, Espada S, Iversen N, Sporsheim B, Bjerkeli V, Dahl TB, Sandset PM, Skjelland M, Espevik T, Skretting G, Halvorsen B (2017)
    Increased expression of TFPI in human carotid stenosis
    Thromb Res, 155, 31-37
    DOI 10.1016/j.thromres.2017.04.024, PubMed 28482260
  45. Steffensen IL, Frølich W, Dahl KH, Iversen PO, Lyche JL, Lillegaard ITL, Alexander J (2017)
    Benefit and risk assessment of increasing potassium intake by replacement of sodium chloride with potassium chloride in industrial food products in Norway
    Food Chem Toxicol, 111, 329-340
    DOI 10.1016/j.fct.2017.11.044, PubMed 29175183
  46. Strømmen K, Haag A, Moltu SJ, Veierød MB, Blakstad EW, Nakstad B, Almaas AN, Brække K, Rønnestad AE, Daniel H, Drevon CA, Iversen PO (2017)
    Enhanced nutrient supply to very low birth weight infants is associated with higher blood amino acid concentrations and improved growth
    Clin Nutr ESPEN, 18, 16-22
    DOI 10.1016/j.clnesp.2017.01.003, PubMed 29132733
  47. Tikkinen KAO, Craigie S, Agarwal A, Siemieniuk RAC, Cartwright R, Violette PD, Novara G, Naspro R, Agbassi C, Ali B, Imam M, Ismaila N, Kam D, Gould MK, Sandset PM, Guyatt GH (2017)
    Procedure-specific Risks of Thrombosis and Bleeding in Urological Non-cancer Surgery: Systematic Review and Meta-analysis
    Eur Urol, 73 (2), 236-241
    DOI 10.1016/j.eururo.2017.02.025, PubMed 28284738
  48. Tikkinen KAO, Craigie S, Agarwal A, Violette PD, Novara G, Cartwright R, Naspro R, Siemieniuk RAC, Ali B, Eryuzlu L, Geraci J, Winkup J, Yoo D, Gould MK, Sandset PM, Guyatt GH (2017)
    Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysis
    Eur Urol, 73 (2), 242-251
    DOI 10.1016/j.eururo.2017.03.008, PubMed 28342641
  49. Tjønnfjord E, Vengen ØA, Berentsen S, Tjønnfjord GE (2017)
    Prophylactic use of eculizumab during surgery in chronic cold agglutinin disease
    BMJ Case Rep, 2017
    DOI 10.1136/bcr-2016-219066, PubMed 28487302
  50. Torkildsen S, Brunetti M, Gorunova L, Spetalen S, Beiske K, Heim S, Panagopoulos I (2017)
    Rearrangement of the Chromatin Organizer Special AT-rich Binding Protein 1 Gene, SATB1, Resulting from a t(3;5)(p24;q14) Chromosomal Translocation in Acute Myeloid Leukemia
    Anticancer Res, 37 (2), 693-698
    DOI 10.21873/anticanres.11365, PubMed 28179318
  51. Vojdeman FJ, Herman SEM, Kirkby N, Wiestner A, van T' Veer MB, Tjønnfjord GE, Itälä-Remes MA, Kimby E, Farooqui MZ, Polliack A, Wu KL, Doorduijn JK, Alemayehu WG, Wittebol S, Kozak T, Walewski J, Abrahamse-Testroote MCJ, van Oers MHJ, Geisler CH, Niemann CU (2017)
    Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia
    Leuk Lymphoma, 58 (10), 2356-2362
    DOI 10.1080/10428194.2017.1285027, PubMed 28278728
  52. Wang D, Fløisand Y, Myklebust CV, Bürgler S, Parente-Ribes A, Hofgaard PO, Bogen B, Taskén K, Tjønnfjord GE, Schjesvold F, Dalgaard J, Tveita A, Munthe LA (2017)
    Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice
    Leukemia, 31 (10), 2114-2121
    DOI 10.1038/leu.2017.69, PubMed 28232741
  53. Wik HS, Enden TR, Ghanima W, Engeseth M, Kahn SR, Sandset PM (2017)
    Diagnostic scales for the post-thrombotic syndrome
    Thromb Res, 164, 110-115
    DOI 10.1016/j.thromres.2017.10.022, PubMed 29126608
  54. Wik HS, Ghanima W, Sandset PM, Kahn SR (2017)
    Scoring Systems for Postthrombotic Syndrome
    Semin Thromb Hemost, 43 (5), 500-504
    DOI 10.1055/s-0037-1599142, PubMed 28470653

Publications 2016

  1. Ali HO, Arroyo AB, González-Conejero R, Stavik B, Iversen N, Sandset PM, Martínez C, Skretting G (2016)
    The role of microRNA-27a/b and microRNA-494 in estrogen-mediated downregulation of tissue factor pathway inhibitor α
    J Thromb Haemost, 14 (6), 1226-37
    DOI 10.1111/jth.13321, PubMed 26999003
  2. Ali HO, Stavik B, Myklebust CF, Andersen E, Dahm AE, Iversen N, Sandset PM, Skretting G (2016)
    Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5'-Flanking Region
    PLoS One, 11 (3), e0152114
    DOI 10.1371/journal.pone.0152114, PubMed 26999742
  3. Barratt-Due A, Fløisand Y, Orrem HL, Kvam AK, Holme PA, Bergseth G, Tjønnfjord GE, Mollnes TE (2016)
    Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
    Rheumatology (Oxford), 55 (7), 1337-9
    DOI 10.1093/rheumatology/kew040, PubMed 27105662
  4. Bates SM, Alonso-Coello P, Tikkinen KA, Ebrahim S, Lopes LC, McDonald SD, Zhou Q, Akl EA, Neumann I, Jacobsen AF, Zhang Y, Santamaría A, Annichino-Bizzacchi JM, Sandset PM, Bitar W, Eckman MH, Guyatt GH (2016)
    Women's values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview
    Thromb Res, 140, 22-9
    DOI 10.1016/j.thromres.2015.12.015, PubMed 27500301
  5. Berger K, Schopohl D, Lowe G, Holme PA, Tait RC, Combescure C, Rauchensteiner S, Klamroth R (2016)
    How to compare cardiovascular disease and risk factors in elderly patients with haemophilia with the general population
    Haemophilia, 22 (5), e406-16
    DOI 10.1111/hae.13069, PubMed 27650262
  6. Biegstraaten M, Cox TM, Belmatoug N, Berger MG, Collin-Histed T, Vom Dahl S, Di Rocco M, Fraga C, Giona F, Giraldo P, Hasanhodzic M, Hughes DA, Iversen PO, Kiewiet AI, Lukina E, Machaczka M, Marinakis T, Mengel E, Pastores GM, Plöckinger U, Rosenbaum H, Serratrice C, Symeonidis A, Szer J, Timmerman J et al. (2016)
    Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease
    Blood Cells Mol Dis, 68, 203-208
    DOI 10.1016/j.bcmd.2016.10.008, PubMed 28274788
  7. Bleker SM, Buchmüller A, Chauleur C, Ní Áinle F, Donnelly J, Verhamme P, Jacobsen AF, Ganzevoort W, Prins M, Beyer-Westendorf J, DeSancho M, Konstantinides S, Pabinger I, Rodger M, Decousus H, Middeldorp S (2016)
    Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses
    Thromb Res, 144, 62-8
    DOI 10.1016/j.thromres.2016.06.001, PubMed 27289488
  8. Broesby-Olsen S, Dybedal I, Gülen T, Kristensen TK, Møller MB, Ackermann L, Sääf M, Karlsson MA, Agertoft L, Brixen K, Hermann P, Stylianou E, Mortz CG, Torfing T, Havelund T, Sander B, Bergström A, Bendix M, Garvey LH, Bjerrum OW, Valent P, Bindslev-Jensen C, Nilsson G, Vestergaard H, Hägglund H (2016)
    Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus
    Acta Derm Venereol, 96 (5), 602-12
    DOI 10.2340/00015555-2325, PubMed 26694951
  9. Bustamante A, Díaz-Fernández B, Giralt D, Boned S, Pagola J, Molina CA, García-Berrocoso T, Kanse SM, Montaner J (2016)
    Factor seven activating protease (FSAP) predicts response to intravenous thrombolysis in acute ischemic stroke
    Int J Stroke, 11 (6), 646-55
    DOI 10.1177/1747493016641949, PubMed 27073188
  10. Bye A, Wesseltoft-Rao N, Iversen PO, Skjegstad G, Holven KB, Ulven S, Hjermstad MJ (2016)
    Alterations in inflammatory biomarkers and energy intake in cancer cachexia: a prospective study in patients with inoperable pancreatic cancer
    Med Oncol, 33 (6), 54
    DOI 10.1007/s12032-016-0768-2, PubMed 27119533
  11. Cui XY, Tinholt M, Stavik B, Dahm AE, Kanse S, Jin Y, Seidl S, Sahlberg KK, Iversen N, Skretting G, Sandset PM (2016)
    Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer
    J Thromb Haemost, 14 (2), 387-96
    DOI 10.1111/jth.13206, PubMed 26598923
  12. Daniel JM, Reichel CA, Schmidt-Woell T, Dutzmann J, Zuchtriegel G, Krombach F, Herold J, Bauersachs J, Sedding DG, Kanse SM (2016)
    Factor VII-activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation
    J Thromb Haemost, 14 (10), 2058-2067
    DOI 10.1111/jth.13417, PubMed 27431088
  13. Fløisand Y, Lundin KEA, Lazarevic V, Kristiansen JD, Osnes LTN, Tjønnfjord GE, Reims HM, Gedde-Dahl T (2016)
    Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease
    Biol Blood Marrow Transplant, 23 (1), 172-175
    DOI 10.1016/j.bbmt.2016.10.009, PubMed 27777142
  14. Garabet L, Gilboe IM, Mowinckel MC, Jacobsen AF, Mollnes TE, Sandset PM, Jacobsen EM (2016)
    Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus
    Scand J Immunol, 84 (2), 95-9
    DOI 10.1111/sji.12445, PubMed 27135178
  15. Haig Y, Enden T, Grøtta O, Kløw NE, Slagsvold CE, Ghanima W, Sandvik L, Hafsahl G, Holme PA, Holmen LO, Njaaastad AM, Sandbæk G, Sandset PM, CaVenT Study Group (2016)
    Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial
    Lancet Haematol, 3 (2), e64-71
    DOI 10.1016/S2352-3026(15)00248-3, PubMed 26853645
  16. Hjorth-Hansen H, Stentoft J, Richter J, Koskenvesa P, Höglund M, Dreimane A, Porkka K, Gedde-Dahl T, Gjertsen BT, Gruber FX, Stenke L, Eriksson KM, Markevärn B, Lübking A, Vestergaard H, Udby L, Bjerrum OW, Persson I, Mustjoki S, Olsson-Strömberg U (2016)
    Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients
    Leukemia, 30 (9), 1853-60
    DOI 10.1038/leu.2016.121, PubMed 27133821
  17. Holstein K, Batorova A, Carvalho M, Fijnvandraat K, Holme P, Kavakli K, Lambert T, Rocino A, Jiménez-Yuste V, Astermark J, European Haemophilia Therapy Strategy Board (EHTSB) (2016)
    Current view and outcome of ITI therapy - A change over time?
    Thromb Res, 148, 38-44
    DOI 10.1016/j.thromres.2016.10.015, PubMed 27770665
  18. Ilander M, Olsson-Strömberg U, Schlums H, Guilhot J, Brück O, Lähteenmäki H, Kasanen T, Koskenvesa P, Söderlund S, Höglund M, Markevärn B, Själander A, Lotfi K, Dreimane A, Lübking A, Holm E, Björeman M, Lehmann S, Stenke L, Ohm L, Gedde-Dahl T, Majeed W, Ehrencrona H, Koskela S, Saussele S et al. (2016)
    Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
    Leukemia, 31 (5), 1108-1116
    DOI 10.1038/leu.2016.360, PubMed 27890936
  19. James PD, Mahlangu J, Bidlingmaier C, Mingot-Castellano ME, Chitlur M, Fogarty PF, Cuker A, Mancuso ME, Holme PA, Grabell J, Satkunam N, Hopman WM, Mathew P, Global Emerging HEmostasis Experts Panel (GEHEP) (2016)
    Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study
    Haemophilia, 22 (6), 912-918
    DOI 10.1111/hae.13089, PubMed 27868369
  20. Kaur P, Bergrem A, Gerlyng P, Reims HM, Leh S, Valeur J (2016)
    A methadone user with anaemia, skeletal pain and altered appearance
    Tidsskr Nor Laegeforen, 136 (10), 925-9
    DOI 10.4045/tidsskr.15.0692, PubMed 27272371
  21. Koenecke C, Heim D, van Biezen A, Heuser M, Aljurf M, Kyrcz-Krzemien S, Volin L, de Souza CA, Gedde-Dahl T, Sengeloev H, Schanz U, Komarnicki M, Arroyo CH, Tholouli E, Gluckman E, Esquirol A, Yakoub-Agha I, Gürman G, Olavarria E, Kröger N (2016)
    Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party
    Bone Marrow Transplant, 51 (9), 1259-61
    DOI 10.1038/bmt.2016.97, PubMed 27111041
  22. Kontro M, Kumar A, Majumder MM, Eldfors S, Parsons A, Pemovska T, Saarela J, Yadav B, Malani D, Fløisand Y, Höglund M, Remes K, Gjertsen BT, Kallioniemi O, Wennerberg K, Heckman CA, Porkka K (2016)
    HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia
    Leukemia, 31 (2), 301-309
    DOI 10.1038/leu.2016.222, PubMed 27499136
  23. Leiting S, Seidl S, Martinez-Palacian A, Muhl L, Kanse SM (2016)
    Transforming Growth Factor-β (TGF-β) Inhibits the Expression of Factor VII-activating Protease (FSAP) in Hepatocytes
    J Biol Chem, 291 (40), 21020-21028
    DOI 10.1074/jbc.M116.744631, PubMed 27462075
  24. Lenartova A, Johannesen TB, Tjønnfjord GE (2016)
    National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953-2012: a systematic analysis of population-based data
    Cancer Med, 5 (12), 3588-3595
    DOI 10.1002/cam4.849, PubMed 27925456
  25. Małecka A, Trøen G, Tierens A, Østlie I, Małecki J, Randen U, Berentsen S, Tjønnfjord GE, Delabie JM (2016)
    Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity
    Haematologica, 101 (9), e361-4
    DOI 10.3324/haematol.2016.146126, PubMed 27198717
  26. Martin K, Beyer-Westendorf J, Davidson BL, Huisman MV, Sandset PM, Moll S (2016)
    Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH
    J Thromb Haemost, 14 (6), 1308-13
    DOI 10.1111/jth.13323, PubMed 27299806
  27. Muhoozi GK, Atukunda P, Mwadime R, Iversen PO, Westerberg AC (2016)
    Nutritional and developmental status among 6- to 8-month-old children in southwestern Uganda: a cross-sectional study
    Food Nutr Res, 60, 30270
    DOI 10.3402/fnr.v60.30270, PubMed 27238555
  28. Mundal L, Veierød MB, Halvorsen T, Holven KB, Ose L, Iversen PO, Tell GS, Leren TP, Retterstøl K (2016)
    Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study
    Eur J Prev Cardiol, 23 (18), 1962-1969
    DOI 10.1177/2047487316666371, PubMed 27558979
  29. Nordheim T, Rustøen T, Iversen PO, Nakstad B (2016)
    Quality of life in parents of preterm infants in a randomized nutritional intervention trial
    Food Nutr Res, 60, 32162
    DOI 10.3402/fnr.v60.32162, PubMed 27839532
  30. Panagopoulos I, Torkildsen S, Gorunova L, Ulvmoen A, Tierens A, Zeller B, Heim S (2016)
    RUNX1 truncation resulting from a cryptic and novel t(6;21)(q25;q22) chromosome translocation in acute myeloid leukemia: A case report
    Oncol Rep, 36 (5), 2481-2488
    DOI 10.3892/or.2016.5119, PubMed 27667292
  31. Robin M, Porcher R, Zinke-Cerwenka W, van Biezen A, Volin L, Mufti G, Craddock C, Finke J, Richard C, Passweg J, Peniket A, Maertens J, Sucak G, Gedde-Dahl T, Vitek A, Nagler A, Blaise D, Beelen D, Maillard N, Schwerdtfeger R, de Witte T, Kroger N (2016)
    Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT
    Bone Marrow Transplant, 52 (2), 209-215
    DOI 10.1038/bmt.2016.266, PubMed 27819688
  32. Rukundo PM, Andreassen BA, Kikafunda J, Rukooko B, Oshaug A, Iversen PO (2016)
    Household food insecurity and diet diversity after the major 2010 landslide disaster in Eastern Uganda: a cross-sectional survey
    Br J Nutr, 115 (4), 718-29
    DOI 10.1017/S0007114515004961, PubMed 26777212
  33. Rukundo PM, Oshaug A, Andreassen BA, Kikafunda J, Rukooko B, Iversen PO (2016)
    Food variety consumption and household food insecurity coping strategies after the 2010 landslide disaster - the case of Uganda
    Public Health Nutr, 19 (17), 3197-3209
    DOI 10.1017/S1368980016001397, PubMed 27278061
  34. Skarpengland T, Holm S, Scheffler K, Gregersen I, Dahl TB, Suganthan R, Segers FM, Østlie I, Otten JJ, Luna L, Ketelhuth DF, Lundberg AM, Neurauter CG, Hildrestrand G, Skjelland M, Bjørndal B, Svardal AM, Iversen PO, Hedin U, Nygård S, Olstad OK, Krohg-Sørensen K, Slupphaug G, Eide L, Kuśnierczyk A et al. (2016)
    Neil3-dependent base excision repair regulates lipid metabolism and prevents atherosclerosis in Apoe-deficient mice
    Sci Rep, 6, 28337
    DOI 10.1038/srep28337, PubMed 27328939
  35. Stavik B, Espada S, Cui XY, Iversen N, Holm S, Mowinkel MC, Halvorsen B, Skretting G, Sandset PM (2016)
    EPAS1/HIF-2 alpha-mediated downregulation of tissue factor pathway inhibitor leads to a pro-thrombotic potential in endothelial cells
    Biochim Biophys Acta, 1862 (4), 670-678
    DOI 10.1016/j.bbadis.2016.01.017, PubMed 26826018
  36. Tavoly M, Utne KK, Jelsness-Jørgensen LP, Wik HS, Klok FA, Sandset PM, Ghanima W (2016)
    Health-related quality of life after pulmonary embolism: a cross-sectional study
    BMJ Open, 6 (11), e013086
    DOI 10.1136/bmjopen-2016-013086, PubMed 27810979
  37. Tekpli X, Urbanucci A, Hashim A, Vågbø CB, Lyle R, Kringen MK, Staff AC, Dybedal I, Mills IG, Klungland A, Staerk J (2016)
    Changes of 5-hydroxymethylcytosine distribution during myeloid and lymphoid differentiation of CD34+ cells
    Epigenetics Chromatin, 9, 21
    DOI 10.1186/s13072-016-0070-8, PubMed 27252783
  38. Tinholt M, Sandset PM, Iversen N (2016)
    Polymorphisms of the coagulation system and risk of cancer
    Thromb Res, 140 Suppl 1, S49-54
    DOI 10.1016/S0049-3848(16)30098-6, PubMed 27067978
  39. Tinholt M, Sandset PM, Mowinckel MC, Garred Ø, Sahlberg KK, Kristensen VN, Børresen-Dale AL, Jacobsen AF, Skretting G, Iversen N (2016)
    Determinants of acquired activated protein C resistance and D-dimer in breast cancer
    Thromb Res, 145, 78-83
    DOI 10.1016/j.thromres.2016.08.003, PubMed 27505249
  40. Tiscia GL, Dørum E, Myklebust CF, Grandone E, Sandset PM, Skretting G (2016)
    Functional characterization of annexin A5 gene promoter allelic variants
    Thromb Res, 144, 93-9
    DOI 10.1016/j.thromres.2016.06.009, PubMed 27318245
  41. Torfoss D, Fladhagen T, Holte H, Brinch L, Schjesvold FH, Fløisand Y, Nyquist E, Dalgaard J, Meyer P, Lehmann AK, Hammerstrøm J, Skjelbakken T, Høiby EA, Sandvik L, Kvaløy S (2016)
    Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial
    Clin Microbiol Infect, 23 (3), 179-187
    DOI 10.1016/j.cmi.2016.10.019, PubMed 27793737
  42. Utne KK, Tavoly M, Wik HS, Jelsness-Jørgensen LP, Holst R, Sandset PM, Ghanima W (2016)
    Health-related quality of life after deep vein thrombosis
    Springerplus, 5 (1), 1278
    DOI 10.1186/s40064-016-2949-z, PubMed 27547653
  43. Vandraas K, Tjønnfjord GE, Johannesen TB, Brandal P (2016)
    Persistent bone marrow depression following short-term treatment with temozolomide
    BMJ Case Rep, 2016
    DOI 10.1136/bcr-2016-215797, PubMed 27130558
  44. Vojdeman FJ, Van't Veer MB, Tjønnfjord GE, Itälä-Remes M, Kimby E, Polliack A, Wu KL, Doorduijn JK, Alemayehu WG, Wittebol S, Kozak T, Walewski J, Abrahamse-Testroote MC, van Oers MH, Geisler CH (2016)
    The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia
    Leuk Lymphoma, 58 (3), 594-600
    DOI 10.1080/10428194.2016.1213831, PubMed 27484290
  45. von Krogh AS, Quist-Paulsen P, Waage A, Langseth ØO, Thorstensen K, Brudevold R, Tjønnfjord GE, Largiadèr CR, Lämmle B, Kremer Hovinga JA (2016)
    High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence
    J Thromb Haemost, 14 (1), 73-82
    DOI 10.1111/jth.13186, PubMed 26566785

Publications 2015

  1. Bazarbachi A, Labopin M, Kharfan-Dabaja MA, Schwerdtfeger R, Volin L, Bourhis JH, Socié G, Daguindau E, Gedde-Dahl T, Rambaldi A, Karas M, Schlimok G, Blaise D, Chevallier P, Malard F, Schmid C, Esteve J, Nagler A, Mohty M (2015)
    Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status
    Haematologica, 101 (1), e34-7
    DOI 10.3324/haematol.2015.135681, PubMed 26405153
  2. Beitland S, Sandven I, Kjærvik LK, Sandset PM, Sunde K, Eken T (2015)
    Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis
    Intensive Care Med, 41 (7), 1209-19
    DOI 10.1007/s00134-015-3840-z, PubMed 25971389
  3. Berentsen S, Randen U, Tjønnfjord GE (2015)
    Cold agglutinin-mediated autoimmune hemolytic anemia
    Hematol Oncol Clin North Am, 29 (3), 455-71
    DOI 10.1016/j.hoc.2015.01.002, PubMed 26043385
  4. Berntsen CF, Kristiansen A, Akl EA, Sandset PM, Jacobsen EM, Guyatt G, Vandvik PO (2015)
    Compression Stockings for Preventing the Postthrombotic Syndrome in Patients with Deep Vein Thrombosis
    Am J Med, 129 (4), 447.e1-447.e20
    DOI 10.1016/j.amjmed.2015.11.031, PubMed 26747198
  5. Boon H, Sjögren RJ, Massart J, Egan B, Kostovski E, Iversen PO, Hjeltnes N, Chibalin AV, Widegren U, Zierath JR (2015)
    MicroRNA-208b progressively declines after spinal cord injury in humans and is inversely related to myostatin expression
    Physiol Rep, 3 (11)
    DOI 10.14814/phy2.12622, PubMed 26603456
  6. Bremer S, Fløisand Y, Brinch L, Gedde-Dahl T, Bergan S (2015)
    Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning
    Ther Drug Monit, 37 (4), 493-500
    DOI 10.1097/FTD.0000000000000180, PubMed 25565670
  7. Chollet ME, Skarpen E, Iversen N, Sandset PM, Skretting G (2015)
    The chemical chaperone sodium 4-phenylbutyrate improves the secretion of the protein CA267T mutant in CHO-K1 cells trough the GRASP55 pathway
    Cell Biosci, 5, 57
    DOI 10.1186/s13578-015-0048-4, PubMed 26457178
  8. Chortatos A, Haugen M, Iversen PO, Vikanes Å, Eberhard-Gran M, Bjelland EK, Magnus P, Veierød MB (2015)
    Pregnancy complications and birth outcomes among women experiencing nausea only or nausea and vomiting during pregnancy in the Norwegian Mother and Child Cohort Study
    BMC Pregnancy Childbirth, 15, 138
    DOI 10.1186/s12884-015-0580-6, PubMed 26100060
  9. Chortatos A, Haugen M, Iversen PO, Vikanes Å, Eberhard-Gran M, Bjelland EK, Magnus P, Veierød MB (2015)
    Erratum: Pregnancy complications and birth outcomes among women experiencing nausea only or nausea and vomiting during pregnancy in the Norwegian Mother and Child Cohort Study
    BMC Pregnancy Childbirth, 15, 167
    DOI 10.1186/s12884-015-0596-y, PubMed 26268704
  10. Comerota AJ, Sandset PM, Konstantinides S, de Graaf R, Wakefield TW, Arnoldussen CW, Lam YL, van Gent WB, de Wolf MA, Catarinella FS, Kurstjens RL, Alshabatat A, Wittens CH (2015)
    Theme 4: Invasive management of (recurrent) VTE and PTS
    Thromb Res, 136 Suppl 1, S19-25
    DOI 10.1016/j.thromres.2015.07.037, PubMed 26387732
  11. Craigie S, Tsui JF, Agarwal A, Sandset PM, Guyatt GH, Tikkinen KA (2015)
    Adherence to mechanical thromboprophylaxis after surgery: A systematic review and meta-analysis
    Thromb Res, 136 (4), 723-6
    DOI 10.1016/j.thromres.2015.06.023, PubMed 26140737
  12. Dahm AE, Tiscia G, Holmgren A, Jacobsen AF, Skretting G, Grandone E, Sandset PM (2015)
    Genetic variations in the annexin A5 gene and the risk of pregnancy-related venous thrombosis
    J Thromb Haemost, 13 (3), 409-13
    DOI 10.1111/jth.12817, PubMed 25495894
  13. Eckman MH, Alonso-Coello P, Guyatt GH, Ebrahim S, Tikkinen KA, Lopes LC, Neumann I, McDonald SD, Zhang Y, Zhou Q, Akl EA, Jacobsen AF, Santamaría A, Annichino-Bizzacchi JM, Bitar W, Sandset PM, Bates SM (2015)
    Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities
    Thromb Res, 136 (2), 341-7
    DOI 10.1016/j.thromres.2015.05.020, PubMed 26033397
  14. Fogarty PF, Mancuso ME, Kasthuri R, Bidlingmaier C, Chitlur M, Gomez K, Holme PA, James P, Kruse-Jarres R, Mahlangu J, Mingot-Castellano ME, Soni A, Global Emerging Hemophilia Panel (GEHEP) (2015)
    Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year survey
    Haemophilia, 21 (5), 589-97
    DOI 10.1111/hae.12652, PubMed 25689278
  15. Ghanima W, Khelif A, Waage A, Michel M, Tjønnfjord GE, Romdhan NB, Kahrs J, Darne B, Holme PA, RITP study group (2015)
    Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
    Lancet, 385 (9978), 1653-61
    DOI 10.1016/S0140-6736(14)61495-1, PubMed 25662413
  16. Gimsing P, Hjertner Ø, Abildgaard N, Andersen NF, Dahl TG, Gregersen H, Klausen TW, Mellqvist UH, Linder O, Lindås R, Tøffner Clausen N, Lenhoff S (2015)
    Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial
    Bone Marrow Transplant, 50 (10), 1306-11
    DOI 10.1038/bmt.2015.125, PubMed 26121108
  17. Holme PA, Combescure C, Tait RC, Berntorp E, Rauchensteiner S, de Moerloose P, ADVANCE Working Group (2015)
    Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe
    Haemophilia, 22 (2), 248-255
    DOI 10.1111/hae.12847, PubMed 27880029
  18. Høyvoll LR, Fløisand Y, Orrem HL, Gunnarsson R, Landrø L, Brevig T, Gaustad P, Nordøy I (2015)
    Hemophagocytic lymphohistiocytosis in leprosy
    Lepr Rev, 86 (4), 403-6
    PubMed 26964439
  19. Iversen PO, Dahm A, Skretting G, Mowinckel MC, Stranda A, Østerud B, Sandset PM, Kostovski E (2015)
    Reduced peak, but no diurnal variation, in thrombin generation upon melatonin supplementation in tetraplegia. A randomised, placebo-controlled study
    Thromb Haemost, 114 (5), 964-8
    DOI 10.1160/TH15-05-0396, PubMed 26202881
  20. Iversen PO, Sioud M (2015)
    Engineering therapeutic cancer vaccines that activate antitumor immunity
    Methods Mol Biol, 1218, 263-8
    DOI 10.1007/978-1-4939-1538-5_15, PubMed 25319656
  21. Johnson KC, Aragaki AK, Jackson R, Reiner A, Sandset PM, Rosing J, Dahm AE, Rosendaal F, Manson JE, Martin LW, Liu S, Kuller LH, Cushman M, Rossouw JE (2015)
    Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy
    Arterioscler Thromb Vasc Biol, 36 (2), 418-24
    DOI 10.1161/ATVBAHA.115.306905, PubMed 26681757
  22. Kostovski E, Dahm AE, Mowinckel MC, Stranda A, Skretting G, Østerud B, Sandset PM, Iversen PO (2015)
    Circadian rhythms of hemostatic factors in tetraplegia: a double-blind, randomized, placebo-controlled cross-over study of melatonin
    Spinal Cord, 53 (4), 285-90
    DOI 10.1038/sc.2014.243, PubMed 25644388
  23. Narverud I, van Lennep JR, Christensen JJ, Versmissen J, Gran JM, Iversen PO, Aukrust P, Halvorsen B, Ueland T, Ulven SM, Ose L, Veierød MB, Sijbrands E, Retterstøl K, Holven KB (2015)
    Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia
    Atherosclerosis, 243 (1), 155-60
    DOI 10.1016/j.atherosclerosis.2015.09.014, PubMed 26386212
  24. Nissen-Meyer LS, Tjønnfjord GE, Golebiowska E, Kjeldsen-Kragh J, Akkök ÇA (2015)
    Paroxysmal nocturnal haemoglobinuria at Oslo University Hospital 2000-2010
    Tidsskr Nor Laegeforen, 135 (11), 1039-43
    DOI 10.4045/tidsskr.14.0444, PubMed 26080779
  25. Parente-Ribes A, Skånland SS, Bürgler S, Os A, Wang D, Bogen B, Tjønnfjord GE, Taskén K, Munthe LA (2015)
    Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells
    Haematologica, 101 (2), e59-62
    DOI 10.3324/haematol.2015.135590, PubMed 26589914
  26. Rukundo PM, Iversen PO, Andreassen BA, Oshaug A, Kikafunda J, Rukooko B (2015)
    Perceptions on the right to adequate food after a major landslide disaster: a cross-sectional survey of two districts in Uganda
    BMC Int Health Hum Rights, 15, 9
    DOI 10.1186/s12914-015-0047-x, PubMed 25909355
  27. Sandset EC, Jusufovic M, Sandset PM, Bath PM, Berge E, SCAST Study Group (2015)
    Effects of blood pressure-lowering treatment in different subtypes of acute ischemic stroke
    Stroke, 46 (3), 877-9
    DOI 10.1161/STROKEAHA.114.008512, PubMed 25657183
  28. Skuterud Wik H, Flem Jacobsen A, Morten Sandset P (2015)
    Long-term outcome after pregnancy-related venous thrombosis
    Thromb Res, 135 Suppl 1, S1-4
    DOI 10.1016/S0049-3848(15)50430-1, PubMed 25903525
  29. Tangen JM (2015)
    Radiation What it is, what you need to know
    Tidsskr. Nor. Laegeforen., 135 (15), 1387
  30. Tangen JM, Tierens A, Caers J, Binsfeld M, Olstad OK, Trøseid AM, Wang J, Tjønnfjord GE, Hetland G (2015)
    Immunomodulatory effects of the Agaricus blazei Murrill-based mushroom extract AndoSan in patients with multiple myeloma undergoing high dose chemotherapy and autologous stem cell transplantation: a randomized, double blinded clinical study
    Biomed Res Int, 2015, 718539
    DOI 10.1155/2015/718539, PubMed 25664323
  31. Tinholt M, Stavik B, Louch W, Carlson CR, Sletten M, Ruf W, Skretting G, Sandset PM, Iversen N (2015)
    Syndecan-3 and TFPI colocalize on the surface of endothelial-, smooth muscle-, and cancer cells
    PLoS One, 10 (1), e0117404
    DOI 10.1371/journal.pone.0117404, PubMed 25617766
  32. Tinholt M, Vollan HK, Sahlberg KK, Jernström S, Kaveh F, Lingjærde OC, Kåresen R, Sauer T, Kristensen V, Børresen-Dale AL, Sandset PM, Iversen N (2015)
    Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF
    Breast Cancer Res, 17, 44
    DOI 10.1186/s13058-015-0548-5, PubMed 25882602
  33. Tjelle TE, Holtung L, Bøhn SK, Aaby K, Thoresen M, Wiik SÅ, Paur I, Karlsen AS, Retterstøl K, Iversen PO, Blomhoff R (2015)
    Polyphenol-rich juices reduce blood pressure measures in a randomised controlled trial in high normal and hypertensive volunteers
    Br J Nutr, 114 (7), 1054-63
    DOI 10.1017/S0007114515000562, PubMed 26227795
  34. Torkildsen S, Gorunova L, Beiske K, Tjønnfjord GE, Heim S, Panagopoulos I (2015)
    Novel ZEB2-BCL11B Fusion Gene Identified by RNA-Sequencing in Acute Myeloid Leukemia with t(2;14)(q22;q32)
    PLoS One, 10 (7), e0132736
    DOI 10.1371/journal.pone.0132736, PubMed 26186352
  35. Utne KK, Ghanima W, Foyn S, Kahn S, Sandset PM, Wik HS (2015)
    Development and validation of a tool for patient reporting of symptoms and signs of the post-thrombotic syndrome
    Thromb Haemost, 115 (2), 361-367
    DOI 10.1160/th15-04-0318, PubMed 26422814
  36. Valentino LA, Holme PA (2015)
    Should anti-inhibitor coagulant complex and tranexamic acid be used concomitantly?
    Haemophilia, 21 (6), 709-14
    DOI 10.1111/hae.12723, PubMed 26036756
  37. Wennström L, Edslev PW, Abrahamsson J, Nørgaard JM, Fløisand Y, Forestier E, Gustafsson G, Heldrup J, Hovi L, Jahnukainen K, Jonsson OG, Lausen B, Palle J, Zeller B, Holmberg E, Juliusson G, Stockelberg D, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO), Danish Acute Leukemia Group, Swedish Acute Myeloid Leukemia Group (2015)
    Acute Myeloid Leukemia in Adolescents and Young Adults Treated in Pediatric and Adult Departments in the Nordic Countries
    Pediatr Blood Cancer, 63 (1), 83-92
    DOI 10.1002/pbc.25713, PubMed 26281822
  38. Wesseltoft-Rao N, Hjermstad MJ, Ikdahl T, Dajani O, Ulven SM, Iversen PO, Bye A (2015)
    Comparing two classifications of cancer cachexia and their association with survival in patients with unresected pancreatic cancer
    Nutr Cancer, 67 (3), 472-80
    DOI 10.1080/01635581.2015.1004728, PubMed 25710201
  39. Wik HS, Jacobsen AF, Mowinckel MC, Sandset PM (2015)
    The role of inflammation in post-thrombotic syndrome after pregnancy-related deep vein thrombosis: A population-based, cross-sectional study
    Thromb Res, 138, 16-21
    DOI 10.1016/j.thromres.2015.12.014, PubMed 26826503

Publications 2014

  1. Akkök ÇA, Bergrem A, Tangen JM (2014)
    Tidsskr Nor Laegeforen, 134 (14), 1365
    DOI 10.4045/tidsskr.13.1559, PubMed 25096431
  2. Ali HO, Stavik B, Dørum E, Iversen N, Sandset PM, Skretting G (2014)
    Oestrogen induced downregulation of TFPI expression is mediated by ERα
    Thromb Res, 134 (1), 138-43
    DOI 10.1016/j.thromres.2014.04.004, PubMed 24785473
  3. Bruserud Ø, Tvedt TH, Paulsen PQ, Ahmed AB, Gedde-Dahl T, Tjønnfjord GE, Slåstad H, Heldal D, Reikvam H (2014)
    Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies
    Cancer Immunol Immunother, 63 (8), 757-77
    DOI 10.1007/s00262-014-1578-z, PubMed 24997173
  4. Bürgler S, Gimeno A, Parente-Ribes A, Wang D, Os A, Devereux S, Jebsen P, Bogen B, Tjønnfjord GE, Munthe LA (2014)
    Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism
    J Immunol, 194 (2), 827-35
    DOI 10.4049/jimmunol.1401350, PubMed 25505279
  5. Döhner H, Lübbert M, Fiedler W, Fouillard L, Haaland A, Brandwein JM, Lepretre S, Reman O, Turlure P, Ottmann OG, Müller-Tidow C, Krämer A, Raffoux E, Döhner K, Schlenk RF, Voss F, Taube T, Fritsch H, Maertens J (2014)
    Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
    Blood, 124 (9), 1426-33
    DOI 10.1182/blood-2014-03-560557, PubMed 25006120
  6. Eide NA, Baerland TP, Sauesund E, Lømo J, Lund-Iversen M, Liestøl S (2014)
    Relapse of acute lymphoblastic leukaemia (ALL)
    Acta Ophthalmol, 93 (5), e395-6
    DOI 10.1111/aos.12619, PubMed 25495443
  7. Geisler CH, van T' Veer MB, Jurlander J, Walewski J, Tjønnfjord G, Itälä Remes M, Kimby E, Kozak T, Polliack A, Wu KL, Wittebol S, Abrahamse-Testroote MC, Doorduijn J, Ghidey Alemayehu W, van Oers MH (2014)
    Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL
    Blood, 123 (21), 3255-62
    DOI 10.1182/blood-2014-01-547737, PubMed 24735962
  8. Haig Y, Enden T, Slagsvold CE, Sandvik L, Sandset PM, Kløw NE (2014)
    Residual rates of reflux and obstruction and their correlation to post-thrombotic syndrome in a randomized study on catheter-directed thrombolysis for deep vein thrombosis
    J Vasc Surg Venous Lymphat Disord, 2 (2), 123-30
    DOI 10.1016/j.jvsv.2013.10.054, PubMed 26993176
  9. Hallstensen RF, Bergseth G, Foss S, Jæger S, Gedde-Dahl T, Holt J, Christiansen D, Lau C, Brekke OL, Armstrong E, Stefanovic V, Andersen JT, Sandlie I, Mollnes TE (2014)
    Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn
    Immunobiology, 220 (4), 452-9
    DOI 10.1016/j.imbio.2014.11.003, PubMed 25468724
  10. Hjorth-Hansen H, Stenke L, Söderlund S, Dreimane A, Ehrencrona H, Gedde-Dahl T, Gjertsen BT, Höglund M, Koskenvesa P, Lotfi K, Majeed W, Markevärn B, Ohm L, Olsson-Strömberg U, Remes K, Suominen M, Simonsson B, Porkka K, Mustjoki S, Richter J, Nordic CML Study Group (2014)
    Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)
    Eur J Haematol, 94 (3), 243-50
    DOI 10.1111/ejh.12423, PubMed 25082346
  11. Husøy MA, Brinch L, Tjønnfjord GE, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I, Kolstad A, Akkök ÇA, Rollag H, Gaustad P, Bergan S, Egeland T, Josefsen D, Kvalheim G, Fløisand Y (2014)
    [Allogeneic stem-cell transplantation in adults 1985-2012: results and development]
    Tidsskr Nor Laegeforen, 134 (16), 1569-75
    DOI 10.4045/tidsskr.13.1415, PubMed 25178233
  12. Knudsen E, Carlsen H, Bøyum A, Benestad HB, Iversen PO (2014)
    No major role for the transcription factor NF-κB in bone marrow function during peritonitis in the mouse
    Int J Hematol, 100 (2), 111-8
    DOI 10.1007/s12185-014-1598-7, PubMed 24859830
  13. Kostovski E, Hjeltnes N, Eriksen EF, Kolset SO, Iversen PO (2014)
    Differences in bone mineral density, markers of bone turnover and extracellular matrix and daily life muscular activity among patients with recent motor-incomplete versus motor-complete spinal cord injury
    Calcif Tissue Int, 96 (2), 145-54
    DOI 10.1007/s00223-014-9947-3, PubMed 25539858
  14. Kristiansen A, Brandt L, Agoritsas T, Akl EA, Berge E, Bondi J, Dahm AE, Granan LP, Halvorsen S, Holme PA, Flem Jacobsen A, Jacobsen EM, Neumann I, Sandset PM, Sætre T, Tveit A, Vartdal T, Guyatt G, Vandvik PO (2014)
    Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process
    Chest, 146 (3), 727-734
    DOI 10.1378/chest.13-2828, PubMed 25180723
  15. Kristiansen HA, Spetalen S, Fløisand Y, Heldal D (2014)
    Eltrombopag in Good's Syndrome
    Case Rep Hematol, 2014, 172139
    DOI 10.1155/2014/172139, PubMed 25389501
  16. Kverneland M, Taubøll E, Selmer KK, Iversen PO, Nakken KO (2014)
    Modified Atkins diet may reduce serum concentrations of antiepileptic drugs
    Acta Neurol Scand, 131 (3), 187-90
    DOI 10.1111/ane.12330, PubMed 25312999
  17. Misceo D, Holmgren A, Louch WE, Holme PA, Mizobuchi M, Morales RJ, De Paula AM, Stray-Pedersen A, Lyle R, Dalhus B, Christensen G, Stormorken H, Tjønnfjord GE, Frengen E (2014)
    A dominant STIM1 mutation causes Stormorken syndrome
    Hum Mutat, 35 (5), 556-64
    DOI 10.1002/humu.22544, PubMed 24619930
  18. Moltu SJ, Sachse D, Blakstad EW, Strømmen K, Nakstad B, Almaas AN, Westerberg AC, Rønnestad A, Brække K, Veierød MB, Iversen PO, Rise F, Berg JP, Drevon CA (2014)
    Urinary metabolite profiles in premature infants show early postnatal metabolic adaptation and maturation
    Nutrients, 6 (5), 1913-30
    DOI 10.3390/nu6051913, PubMed 24824288
  19. Mundal L, Sarancic M, Ose L, Iversen PO, Borgan JK, Veierød MB, Leren TP, Retterstøl K (2014)
    Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010
    J Am Heart Assoc, 3 (6), e001236
    DOI 10.1161/JAHA.114.001236, PubMed 25468658
  20. Narverud I, Retterstøl K, Iversen PO, Halvorsen B, Ueland T, Ulven SM, Ose L, Aukrust P, Veierød MB, Holven KB (2014)
    Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review
    Atherosclerosis, 235 (2), 299-309
    DOI 10.1016/j.atherosclerosis.2014.05.917, PubMed 24908240
  21. Panagopoulos I, Torkildsen S, Gorunova L, Tierens A, Tjønnfjord GE, Heim S (2014)
    Comparison between karyotyping-FISH-reverse transcription PCR and RNA-sequencing-fusion gene identification programs in the detection of KAT6A-CREBBP in acute myeloid leukemia
    PLoS One, 9 (5), e96570
    DOI 10.1371/journal.pone.0096570, PubMed 24798186
  22. Pitkänen H, Jouppila A, Mowinckel MC, Lemponen M, Patiwael S, Sandset PM, Lassila R, Brinkman HJ (2014)
    Enhanced thrombin generation and reduced intact protein S in processed solvent detergent plasma
    Thromb Res, 135 (1), 167-74
    DOI 10.1016/j.thromres.2014.10.020, PubMed 25466844
  23. Ruffini PA, Os A, Dolcetti R, Tjønnfjord GE, Munthe LA, Bogen B (2014)
    Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice
    J Transl Med, 12, 207
    DOI 10.1186/1479-5876-12-207, PubMed 25059102
  24. Samarakoon PS, Sorte HS, Kristiansen BE, Skodje T, Sheng Y, Tjønnfjord GE, Stadheim B, Stray-Pedersen A, Rødningen OK, Lyle R (2014)
    Identification of copy number variants from exome sequence data
    BMC Genomics, 15, 661
    DOI 10.1186/1471-2164-15-661, PubMed 25102989
  25. Sandset PM (2014)
    Combined oral contraceptives increase risk of venous thrombosis according to oestrogen dose and type of progestogen
    Evid Based Med, 19 (5), 194
    DOI 10.1136/ebmed-2014-110011, PubMed 24948124
  26. Subramaniam S, Thielmann I, Morowski M, Pragst I, Sandset PM, Nieswandt B, Etscheid M, Kanse SM (2014)
    Defective thrombus formation in mice lacking endogenous factor VII activating protease (FSAP)
    Thromb Haemost, 113 (4), 870-80
    DOI 10.1160/TH14-06-0519, PubMed 25427855
  27. Taraldsrud E, Fevang B, Aukrust P, Beiske KH, Fløisand Y, Frøland S, Rollag H, Olweus J (2014)
    Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9
    Clin Exp Immunol, 175 (3), 439-48
    DOI 10.1111/cei.12239, PubMed 24237110
  28. Tavoly M, Jelsness-Jørgensen LP, Wik HS, Roaldsnes C, Sandset PM, Ghanima W (2014)
    Quality of life after pulmonary embolism: first cross-cultural evaluation of the pulmonary embolism quality-of-life (PEmb-QoL) questionnaire in a Norwegian cohort
    Qual Life Res, 24 (2), 417-25
    DOI 10.1007/s11136-014-0779-4, PubMed 25120017
  29. Tinholt M, Viken MK, Dahm AE, Vollan HK, Sahlberg KK, Garred O, Børresen-Dale AL, Jacobsen AF, Kristensen V, Bukholm I, Kåresen R, Schlichting E, Skretting G, Lie BA, Sandset PM, Iversen N (2014)
    Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study
    BMC Cancer, 14, 845
    DOI 10.1186/1471-2407-14-845, PubMed 25407022
  30. Tobiasson M, Dybedahl I, Holm MS, Karimi M, Brandefors L, Garelius H, Grövdal M, Högh-Dufva I, Grønbæk K, Jansson M, Marcher C, Nilsson L, Kittang AO, Porwit A, Saft L, Möllgård L, Hellström-Lindberg E (2014)
    Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial
    Blood Cancer J, 4, e189
    DOI 10.1038/bcj.2014.8, PubMed 24608733
  31. Tran HT, Sørensen B, Bjørnsen S, Pripp AH, Tjønnfjord GE, Andre Holme P (2014)
    Monitoring bypassing agent therapy - a prospective crossover study comparing thromboelastometry and thrombin generation assay
    Haemophilia, 21 (2), 275-83
    DOI 10.1111/hae.12570, PubMed 25521720
  32. Tvedt TH, Holme PA, Bruserud Ø (2014)
    [A man in his 80s with muscle stiffness and skin bleeding]
    Tidsskr Nor Laegeforen, 134 (10), 1058-61
    DOI 10.4045/tidsskr.13.0817, PubMed 24865732
  33. Vangen S, Ellingsen L, Andersgaard AB, Jacobsen AF, Lorentzen B, Nyfløt LT, Rygh AB, Skulstad SM, Tappert C, Øian P (2014)
    Maternal deaths in Norway 2005-2009
    Tidsskr Nor Laegeforen, 134 (8), 836-9
    DOI 10.4045/tidsskr.13.0203, PubMed 24780982
  34. von Krogh AS, Kremer Hovinga JA, Tjønnfjord GE, Ringen IM, Lämmle B, Waage A, Quist-Paulsen P (2014)
    The impact of congenital thrombotic thrombocytopenic purpura on pregnancy complications
    Thromb Haemost, 111 (6), 1180-3
    DOI 10.1160/TH13-08-0713, PubMed 24499950
  35. Woll PS, Kjällquist U, Chowdhury O, Doolittle H, Wedge DC, Thongjuea S, Erlandsson R, Ngara M, Anderson K, Deng Q, Mead AJ, Stenson L, Giustacchini A, Duarte S, Giannoulatou E, Taylor S, Karimi M, Scharenberg C, Mortera-Blanco T, Macaulay IC, Clark SA, Dybedal I, Josefsen D, Fenaux P, Hokland P et al. (2014)
    Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
    Cancer Cell, 25 (6), 794-808
    DOI 10.1016/j.ccr.2014.03.036, PubMed 24835589
  36. Zeidler C, Grote UA, Nickel A, Brand B, Carlsson G, Cortesão E, Dufour C, Duhem C, Notheis G, Papadaki HA, Tamary H, Tjønnfjord GE, Tucci F, Van Droogenbroeck J, Vermylen C, Voglova J, Xicoy B, Welte K (2014)
    Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry
    Haematologica, 99 (8), 1395-402
    DOI 10.3324/haematol.2013.099101, PubMed 24997149

Publications 2013

  1. Cui XY, Skretting G, Jing Y, Sun H, Sandset PM, Sun L (2013)
    Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells
    Blood Cells Mol Dis, 51 (3), 177-84
    DOI 10.1016/j.bcmd.2013.05.003, PubMed 23725749
  2. Dahm A (2013)
    [A. Dahm replies]
    Tidsskr Nor Laegeforen, 133 (16), 1687
    DOI 10.4045/tidsskr.13.1020, PubMed 24005699
  3. Enden T, Kløw NE, Sandset PM (2013)
    Symptom burden and job absenteeism after treatment with additional catheter-directed thrombolysis for deep vein thrombosis
    Patient Relat Outcome Meas, 4, 55-9
    DOI 10.2147/PROM.S47233, PubMed 24082798
  4. Enden T, Resch S, White C, Wik HS, Kløw NE, Sandset PM (2013)
    Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis
    J Thromb Haemost, 11 (6), 1032-42
    DOI 10.1111/jth.12184, PubMed 23452204
  5. Enden T, Wik HS, Kvam AK, Haig Y, Kløw NE, Sandset PM (2013)
    Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study
    BMJ Open, 3 (8), e002984
    DOI 10.1136/bmjopen-2013-002984, PubMed 23988361
  6. Fernandes AM, Herlofsen SR, Karlsen TA, Küchler AM, Fløisand Y, Brinchmann JE (2013)
    Similar properties of chondrocytes from osteoarthritis joints and mesenchymal stem cells from healthy donors for tissue engineering of articular cartilage
    PLoS One, 8 (5), e62994
    DOI 10.1371/journal.pone.0062994, PubMed 23671648
  7. Gerull S, Stern M, Apperley J, Beelen D, Brinch L, Bunjes D, Butler A, Ganser A, Ghavamzadeh A, Koh MB, Komarnicki M, Kröger N, Maertens J, Maschan A, Peters C, Rovira M, Sengeløv H, Socié G, Tischer J, Oneto R, Passweg J, Marsh J (2013)
    Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation
    Haematologica, 98 (11), 1804-9
    DOI 10.3324/haematol.2013.091074, PubMed 23894010
  8. Ghanima W, Atar D, Sandset PM (2013)
    New oral anticoagulants--a review
    Tidsskr Nor Laegeforen, 133 (18), 1940-5
    DOI 10.4045/tidsskr.12.1111, PubMed 24084970
  9. Ghanima W, Knutsen H, Delabie J, Bruserud Ø (2013)
    [Primary myelofibrosis--pathogenesis, diagnosis and treatment]
    Tidsskr Nor Laegeforen, 133 (18), 1946-50
    DOI 10.4045/tidsskr.12.1106, PubMed 24084971
  10. Gravensteen IK, Helgadóttir LB, Jacobsen EM, Rådestad I, Sandset PM, Ekeberg O (2013)
    Women's experiences in relation to stillbirth and risk factors for long-term post-traumatic stress symptoms: a retrospective study
    BMJ Open, 3 (10), e003323
    DOI 10.1136/bmjopen-2013-003323, PubMed 24154514
  11. Helgadóttir LB, Turowski G, Skjeldestad FE, Jacobsen AF, Sandset PM, Roald B, Jacobsen EM (2013)
    Classification of stillbirths and risk factors by cause of death--a case-control study
    Acta Obstet Gynecol Scand, 92 (3), 325-33
    DOI 10.1111/aogs.12044, PubMed 23157574
  12. Holm AM, Riise GC, Brinch L, Bjørtuft O, Iversen M, Simonsen S, Fløisand Y (2013)
    Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: unresolved questions
    Transplantation, 96 (4), e21-2
    DOI 10.1097/TP.0b013e31829df2c0, PubMed 23958883
  13. Iversen PO, Negaard H, Østenstad B, Sandset PM, Kolset SO (2013)
    Evidence for long-term hypercoagulopathy, but normalization of markers of extracellular matrix turnover, in patients with non-Hodgkin lymphoma
    Leuk Lymphoma, 56 (8), 2479-81
    DOI 10.3109/10428194.2013.803227, PubMed 23656198
  14. Kostovski E, Boon H, Hjeltnes N, Lundell LS, Ahlsén M, Chibalin AV, Krook A, Iversen PO, Widegren U (2013)
    Altered content of AMP-activated protein kinase isoforms in skeletal muscle from spinal cord injured subjects
    Am J Physiol Endocrinol Metab, 305 (9), E1071-80
    DOI 10.1152/ajpendo.00132.2013, PubMed 24022865
  15. Mathijssen NC, Masereeuw R, Holme PA, van Kraaij MG, Laros-van Gorkom BA, Peyvandi F, van Heerde WL (2013)
    Increased volume of distribution for recombinant activated factor VII and longer plasma-derived factor VII half-life may explain their long lasting prophylactic effect
    Thromb Res, 132 (2), 256-62
    DOI 10.1016/j.thromres.2013.05.027, PubMed 23834817
  16. Mellqvist UH, Gimsing P, Hjertner O, Lenhoff S, Laane E, Remes K, Steingrimsdottir H, Abildgaard N, Ahlberg L, Blimark C, Dahl IM, Forsberg K, Gedde-Dahl T, Gregersen H, Gruber A, Guldbrandsen N, Haukås E, Carlson K, Kvam AK, Nahi H, Lindås R, Andersen NF, Turesson I, Waage A, Westin J et al. (2013)
    Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
    Blood, 121 (23), 4647-54
    DOI 10.1182/blood-2012-11-464503, PubMed 23616624
  17. Mustjoki S, Richter J, Barbany G, Ehrencrona H, Fioretos T, Gedde-Dahl T, Gjertsen BT, Hovland R, Hernesniemi S, Josefsen D, Koskenvesa P, Dybedal I, Markevärn B, Olofsson T, Olsson-Strömberg U, Rapakko K, Thunberg S, Stenke L, Simonsson B, Porkka K, Hjorth-Hansen H, Nordic CML Study Group (NCMLSG) (2013)
    Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
    Leukemia, 27 (7), 1520-6
    DOI 10.1038/leu.2013.19, PubMed 23328954
  18. Os A, Bürgler S, Ribes AP, Funderud A, Wang D, Thompson KM, Tjønnfjord GE, Bogen B, Munthe LA (2013)
    Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells
    Cell Rep, 4 (3), 566-77
    DOI 10.1016/j.celrep.2013.07.011, PubMed 23933259
  19. Randen U, Tierens AM, Tjønnfjord GE, Delabie J (2013)
    Bone marrow histology in monoclonal B-cell lymphocytosis shows various B-cell infiltration patterns
    Am J Clin Pathol, 139 (3), 390-5
    DOI 10.1309/AJCPPHSUQM8XBJH7, PubMed 23429376
  20. Randen U, Trøen G, Tierens A, Steen C, Warsame A, Beiske K, Tjønnfjord GE, Berentsen S, Delabie J (2013)
    Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma
    Haematologica, 99 (3), 497-504
    DOI 10.3324/haematol.2013.091702, PubMed 24143001
  21. Raps M, Helmerhorst FM, Fleischer K, Dahm AE, Rosendaal FR, Rosing J, Reitsma P, Sandset PM, van Vliet HA (2013)
    The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI
    Thromb Haemost, 109 (4), 606-13
    DOI 10.1160/TH12-10-0771, PubMed 23407778
  22. Sandset PM (2013)
    Mechanisms of hormonal therapy related thrombosis
    Thromb Res, 131 Suppl 1, S4-7
    DOI 10.1016/S0049-3848(13)70009-4, PubMed 23452740
  23. Sandset PM (2013)
    Genotype of proband and thrombophilia screening
    Blood, 122 (15), 2528-9
    DOI 10.1182/blood-2013-08-519801, PubMed 24113791
  24. Schjesvold F, Wiencke K, Tjønnfjord GE (2013)
    [Investigation of anemia]
    Tidsskr Nor Laegeforen, 133 (6), 610
    DOI 10.4045/tidsskr.13.0256, PubMed 23552139
  25. Schjesvold FH (2013)
    [Investigation of amyloidosis]
    Tidsskr Nor Laegeforen, 133 (3), 266
    DOI 10.4045/tidsskr.13.0044, PubMed 23381155
  26. Stavik B, Tinholt M, Sletten M, Skretting G, Sandset PM, Iversen N (2013)
    TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity
    J Hematol Oncol, 6, 5
    DOI 10.1186/1756-8722-6-5, PubMed 23320987
  27. Tran HT, Sørensen B, Rea CJ, Bjørnsen S, Ueland T, Pripp AH, Tjønnfjord GE, Holme PA (2013)
    Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors
    Haemophilia, 20 (3), 369-75
    DOI 10.1111/hae.12318, PubMed 24251535
  28. Tran HT, Tjønnfjord GE, Holme PA (2013)
    Use of thromboelastography and thrombin generation assay to predict clinical phenotype in patients with severe FVII deficiency
    Haemophilia, 20 (1), 141-6
    DOI 10.1111/hae.12256, PubMed 23992369
  29. van Geffen M, Mathijssen NC, Holme PA, Laros-van Gorkom BA, van Kraaij MG, Masereeuw R, Peyvandi F, van Heerde WL (2013)
    Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients
    Thromb Res, 132 (1), 116-22
    DOI 10.1016/j.thromres.2013.04.021, PubMed 23731565
  30. Vojdeman FJ, Jurlander J, van't Veer M, Itälä-Remes M, Kimby E, Tjønnfjord GE, Walewski J, Kozák T, Polliack A, Montagna M, Regazzi M, Kirkby N, van Oers M, Geisler CH (2013)
    Plasma alemtuzumab levels in patients with chronic lymphocytic leukemia treated with alemtuzumab combined with chemotherapy reflect the efficacy of the treatment: a hypothesis
    Leuk Lymphoma, 54 (4), 790-3
    DOI 10.3109/10428194.2012.720373, PubMed 23025267
  31. Westberg M, Paus AC, Holme PA, Tjønnfjord GE (2013)
    Haemophilic arthropathy: long-term outcomes in 107 primary total knee arthroplasties
    Knee, 21 (1), 147-50
    DOI 10.1016/j.knee.2013.09.010, PubMed 24156923
  32. Whiteley WN, Adams HP, Bath PM, Berge E, Sandset PM, Dennis M, Murray GD, Wong KS, Sandercock PA (2013)
    Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials
    Lancet Neurol, 12 (6), 539-45
    DOI 10.1016/S1474-4422(13)70079-6, PubMed 23642343
  33. Wik HS, Jacobsen AF, Fagerland MW, Sandvik L, Sandset PM (2013)
    Long-term mortality and incidence of cancer after pregnancy-related venous thrombosis: results of a population-based cohort study
    Thromb Res, 131 (6), 497-501
    DOI 10.1016/j.thromres.2013.04.035, PubMed 23726964

Publications 2012

  1. Abildgaard U, Heimdal K (2012)
    Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review
    Eur J Obstet Gynecol Reprod Biol, 166 (2), 117-23
    DOI 10.1016/j.ejogrb.2012.09.026, PubMed 23107053
  2. Akkök CA, Haugaa H, Galgerud A, Brinch L (2012)
    Severe hemolytic transfusion reaction due to anti-A1 following allogeneic stem cell transplantation with minor ABO incompatibility
    Transfus Apher Sci, 48 (1), 63-6
    DOI 10.1016/j.transci.2012.07.006, PubMed 22902604
  3. Bastani NE, Kostovski E, Sakhi AK, Karlsen A, Carlsen MH, Hjeltnes N, Blomhoff R, Iversen PO (2012)
    Reduced antioxidant defense and increased oxidative stress in spinal cord injured patients
    Arch Phys Med Rehabil, 93 (12), 2223-8.e2
    DOI 10.1016/j.apmr.2012.06.021, PubMed 22772083
  4. Batorova A, Holme P, Gringeri A, Richards M, Hermans C, Altisent C, Lopez-Fernández M, Fijnvandraat K, European Haemophilia Treatment Standardisation Board (2012)
    Continuous infusion in haemophilia: current practice in Europe
    Haemophilia, 18 (5), 753-9
    DOI 10.1111/j.1365-2516.2012.02810.x, PubMed 22530687
  5. Berentsen S, Tjønnfjord GE (2012)
    Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia
    Blood Rev, 26 (3), 107-15
    DOI 10.1016/j.blre.2012.01.002, PubMed 22330255
  6. Bergrem A, Dahm AE, Jacobsen AF, Sandvik L, Sandset PM (2012)
    Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism: a population-based case-control study
    Thromb Haemost, 108 (6), 1165-71
    DOI 10.1160/TH12-05-0350, PubMed 23015030
  7. Boon H, Kostovski E, Pirkmajer S, Song M, Lubarski I, Iversen PO, Hjeltnes N, Widegren U, Chibalin AV (2012)
    Influence of chronic and acute spinal cord injury on skeletal muscle Na+-K+-ATPase and phospholemman expression in humans
    Am J Physiol Endocrinol Metab, 302 (7), E864-71
    DOI 10.1152/ajpendo.00625.2011, PubMed 22275761
  8. Bye A, Jordhøy MS, Skjegstad G, Ledsaak O, Iversen PO, Hjermstad MJ (2012)
    Symptoms in advanced pancreatic cancer are of importance for energy intake
    Support Care Cancer, 21 (1), 219-27
    DOI 10.1007/s00520-012-1514-8, PubMed 22684989
  9. Dahm AE, Bezemer ID, Bergrem A, Jacobsen AF, Jacobsen EM, Skretting G, Rosendaal FR, Sandset PM (2012)
    Candidate gene polymorphisms and the risk for pregnancy-related venous thrombosis
    Br J Haematol, 157 (6), 753-61
    DOI 10.1111/j.1365-2141.2012.09121.x, PubMed 22533697
  10. Dahm AE, Eilertsen AL, Goeman J, Olstad OK, Ovstebø R, Kierulf P, Mowinckel MC, Skretting G, Sandset PM (2012)
    A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women
    Thromb Res, 130 (1), 45-51
    DOI 10.1016/j.thromres.2011.12.009, PubMed 22217510
  11. Enden T, Klow NE, Sandset PM (2012)
    Catheter-directed thrombolysis for acute deep vein thrombosis Reply
    Lancet, 379 (9828), 1786-1787
  12. Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE, Dybedal I, Holte H, Heldal D, Torfoss D, Aurlien E, Lauritzsen GF, Fosså A, Lehne G, Baggerød E, Kvalheim G, Egeland T, Bishop MR, Fowler DH, Kolstad A (2012)
    Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation
    Bone Marrow Transplant, 47 (12), 1552-7
    DOI 10.1038/bmt.2012.63, PubMed 22522568
  13. Fløisand Y, Tjønnfjord G, Beiske K (2012)
    [Invasive fungal infection]
    Tidsskr Nor Laegeforen, 132 (23-24), 2618
    DOI 10.4045/tidsskr.12.0603, PubMed 23338093
  14. Ghanima W, Lee SY, Barsam S, Miller A, Sandset PM, Bussel JB (2012)
    Venous thromboembolism and coagulation activity in patients with immune thrombocytopenia treated with thrombopoietin receptor agonists
    Br J Haematol, 158 (6), 811-4
    DOI 10.1111/j.1365-2141.2012.09227.x, PubMed 22816787
  15. Gravensteen IK, Helgadottir LB, Jacobsen EM, Sandset PM, Ekeberg Ø (2012)
    Long-term impact of intrauterine fetal death on quality of life and depression: a case-control study
    BMC Pregnancy Childbirth, 12, 43
    DOI 10.1186/1471-2393-12-43, PubMed 22676992
  16. Haig Y, Enden T, Slagsvold CE, Sandvik L, Sandset PM, Kløw NE (2012)
    Determinants of early and long-term efficacy of catheter-directed thrombolysis in proximal deep vein thrombosis
    J Vasc Interv Radiol, 24 (1), 17-24; quiz 26
    DOI 10.1016/j.jvir.2012.09.023, PubMed 23176966
  17. Hjorth M, Hjertner Ø, Knudsen LM, Gulbrandsen N, Holmberg E, Pedersen PT, Andersen NF, Andréasson B, Billström R, Carlson K, Carlsson MS, Flogegård M, Forsberg K, Gimsing P, Karlsson T, Linder O, Nahi H, Othzén A, Swedin A, Nordic Myeloma Study Group (NMSG) (2012)
    Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study
    Eur J Haematol, 88 (6), 485-96
    DOI 10.1111/j.1600-0609.2012.01775.x, PubMed 22404182
  18. Holm AM, Riise GC, Hansson L, Brinch L, Bjørtuft O, Iversen M, Simonsen S, Fløisand Y (2012)
    Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT
    Bone Marrow Transplant, 48 (5), 703-7
    DOI 10.1038/bmt.2012.197, PubMed 23064037
  19. Holmström M, Tran HT, Holme PA (2012)
    Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A--a two-centre experience
    Haemophilia, 18 (4), 544-9
    DOI 10.1111/j.1365-2516.2012.02748.x, PubMed 22348384
  20. IST-3 collaborative group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A (2012)
    The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
    Lancet, 379 (9834), 2352-63
    DOI 10.1016/S0140-6736(12)60768-5, PubMed 22632908
  21. Jacobsen AF, Sandset PM (2012)
    Venous thromboembolism associated with pregnancy and hormonal therapy
    Best Pract Res Clin Haematol, 25 (3), 319-32
    DOI 10.1016/j.beha.2012.07.006, PubMed 22959548
  22. Narverud I, Iversen PO, Aukrust P, Halvorsen B, Ueland T, Johansen SG, Nenseter MS, Sandset PM, Ulven SM, Ose L, Retterstøl K, Holven KB (2012)
    Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH
    Thromb Res, 131 (2), 178-82
    DOI 10.1016/j.thromres.2012.11.008, PubMed 23199546
  23. Nyquist KB, Panagopoulos I, Thorsen J, Roberto R, Wik HS, Tierens A, Heim S, Micci F (2012)
    t(12;13)(q14;q31) leading to HMGA2 upregulation in acute myeloid leukaemia
    Br J Haematol, 157 (6), 769-71
    DOI 10.1111/j.1365-2141.2012.09081.x, PubMed 22404713
  24. Sandset EC, Murray GD, Bath PM, Kjeldsen SE, Berge E, Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group (2012)
    Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome
    Stroke, 43 (8), 2108-14
    DOI 10.1161/STROKEAHA.111.647362, PubMed 22627991
  25. Sandset PM (2012)
    CXCL4-platelet factor 4, heparin-induced thrombocytopenia and cancer
    Thromb Res, 129 Suppl 1, S97-100
    DOI 10.1016/S0049-3848(12)70026-9, PubMed 22682144
  26. Skretting G, Iversen N, Myklebust CF, Dahm AE, Sandset PM (2012)
    Overexpression of tissue factor pathway inhibitor in CHO-K1 cells results in increased activation of NF-κB and apoptosis mediated by a caspase-3 independent pathway
    Mol Biol Rep, 39 (12), 10089-96
    DOI 10.1007/s11033-012-1882-7, PubMed 22932941
  27. Stavik B, Skretting G, Olstad OK, Sletten M, Dehli Vigeland M, Sandset PM, Iversen N (2012)
    TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells
    PLoS One, 7 (10), e47184
    DOI 10.1371/journal.pone.0047184, PubMed 23071754
  28. Thorsen J, Aamot HV, Roberto R, Tjønnfjord GE, Micci F, Heim S (2012)
    Myelodysplastic syndrome with a t(2;11)(p21;q23-24) and translocation breakpoint close to miR-125b-1
    Cancer Genet, 205 (10), 528-32
    DOI 10.1016/j.cancergen.2012.06.003, PubMed 22944560
  29. Tjønnfjord GE, Jønsson V, Ly BE, Johannesen TB (2012)
    Familial occurrence of chronic lymphocytic leukaemia in Norway
    Tidsskr Nor Laegeforen, 132 (18), 2060-3
    DOI 10.4045/tidsskr.11.1350, PubMed 23038196
  30. Tjønnfjord GE, Ly BE, Johannesen TB, Tierens A, Beiske K, Heim S, Jønsson V (2012)
    Chronic lymphocytic leukaemia in Norway--incidence and prognostic markers at diagnosis
    Tidsskr Nor Laegeforen, 132 (18), 2056-9
    DOI 10.4045/tidsskr.11.1349, PubMed 23038195
  31. Turowski G, Berge LN, Helgadottir LB, Jacobsen EM, Roald B (2012)
    A new, clinically oriented, unifying and simple placental classification system
    Placenta, 33 (12), 1026-35
    DOI 10.1016/j.placenta.2012.10.002, PubMed 23110739
  32. Vandvik PO, Sandset PM (2012)
    [Confusion regarding evidence-based advice]
    Tidsskr Nor Laegeforen, 132 (10), 1204
    DOI 10.4045/tidsskr.12.0490, PubMed 22669369
  33. Wik HS, Jacobsen AF, Sandvik L, Sandset PM (2012)
    Long-term impact of pregnancy-related venous thrombosis on quality-of-life, general health and functioning: results of a cross-sectional, case-control study
    BMJ Open, 2 (6)
    DOI 10.1136/bmjopen-2012-002048, PubMed 23144263
  34. Wik HS, Jacobsen AF, Sandvik L, Sandset PM (2012)
    Prevalence and predictors for post-thrombotic syndrome 3 to 16 years after pregnancy-related venous thrombosis: a population-based, cross-sectional, case-control study
    J Thromb Haemost, 10 (5), 840-7
    DOI 10.1111/j.1538-7836.2012.04690.x, PubMed 22452811

Publications 2011

  1. Abelsson J, Merup M, Birgegård G, WeisBjerrum O, Brinch L, Brune M, Johansson P, Kauppila M, Lenhoff S, Liljeholm M, Malm C, Remes K, Vindelöv L, Andréasson B, Nordic MPD Study Group (2011)
    The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries
    Bone Marrow Transplant, 47 (3), 380-6
    DOI 10.1038/bmt.2011.91, PubMed 21552298
  2. Alatri A, Armstrong AE, Greinacher A, Koster A, Kozek-Langenecker SA, Lancé MD, Link A, Nielsen JD, Sandset PM, Spanjersberg AJ, Spannagl M (2011)
    Results of a consensus meeting on the use of argatroban in patients with heparin-induced thrombocytopenia requiring antithrombotic therapy - a European Perspective
    Thromb Res, 129 (4), 426-33
    DOI 10.1016/j.thromres.2011.11.041, PubMed 22178575
  3. Andresen MS, Sandven I, Brunborg C, Njaastad AM, Strekerud F, Abdelnoor M, Smith P, Abildgaard U (2011)
    Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy
    Thromb Res, 127 (6), 540-6
    DOI 10.1016/j.thromres.2011.02.017, PubMed 21435698
  4. Bergrem A, Dahm AE, Jacobsen AF, Mowinckel MC, Sandvik L, Sandset PM (2011)
    Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism
    Br J Haematol, 154 (2), 241-7
    DOI 10.1111/j.1365-2141.2011.08712.x, PubMed 21564075
  5. Enden T, Haig Y, Kløw NE, Slagsvold CE, Sandvik L, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbæk G, Sandset PM, CaVenT Study Group (2011)
    Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial
    Lancet, 379 (9810), 31-8
    DOI 10.1016/S0140-6736(11)61753-4, PubMed 22172244
  6. Fløisand Y, Delabie J, Fosså A, Helseth E, Jacobsen EA, Rolke J, Tjønnfjord GE (2011)
    Richter syndrome presenting as a solitary cerebellar tumor during first-line treatment for chronic lymphocytic leukemia
    Leuk Lymphoma, 52 (10), 2007-9
    DOI 10.3109/10428194.2011.580480, PubMed 21663503
  7. Frøyland M, Ruffini PA, Thompson KM, Gedde-Dahl T, Fredriksen AB, Bogen B (2011)
    Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing
    Eur J Haematol, 86 (5), 385-95
    DOI 10.1111/j.1600-0609.2011.01590.x, PubMed 21332794
  8. Ghanima W, Kleven IW, Enden T, Rosales A, Wik HS, Pederstad L, Holme PA, Sandset PM (2011)
    Recurrent venous thrombosis, post-thrombotic syndrome and quality of life after catheter-directed thrombolysis in severe proximal deep vein thrombosis
    J Thromb Haemost, 9 (6), 1261-3
    DOI 10.1111/j.1538-7836.2011.04298.x, PubMed 21489133
  9. Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM (2011)
    The association of antiphospholipid antibodies with intrauterine fetal death: a case-control study
    Thromb Res, 130 (1), 32-7
    DOI 10.1016/j.thromres.2011.11.029, PubMed 22178574
  10. Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM (2011)
    The association of inherited thrombophilia and intrauterine fetal death: a case-control study
    Blood Coagul Fibrinolysis, 22 (8), 651-6
    DOI 10.1097/MBC.0b013e32834a614c, PubMed 22198364
  11. Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM (2011)
    Incidence and risk factors of fetal death in Norway: a case-control study
    Acta Obstet Gynecol Scand, 90 (4), 390-7
    DOI 10.1111/j.1600-0412.2011.01079.x, PubMed 21306337
  12. Jønsson V, Awan H, Nyquist E, Maisenhølder M, Johannesen TB, Ly B, Tjønnfjord GE (2011)
    Familial Hodgkin's lymphoma in Scandinavia
    In Vivo, 25 (3), 431-7
    PubMed 21576419
  13. Karlsen TA, Mirtaheri P, Shahdadfar A, Fløisand Y, Brinchmann JE (2011)
    Effect of three-dimensional culture and incubator gas concentration on phenotype and differentiation capability of human mesenchymal stem cells
    J Cell Biochem, 112 (2), 684-93
    DOI 10.1002/jcb.22978, PubMed 21268090
  14. Knudsen E, Iversen PO, Bøyum A, Seierstad T, Nicolaysen G, Benestad HB (2011)
    G-CSF enhances the proliferation and mobilization, but not the maturation rate, of murine myeloid cells
    Eur J Haematol, 87 (4), 302-11
    DOI 10.1111/j.1600-0609.2011.01658.x, PubMed 21623923
  15. Kostovski E, Dahm AE, Iversen N, Hjeltnes N, Østerud B, Sandset PM, Iversen PO (2011)
    Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium
    Blood Coagul Fibrinolysis, 22 (4), 254-9
    DOI 10.1097/MBC.0b013e3283442ce2, PubMed 21297449
  16. Kvam AK, Fayers PM, Wisloff F (2011)
    Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma
    Eur J Haematol, 87 (4), 330-7
    DOI 10.1111/j.1600-0609.2011.01665.x, PubMed 21668504
  17. Lassila R, Antovic JP, Armstrong E, Baghaei F, Dalsgaard-Nielsen J, Hillarp A, Holme PA, Holmström M, Johnsson H, Joutsi-Korhonen L, Sandset PM (2011)
    Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia
    Semin Thromb Hemost, 37 (3), 328-36
    DOI 10.1055/s-0031-1274516, PubMed 21455867
  18. Lassila R, Holme PA, Landorph A, Petrini P, Onundarson PT, Hillarp A (2011)
    Nordic Haemophilia Council's practical guidelines on diagnosis and management of von Willebrand disease
    Semin Thromb Hemost, 37 (5), 495-502
    DOI 10.1055/s-0031-1281034, PubMed 22102192
  19. Ljungman P, Locasciulli A, de Soria VG, Békássy AN, Brinch L, Espigado I, Ferrant A, Franklin IM, O'Riordan J, Rovira M, Shaw P, Einsele H, Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (2011)
    Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy
    Bone Marrow Transplant, 47 (9), 1217-21
    DOI 10.1038/bmt.2011.238, PubMed 22158388
  20. Mead GE, Graham C, Dorman P, Bruins SK, Lewis SC, Dennis MS, Sandercock PA, UK Collaborators of IST (2011)
    Fatigue after stroke: baseline predictors and influence on survival. Analysis of data from UK patients recruited in the International Stroke Trial
    PLoS One, 6 (3), e16988
    DOI 10.1371/journal.pone.0016988, PubMed 21445242
  21. Negaard HF, Sandset PM, Kolset SO, Svennevig K, Østenstad B, Iversen PO (2011)
    Associations between regulators of extracellular matrix and hemostatic factors in hematologic neoplasias
    Leuk Lymphoma, 52 (6), 1157-9
    DOI 10.3109/10428194.2011.563886, PubMed 21463121
  22. Nilsson-Ehle H, Birgegård G, Samuelsson J, Antunovic P, Astermark J, Garelius H, Engström LM, Kjeldsen L, Nilsson L, Olsson A, Skov-Holm M, Wallvik J, Gulbrandsen N, Hellström-Lindberg E (2011)
    Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions
    Eur J Haematol, 87 (3), 244-52
    DOI 10.1111/j.1600-0609.2011.01654.x, PubMed 21623919
  23. Nyquist KB, Thorsen J, Zeller B, Haaland A, Trøen G, Heim S, Micci F (2011)
    Identification of the TAF15-ZNF384 fusion gene in two new cases of acute lymphoblastic leukemia with a t(12;17)(p13;q12)
    Cancer Genet, 204 (3), 147-52
    DOI 10.1016/j.cancergen.2011.01.003, PubMed 21504714
  24. Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, Aandahl EM, Sandset PM, Taskén K, Kvale D (2011)
    An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
    J Virol, 85 (13), 6557-66
    DOI 10.1128/JVI.00073-11, PubMed 21490090
  25. Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, Thijs V, Berge E, SCAST Study Group (2011)
    The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
    Lancet, 377 (9767), 741-50
    DOI 10.1016/S0140-6736(11)60104-9, PubMed 21316752
  26. Slaastad H, Wu W, Goullart L, Kanderova V, Tjønnfjord G, Stuchly J, Kalina T, Holm A, Lund-Johansen F (2011)
    Multiplexed immuno-precipitation with 1725 commercially available antibodies to cellular proteins
    Proteomics, 11 (23), 4578-82
    DOI 10.1002/pmic.201000744, PubMed 21956872
  27. Stavik B, Skretting G, Aasheim HC, Tinholt M, Zernichow L, Sletten M, Sandset PM, Iversen N (2011)
    Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility
    BMC Cancer, 11, 357
    DOI 10.1186/1471-2407-11-357, PubMed 21849050
  28. Tangen JM, Jaworska A, Mattsson H (2011)
    The Fukushima accident--health consequences
    Tidsskr Nor Laegeforen, 131 (23), 2342-3
    DOI 10.4045/tidsskr.11.0957, PubMed 22139113
  29. Tjeldhorn L, Iversen N, Sandvig K, Bergan J, Sandset PM, Skretting G (2011)
    Protein C mutation (A267T) results in ER retention and unfolded protein response activation
    PLoS One, 6 (8), e24009
    DOI 10.1371/journal.pone.0024009, PubMed 21901152
  30. Tran HT, Tjønnfjord GE, Paus A, Holme PA (2011)
    rFVIIa administered by continuous infusion during surgery in patients with severe congenital FVII deficiency
    Haemophilia, 17 (5), 764-70
    DOI 10.1111/j.1365-2516.2011.02596.x, PubMed 21707871
  31. Vetlesen A, Holme PA, Lyberg T, Kjeldsen-Kragh J (2011)
    Recovery, survival, and function of transfused platelets and detection of platelet engraftment after allogeneic stem cell transplantation
    Transfusion, 52 (6), 1321-32
    DOI 10.1111/j.1537-2995.2011.03442.x, PubMed 22084943
  32. Wang Y, Brinch L, Jebsen P, Tanbo T, Kirschner R (2011)
    A clinical study of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation
    Biol Blood Marrow Transplant, 18 (5), 747-53
    DOI 10.1016/j.bbmt.2011.09.012, PubMed 21963879
  33. Westerberg AC, Schei R, Henriksen C, Smith L, Veierød MB, Drevon CA, Iversen PO (2011)
    Attention among very low birth weight infants following early supplementation with docosahexaenoic and arachidonic acid
    Acta Paediatr, 100 (1), 47-52
    DOI 10.1111/j.1651-2227.2010.01946.x, PubMed 20624152
  34. Wik HS, Enden TR, Jacobsen AF, Sandset PM (2011)
    Long-term quality of life after pregnancy-related deep vein thrombosis and the influence of socioeconomic factors and comorbidity
    J Thromb Haemost, 9 (10), 1931-6
    DOI 10.1111/j.1538-7836.2011.04468.x, PubMed 21848904

Publications 2010

  1. Abrahamsen IW, Stronen E, Wälchli S, Johansen JN, Kjellevoll S, Kumari S, Komada M, Gaudernack G, Tjonnfjord G, Toebes M, Schumacher TN, Lund-Johansen F, Olweus J (2010)
    Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif
    Leukemia, 24 (11), 1901-9
    DOI 10.1038/leu.2010.186, PubMed 20844564
  2. Astermark J, Altisent C, Batorova A, Diniz MJ, Gringeri A, Holme PA, Karafoulidou A, Lopez-Fernández MF, Reipert BM, Rocino A, Schiavoni M, von Depka M, Windyga J, Fijnvandraat K, European Haemophilia Therapy Standardisation Board (2010)
    Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report
    Haemophilia, 16 (5), 747-66
    DOI 10.1111/j.1365-2516.2010.02231.x, PubMed 20398077
  3. Austbø L, Røed KH, Dolvik NI, Skretting G (2010)
    Identification of differentially expressed genes associated with osteochondrosis in standardbred horses using RNA arbitrarily primed PCR
    Anim Biotechnol, 21 (2), 135-9
    DOI 10.1080/10495391003608316, PubMed 20379890
  4. Berentsen S, Randen U, Vågan AM, Hjorth-Hansen H, Vik A, Dalgaard J, Jacobsen EM, Thoresen AS, Beiske K, Tjønnfjord GE (2010)
    High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease
    Blood, 116 (17), 3180-4
    DOI 10.1182/blood-2010-06-288647, PubMed 20634373
  5. Bergrem A, Jacobsen EM, Skjeldestad FE, Jacobsen AF, Skogstad M, Sandset PM (2010)
    The association of antiphospholipid antibodies with pregnancy-related first time venous thrombosis--a population-based case-control study
    Thromb Res, 125 (5), e222-7
    DOI 10.1016/j.thromres.2009.12.006, PubMed 20051285
  6. Bjornaas MA, Jacobsen EM, Jacobsen D (2010)
    Nonfatal self-poisoning with LMW heparin and the use of antidote
    Thromb Res, 126 (5), e403-5
    DOI 10.1016/j.thromres.2010.08.026, PubMed 20870279
  7. Dahm AE, Bezemer ID, Sandset PM, Rosendaal FR (2010)
    Interaction between tissue factor pathway inhibitor and factor V levels on the risk of venous thrombosis
    J Thromb Haemost, 8 (5), 1130-2
    DOI 10.1111/j.1538-7836.2010.03805.x, PubMed 20149077
  8. Enden T, Storås TH, Negård A, Haig Y, Sandvik L, Gjesdal KI, Sandset PM, Kløw NE (2010)
    Visualization of deep veins and detection of deep vein thrombosis (DVT) with balanced turbo field echo (b-TFE) and contrast-enhanced T1 fast field echo (CE-FFE) using a blood pool agent (BPA)
    J Magn Reson Imaging, 31 (2), 416-24
    DOI 10.1002/jmri.22046, PubMed 20099355
  9. Fløisand Y, Sioud M (2010)
    Recent advances in hematopoietic stem cell transplantation and perspectives of RNAi applications
    Methods Mol Biol, 629, 507-23
    DOI 10.1007/978-1-60761-657-3_30, PubMed 20387168
  10. Gimsing P, Carlson K, Turesson I, Fayers P, Waage A, Vangsted A, Mylin A, Gluud C, Juliusson G, Gregersen H, Hjorth-Hansen H, Nesthus I, Dahl IM, Westin J, Nielsen JL, Knudsen LM, Ahlberg L, Hjorth M, Abildgaard N, Andersen NF, Linder O, Wisløff F (2010)
    Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial
    Lancet Oncol, 11 (10), 973-82
    DOI 10.1016/S1470-2045(10)70198-4, PubMed 20863761
  11. Grövdal M, Karimi M, Khan R, Aggerholm A, Antunovic P, Astermark J, Bernell P, Engström LM, Kjeldsen L, Linder O, Nilsson L, Olsson A, Holm MS, Tangen JM, Wallvik J, Oberg G, Hokland P, Jacobsen SE, Porwit A, Hellström-Lindberg E (2010)
    Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy
    Br J Haematol, 150 (3), 293-302
    DOI 10.1111/j.1365-2141.2010.08235.x, PubMed 20497178
  12. Ha L, Hauge T, Iversen PO (2010)
    Body composition in older acute stroke patients after treatment with individualized, nutritional supplementation while in hospital
    BMC Geriatr, 10, 75
    DOI 10.1186/1471-2318-10-75, PubMed 20955603
  13. Ha L, Hauge T, Spenning AB, Iversen PO (2010)
    Individual, nutritional support prevents undernutrition, increases muscle strength and improves QoL among elderly at nutritional risk hospitalized for acute stroke: a randomized, controlled trial
    Clin Nutr, 29 (5), 567-73
    DOI 10.1016/j.clnu.2010.01.011, PubMed 20176418
  14. Iversen PO, Sørensen DR, Sioud M (2010)
    A combined immunostimulatory and immunoinhibitory short interference RNA reduces hypercoagulability in a rat model of acute promyelocytic leukaemia
    Thromb Haemost, 104 (2), 350-4
    DOI 10.1160/TH09-12-0816, PubMed 20539915
  15. Jacobsen AF, Dahm A, Bergrem A, Jacobsen EM, Sandset PM (2010)
    Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms
    J Thromb Haemost, 8 (11), 2443-9
    DOI 10.1111/j.1538-7836.2010.04038.x, PubMed 20735725
  16. Jensen K, Schaffer L, Olstad OK, Bechensteen AG, Hellebostad M, Tjønnfjord GE, Kierulf P, Gautvik KM, Osnes LT (2010)
    Striking decrease in the total precursor B-cell compartment during early childhood as evidenced by flow cytometry and gene expression changes
    Pediatr Hematol Oncol, 27 (1), 31-45
    DOI 10.3109/08880010903420687, PubMed 20121553
  17. Johnsen HE, Klausen TW, Boegsted M, Lenhoff S, Gimsing P, Christiansen I, Gedde-Dahl T, Lindås R, Mellqvist UH, Nordic Myeloma Study Group (2010)
    Improved survival for multiple myeloma in denmark based on autologous stem cell transplantation and novel drug therapy in collaborative trials: analysis of accrual, prognostic variables, selection bias, and clinical behavior on survival in more than 1200 patients in trials of the nordic myeloma study group
    Clin Lymphoma Myeloma Leuk, 10 (4), 290-6
    DOI 10.3816/CLML.2010.n.060, PubMed 20709667
  18. Jønsson V, Tjønnfjord GE, Johannesen TB, Ly B, Olsen JH, Yuille M (2010)
    Familial chronic lymphocytic leukemia in Norway and Denmark. Comments on pleiotropy and birth order
    In Vivo, 24 (1), 85-95
    PubMed 20133982
  19. Krarup LH, Sandset EC, Sandset PM, Berge E (2010)
    D-dimer levels and stroke progression in patients with acute ischemic stroke and atrial fibrillation
    Acta Neurol Scand, 124 (1), 40-4
    DOI 10.1111/j.1600-0404.2010.01409.x, PubMed 20726843
  20. Kringen MK, Narum S, Lygren I, Seljeflot I, Sandset PM, Trøseid AM, Johansen PW, Brørs O, Holthe MR (2010)
    Reduced platelet function and role of drugs in acute gastrointestinal bleeding
    Basic Clin Pharmacol Toxicol, 108 (3), 194-201
    DOI 10.1111/j.1742-7843.2010.00643.x, PubMed 21118353
  21. Krishnan B, Else M, Tjonnfjord GE, Cazin B, Carney D, Carter J, Ketterer N, Catovsky D, Ethell M, Matutes E, Dearden CE (2010)
    Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study
    Br J Haematol, 149 (6), 907-10
    DOI 10.1111/j.1365-2141.2010.08134.x, PubMed 20201944
  22. Kvam AK, Wisløff F, Fayers PM (2010)
    Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma
    Health Qual Life Outcomes, 8, 79
    DOI 10.1186/1477-7525-8-79, PubMed 20678240
  23. Opstad TB, Eilertsen AL, Høibraaten E, Skretting G, Sandset PM (2010)
    Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy
    Blood Coagul Fibrinolysis, 21 (6), 516-21
    DOI 10.1097/MBC.0b013e32833a06cd, PubMed 20453636
  24. Ruland CM, Holte HH, Røislien J, Heaven C, Hamilton GA, Kristiansen J, Sandbaek H, Kvaløy SO, Hasund L, Ellison MC (2010)
    Effects of a computer-supported interactive tailored patient assessment tool on patient care, symptom distress, and patients' need for symptom management support: a randomized clinical trial
    J Am Med Inform Assoc, 17 (4), 403-10
    DOI 10.1136/jamia.2010.005660, PubMed 20595307
  25. Sandset EC, Murray G, Boysen G, Jatuzis D, Kõrv J, Lüders S, Richter PS, Roine RO, Terént A, Thijs V, Berge E, SCAST Study Group (2010)
    Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003)
    Int J Stroke, 5 (5), 423-7
    DOI 10.1111/j.1747-4949.2010.00473.x, PubMed 20854630
  26. Sandset PM (2010)
    Immunobiology of heparin-induced thrombocytopenia
    Curr Top Microbiol Immunol, 341, 193-202
    DOI 10.1007/82_2010_17, PubMed 20369319
  27. Sandset PM, Arnesen H, Jacobsen AF, Wergeland H (2010)
    Prophylaxis against prosthetic mitral valve thrombosis with unfractionated heparin administered by an elastometric infusion pump
    Thromb Res, 126 (3), e232-4
    DOI 10.1016/j.thromres.2010.05.005, PubMed 20553950
  28. Sandset PM, Francis C (2010)
    Thrombosis Research--affiliation with the European Thrombosis Research Organization (ETRO)
    Thromb Res, 125 (1), 1
    DOI 10.1016/j.thromres.2010.01.008, PubMed 20171348
  29. Semaeva E, Tenstad O, Skavland J, Enger M, Iversen PO, Gjertsen BT, Wiig H (2010)
    Access to the spleen microenvironment through lymph shows local cytokine production, increased cell flux, and altered signaling of immune cells during lipopolysaccharide-induced acute inflammation
    J Immunol, 184 (8), 4547-56
    DOI 10.4049/jimmunol.0902049, PubMed 20237290
  30. Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2010)
    Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation
    Scand J Immunol, 71 (4), 267-74
    DOI 10.1111/j.1365-3083.2010.02378.x, PubMed 20384870
  31. Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2010)
    Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins
    Int J Oncol, 38 (2), 385-90
    DOI 10.3892/ijo.2010.869, PubMed 21165555
  32. Skretting G, Stavik B, Landvik NE, Myklebust CF, Iversen N, Zienolddiny S, Sandset PM (2010)
    Functional characterization of polymorphisms in the human TFPI gene
    Biochem Biophys Res Commun, 397 (1), 106-11
    DOI 10.1016/j.bbrc.2010.05.078, PubMed 20519147
  33. Smeland EB, Vartdal F, Wisløff F (2010)
    [Close cooperation, but not oversteering]
    Tidsskr Nor Laegeforen, 130 (6), 590-1
    DOI 10.4045/tidsskr.10.0153, PubMed 20348990
  34. Smeland EB, Vartdal F, Wisløff F (2010)
    [Leadership and academic competence]
    Tidsskr Nor Laegeforen, 130 (6), 591
    DOI 10.4045/tidsskr.10.0217, PubMed 20348994
  35. Stavik B, Skretting G, Sletten M, Sandset PM, Iversen N (2010)
    Overexpression of both TFPIα and TFPIβ induces apoptosis and expression of genes involved in the death receptor pathway in breast cancer cells
    Mol Carcinog, 49 (11), 951-63
    DOI 10.1002/mc.20679, PubMed 20886581
  36. Tangen JM, Fløisand Y, Haukås E, Naess IA, Skjelbakken T, Stapnes C, Tjønnfjord GE (2010)
    [Survival in adults with acute lymphoblastic leukaemia]
    Tidsskr Nor Laegeforen, 130 (17), 1710-3
    DOI 10.4045/tidsskr.09.1293, PubMed 20835280
  37. Tjeldhorn L, Iversen N, Sandvig K, Bergan J, Sandset PM, Skretting G (2010)
    Functional characterization of the protein C A267T mutation: evidence for impaired secretion due to defective intracellular transport
    BMC Cell Biol, 11, 67
    DOI 10.1186/1471-2121-11-67, PubMed 20815936
  38. Westerberg AC, Henriksen C, Ellingvåg A, Veierød MB, Júlíusson PB, Nakstad B, Aurvåg AK, Rønnestad A, Grønn M, Iversen PO, Drevon CA (2010)
    First year growth among very low birth weight infants
    Acta Paediatr, 99 (4), 556-62
    DOI 10.1111/j.1651-2227.2009.01667.x, PubMed 20096031
  39. Waage A, Gimsing P, Fayers P, Abildgaard N, Ahlberg L, Björkstrand B, Carlson K, Dahl IM, Forsberg K, Gulbrandsen N, Haukås E, Hjertner O, Hjorth M, Karlsson T, Knudsen LM, Nielsen JL, Linder O, Mellqvist UH, Nesthus I, Rolke J, Strandberg M, Sørbø JH, Wisløff F, Juliusson G, Turesson I et al. (2010)
    Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
    Blood, 116 (9), 1405-12
    DOI 10.1182/blood-2009-08-237974, PubMed 20448107

Publications 2009

  1. Abildgaard U, Sandset PM, Hammerstrøm J, Gjestvang FT, Tveit A (2009)
    Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin
    Thromb Res, 124 (3), 262-7
    DOI 10.1016/j.thromres.2008.12.005, PubMed 19162303
  2. Astermark J, Negrier C, Hermans C, Holme PA, Klamroth R, Kotsi P, de Moerloose P, Pasi J, Rocino A, von Depka M, Windyga J, Ludlam CA, Interdisciplinary Working Group IDWG (2009)
    European curriculum for thrombosis and haemostasis
    Haemophilia, 15 (1), 337-44
    DOI 10.1111/j.1365-2516.2008.01836.x, PubMed 19149857
  3. Bird J, Behrens J, Westin J, Turesson I, Drayson M, Beetham R, D'Sa S, Soutar R, Waage A, Gulbrandsen N, Gregersen H, Low E, Haemato-oncology Task Force of the British Committee for Standards in Haematology, UK Myeloma Forum and Nordic Myeloma Study Group (2009)
    UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)
    Br J Haematol, 147 (1), 22-42
    DOI 10.1111/j.1365-2141.2009.07807.x, PubMed 19673884
  4. Damås JK, Landrø L, Fevang B, Heggelund L, Tjønnfjord GE, Fløisand Y, Halvorsen B, Frøland SS, Aukrust P (2009)
    Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication
    Clin Exp Immunol, 157 (3), 400-7
    DOI 10.1111/j.1365-2249.2009.03976.x, PubMed 19664149
  5. Enden T, Kløw NE, Sandvik L, Slagsvold CE, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbaek G, Sandset PM, CaVenT study group (2009)
    Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency
    J Thromb Haemost, 7 (8), 1268-75
    DOI 10.1111/j.1538-7836.2009.03464.x, PubMed 19422443
  6. Haram K, Svendsen E, Abildgaard U (2009)
    The HELLP syndrome: clinical issues and management. A Review
    BMC Pregnancy Childbirth, 9, 8
    DOI 10.1186/1471-2393-9-8, PubMed 19245695
  7. Henriksen C, Westerberg AC, Rønnestad A, Nakstad B, Veierød MB, Drevon CA, Iversen PO (2009)
    Growth and nutrient intake among very-low-birth-weight infants fed fortified human milk during hospitalisation
    Br J Nutr, 102 (8), 1179-86
    DOI 10.1017/S0007114509371755, PubMed 19445820
  8. Holme PA, Glomstein A, Grønhaug S, Tjønnfjord GE (2009)
    Home treatment with bypassing products in inhibitor patients: a 7.5-year experience
    Haemophilia, 15 (3), 727-32
    DOI 10.1111/j.1365-2516.2009.02017.x, PubMed 19320748
  9. Iversen PO, Andersson KB, Finsen AV, Sjaastad I, von Lueder TG, Sejersted OM, Attramadal H, Christensen G (2009)
    Separate mechanisms cause anemia in ischemic vs. nonischemic murine heart failure
    Am J Physiol Regul Integr Comp Physiol, 298 (3), R808-14
    DOI 10.1152/ajpregu.00250.2009, PubMed 20032264
  10. Iversen PO, Semaeva E, Sorensen DR, Wiig H, Sioud M (2009)
    Dendritic Cells Loaded with Tumor Antigens and a Dual Immunostimulatory and Anti-Interleukin 10-Specific Small Interference RNA Prime T Lymphocytes against Leukemic Cells
    Transl Oncol, 2 (4), 242-6
    DOI 10.1593/tlo.09154, PubMed 19956385
  11. Iversen PO, Wisløff F, Gulbrandsen N (2009)
    Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support
    Clin Nutr, 29 (4), 488-91
    DOI 10.1016/j.clnu.2009.12.002, PubMed 20044183
  12. Kardel KR, Johansen B, Voldner N, Iversen PO, Henriksen T (2009)
    Association between aerobic fitness in late pregnancy and duration of labor in nulliparous women
    Acta Obstet Gynecol Scand, 88 (8), 948-52
    DOI 10.1080/00016340903093583, PubMed 19562561
  13. Kvam AK, Fayers P, Hjermstad M, Gulbrandsen N, Wisloff F (2009)
    Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations
    Eur J Haematol, 83 (4), 279-89
    DOI 10.1111/j.1600-0609.2009.01303.x, PubMed 19558508
  14. Kvam AK, Fayers P, Wisloff F (2009)
    What changes in health-related quality of life matter to multiple myeloma patients? A prospective study
    Eur J Haematol, 84 (4), 345-53
    DOI 10.1111/j.1600-0609.2009.01404.x, PubMed 20041946
  15. Micci F, Panagopoulos I, Haugom L, Andersen HK, Tjønnfjord GE, Beiske K, Heim S (2009)
    t(3;21)(q22;q22) leading to truncation of the RYK gene in atypical chronic myeloid leukemia
    Cancer Lett, 277 (2), 205-11
    DOI 10.1016/j.canlet.2008.12.016, PubMed 19168282
  16. Negaard HF, Svennevig K, Kolset SO, Iversen N, Lothe IM, Østenstad B, Sandset PM, Iversen PO (2009)
    Alterations in regulators of the extracellular matrix in non-Hodgkin lymphomas
    Leuk Lymphoma, 50 (6), 998-1004
    DOI 10.1080/10428190902889270, PubMed 19373600
  17. Perry D, Berntorp E, Tait C, Dolan G, Holme PA, Laffan M, Lassila R, Mumford A, Pasi J, Wilde J, Will A, Yee TT (2009)
    FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations
    Haemophilia, 16 (1), 80-9
    DOI 10.1111/j.1365-2516.2009.02104.x, PubMed 19780845
  18. Rehn TA, Borge BA, Lunde PK, Munkvik M, Sneve ML, Grøndahl F, Aronsen JM, Sjaastad I, Prydz K, Kolset SO, Wiig H, Sejersted OM, Iversen PO (2009)
    Temporary fatigue and altered extracellular matrix in skeletal muscle during progression of heart failure in rats
    Am J Physiol Regul Integr Comp Physiol, 297 (1), R26-33
    DOI 10.1152/ajpregu.90617.2008, PubMed 19339678
  19. Reseland JE, Reppe S, Olstad OK, Hjorth-Hansen H, Brenne AT, Syversen U, Waage A, Iversen PO (2009)
    Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma
    Eur J Haematol, 83 (5), 460-70
    DOI 10.1111/j.1600-0609.2009.01311.x, PubMed 19572994
  20. Sandset PM, Francis C (2009)
    Thrombosis Research: Introduction of e-pages
    Thromb Res, 124 (3), 251
    DOI 10.1016/j.thromres.2009.06.001, PubMed 19596224
  21. Sandset PM, Francis C, Key N (2009)
    Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)
    Thromb Res, 124 (5), 515
    DOI 10.1016/j.thromres.2009.09.021, PubMed 19837232
  22. Sandset PM, Høibraaten E, Eilertsen AL, Dahm A (2009)
    Mechanisms of thrombosis related to hormone therapy
    Thromb Res, 123 Suppl 2, S70-3
    DOI 10.1016/S0049-3848(09)70015-5, PubMed 19217481
  23. Schjesvold FH (2009)
    [Erythrocytosis as a problem]
    Tidsskr Nor Laegeforen, 129 (22), 2387; author reply 2387
    DOI 10.4045/tidsskr.09.1196, PubMed 19935946
  24. Stronen E, Abrahamsen IW, Gaudernack G, Wälchli S, Munthe E, Buus S, Johansen FE, Lund-Johansen F, Olweus J (2009)
    Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells
    Scand J Immunol, 69 (4), 319-28
    DOI 10.1111/j.1365-3083.2008.02223.x, PubMed 19284496
  25. Taraldsrud E, Grøgaard HK, Solheim S, Lunde K, Fløisand Y, Arnesen H, Seljeflot I, Egeland T (2009)
    Age and stress related phenotypical changes in bone marrow CD34+ cells
    Scand J Clin Lab Invest, 69 (1), 79-84
    DOI 10.1080/00365510802419447, PubMed 18836945
  26. Tjeldhorn L, Sandset PM, Haugbro K, Skretting G (2009)
    Hereditary protein C deficiency caused by the Ala267Thr mutation in the protein C gene is associated with symptomatic and asymptomatic venous thrombosis
    Thromb Res, 125 (3), 230-4
    DOI 10.1016/j.thromres.2009.05.013, PubMed 19535131
  27. Vik A, Holme PA, Singh K, Dorenberg E, Nordhus KC, Kumar S, Hansen JB (2009)
    Catheter-directed thrombolysis for treatment of deep venous thrombosis in the upper extremities
    Cardiovasc Intervent Radiol, 32 (5), 980-7
    DOI 10.1007/s00270-009-9655-y, PubMed 19641959

Publications 2008

  1. Akkök CA, Holte MR, Tangen JM, Ostenstad B, Bruserud O (2008)
    Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells
    Transfusion, 49 (2), 354-61
    DOI 10.1111/j.1537-2995.2008.01949.x, PubMed 18980622
  2. Austbø L, Kampmann A, Müller-Ladner U, Neumann E, Olsaker I, Skretting G (2008)
    Identification of differentially expressed genes in ileal Peyer's patch of scrapie-infected sheep using RNA arbitrarily primed PCR
    BMC Vet Res, 4, 12
    DOI 10.1186/1746-6148-4-12, PubMed 18373840
  3. Benestad HB, Wisløff F (2008)
    [Research ethics and University of Oslo]
    Tidsskr Nor Laegeforen, 128 (15), 1683-4
    PubMed 18704143
  4. Brinch L, Tjønnfjord G, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I (2008)
    [Allogeneic stem cell transplantation in acute myelogenous leukemia]
    Tidsskr Nor Laegeforen, 128 (15), 1681-2; author reply 1682
    PubMed 18704137
  5. Crowther-Swanepoel D, Wild R, Sellick G, Dyer MJ, Mauro FR, Cuthbert RJ, Jonsson V, Matutes E, Dearden C, Wiley J, Fuller S, Catovsky D, Houlston RS (2008)
    Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL
    Blood, 111 (12), 5691-3
    DOI 10.1182/blood-2008-03-142349, PubMed 18424666
  6. Eilertsen AL, Karssemeijer N, Skaane P, Qvigstad E, Sandset PM (2008)
    Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method
    BJOG, 115 (6), 773-9
    DOI 10.1111/j.1471-0528.2008.01690.x, PubMed 18355366
  7. Eilertsen AL, Sandvik L, Steinsvik B, Sandset PM (2008)
    Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers
    J Thromb Haemost, 6 (6), 928-34
    DOI 10.1111/j.1538-7836.2008.02970.x, PubMed 18394014
  8. Enden T, Garratt AM, Kløw NE, Sandset PM (2008)
    Assessing burden of illness following acute deep vein thrombosis: data quality, reliability and validity of the Norwegian version of VEINES-QOL/Sym, a disease-specific questionnaire
    Scand J Caring Sci, 23 (2), 369-74
    DOI 10.1111/j.1471-6712.2008.00618.x, PubMed 19068041
  9. Fløisand Y, Brinch L, Dybedal I, Gedde-Dahl T, Heldal D, Holme PA, Egeland T, Tjønnfjord GE (2008)
    [Allogeneic stem cell transplantation in adults with acute lymphoblastic leukaemia]
    Tidsskr Nor Laegeforen, 128 (22), 2563-6
    PubMed 19023351
  10. Haga HJ, Jacobsen EM, Peen E (2008)
    Incidence of thromboembolic events in patients with primary Sjögren's syndrome
    Scand J Rheumatol, 37 (2), 127-9
    DOI 10.1080/03009740701716843, PubMed 18415770
  11. Holme PA, Michelsen AE (2008)
    [A 40-year old woman with dizziness and vomiting]
    Tidsskr Nor Laegeforen, 128 (12), 1413-5
    PubMed 18584769
  12. Iversen PO, Ukrainchenko E, Afanasyev B, Hulbekkmo K, Choukah A, Gulbrandsen N, Wisløff F, Tangen JM (2008)
    Impaired nutritional status during intensive chemotherapy in Russian and Norwegian cohorts with acute myeloid leukemia
    Leuk Lymphoma, 49 (10), 1916-24
    DOI 10.1080/10428190802339723, PubMed 18949615
  13. Jacobsen AF, Skjeldestad FE, Sandset PM (2008)
    Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study
    J Thromb Haemost, 6 (6), 905-12
    DOI 10.1111/j.1538-7836.2008.02961.x, PubMed 18363820
  14. Jädersten M, Malcovati L, Dybedal I, Della Porta MG, Invernizzi R, Montgomery SM, Pascutto C, Porwit A, Cazzola M, Hellström-Lindberg E (2008)
    Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome
    J Clin Oncol, 26 (21), 3607-13
    DOI 10.1200/JCO.2007.15.4906, PubMed 18559873
  15. Jønsson V, Samuelsen SO, Tjønnfjord G, Johannesen T (2008)
    Looking for CLL genes
    Leuk Lymphoma, 49 (1), 10-1
    DOI 10.1080/10428190701713705, PubMed 18203003
  16. Jønsson V, Tjønnfjord GE, Johannesen TB, Samuelsen SO, Ly B (2008)
    Possible imprinting and microchimerism in chronic lymphocytic leukemia and related lymphoproliferative disorders
    Transl Oncogenomics, 3, 15-20
    PubMed 21566740
  17. Kolstad A, Tjønnfjord G, Jønsson V (2008)
    High frequency of unrecognized indolent hematological disorders among HLA-matched siblings of patients with lymphoproliferative malignancies eligible for allo-SCT
    Bone Marrow Transplant, 42 (6), 427-8
    DOI 10.1038/bmt.2008.183, PubMed 18587433
  18. Larson RA, Druker BJ, Guilhot F, O'Brien SG, Riviere GJ, Krahnke T, Gathmann I, Wang Y, IRIS (International Randomized Interferon vs STI571) Study Group (2008)
    Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study
    Blood, 111 (8), 4022-8
    DOI 10.1182/blood-2007-10-116475, PubMed 18256322
  19. Lunde K, Solheim S, Forfang K, Arnesen H, Brinch L, Bjørnerheim R, Ragnarsson A, Egeland T, Endresen K, Ilebekk A, Mangschau A, Aakhus S (2008)
    Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up
    J Am Coll Cardiol, 51 (6), 674-6
    DOI 10.1016/j.jacc.2007.10.032, PubMed 18261689
  20. Mellqvist UH, Lenhoff S, Johnsen HE, Hjorth M, Holmberg E, Juliusson G, Tangen JM, Westin J, Nordic Myeloma Study Group (2008)
    Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone
    Cancer, 112 (1), 129-35
    DOI 10.1002/cncr.23145, PubMed 17973267
  21. Negaard HF, Iversen N, Bowitz-Lothe IM, Sandset PM, Steinsvik B, Ostenstad B, Iversen PO (2008)
    Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors
    Leukemia, 23 (1), 162-9
    DOI 10.1038/leu.2008.255, PubMed 18800145
  22. Negaard HF, Iversen PO, Ostenstad B, Mowinckel MC, Sandset PM (2008)
    Increased acquired activated protein C resistance in unselected patients with hematological malignancies
    J Thromb Haemost, 6 (9), 1482-7
    DOI 10.1111/j.1538-7836.2008.03060.x, PubMed 18573186
  23. Negaard HF, Iversen PO, Østenstad B, Iversen N, Holme PA, Sandset PM (2008)
    Hypercoagulability in patients with haematological neoplasia: no apparent initiation by tissue factor
    Thromb Haemost, 99 (6), 1040-8
    DOI 10.1160/TH07-09-0541, PubMed 18521506
  24. Olsen AL, Johannesen TB, Ly B, Samuelsen SO, Tjonnfjord G, Jonsson V (2008)
    Pleiotropy in families with chronic lymphocytic leukemia
    Salud Cienc., 15 (8), 1236-+
  25. Piehler AP, Gulbrandsen N, Kierulf P, Urdal P (2008)
    Quantitation of serum free light chains in combination with protein electrophoresis and clinical information for diagnosing multiple myeloma in a general hospital population
    Clin Chem, 54 (11), 1823-30
    DOI 10.1373/clinchem.2008.106153, PubMed 18801937
  26. Sandercock P, Wardlaw J, Dennis M, Lindley R, Hankey G, Matz K, Peeters A, Phillips S, Gubitz G, Prasad K, Ricci S, Celani MG, Righetti E, Cantisani T, Arauz A, Berge E, Slot KB, Kobayashi A, Czlonkowska A, Correia M, Murray V, Lyrer P, Venables G, IST-3 Collaborative Group (2008)
    EPITHET--where next?
    Lancet Neurol, 7 (7), 570-1; author reply 571-3
    DOI 10.1016/S1474-4422(08)70123-6, PubMed 18565447
  27. Schjesvold FH, Sjo M, Tangen JM, Hammerstrøm J, Brinch L (2008)
    [High-dose treatment of systemic AL-amyloidosis with autologous stem cell support]
    Tidsskr Nor Laegeforen, 128 (12), 1392-6
    PubMed 18552900
  28. Skretting G, Lien T, Sandset PM, Iversen N (2008)
    Expression of the V264M TFPI mutant in endothelial cell cultures may involve mRNA stability
    Thromb Res, 123 (6), 851-5
    DOI 10.1016/j.thromres.2008.09.003, PubMed 19007969
  29. Stamnaes J, Fleckenstein B, Lund-Johansen F, Sollid LM (2008)
    The monoclonal antibody 6B9 recognizes CD44 and not cell surface transglutaminase 2
    Scand J Immunol, 68 (5), 534-42
    DOI 10.1111/j.1365-3083.2008.02173.x, PubMed 18803608
  30. Stelljes M, van Biezen A, Slavin S, Olavarria E, Clark RE, Nagler A, Koza V, Kienast J, Niederwieser D, de Witte T, Ruutu T, complications subcommittee of the Chronic Leukemia Working Party (2008)
    The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation
    Bone Marrow Transplant, 42 (11), 739-42
    DOI 10.1038/bmt.2008.254, PubMed 18724394

Publications 2007

  1. Abildgaard U (2007)
    Antithrombin--early prophecies and present challenges
    Thromb Haemost, 98 (1), 97-104
    DOI 10.1160/Th07-040277, PubMed 17597998
  2. Akkök CA, Brinch L, Lauritzsen GF, Solheim BG, Kjeldsen-Kragh J (2007)
    Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy
    Vox Sang, 93 (1), 42-8
    DOI 10.1111/j.1423-0410.2007.00917.x, PubMed 17547564
  3. Andresen MS, Eilertsen AL, Abildgaard U, Sandset PM (2007)
    Hormone therapy and raloxifene reduce the coagulation inhibitor potential
    Blood Coagul Fibrinolysis, 18 (5), 455-60
    DOI 10.1097/MBC.0b013e32813a2de7, PubMed 17581320
  4. Berge E, Haug KB, Sandset EC, Haugbro KK, Turkovic M, Sandset PM (2007)
    The factor V Leiden, prothrombin gene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ischemic stroke and atrial fibrillation
    Stroke, 38 (3), 1069-71
    DOI 10.1161/01.STR.0000258076.04860.8e, PubMed 17290027
  5. Cocks K, Cohen D, Wisløff F, Sezer O, Lee S, Hippe E, Gimsing P, Turesson I, Hajek R, Smith A, Graham L, Phillips A, Stead M, Velikova G, Brown J, EORTC Quality of Life Group (2007)
    An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma
    Eur J Cancer, 43 (11), 1670-8
    DOI 10.1016/j.ejca.2007.04.022, PubMed 17574838
  6. Dahm AE, Sandset PM, Rosendaal FR (2007)
    The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1
    J Thromb Haemost, 6 (2), 393-5
    DOI 10.1111/j.1538-7836.2007.02859.x, PubMed 18045239
  7. Eilertsen AL, Liestøl S, Mowinckel MC, Hemker HC, Sandset PM (2007)
    Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system
    Thromb Haemost, 97 (6), 938-43
    DOI 10.1160/TH06-11-0632, PubMed 17549295
  8. Enden T, Sandvik L, Kløw NE, Hafsahl G, Holme PA, Holmen LO, Ghanima W, Njaastad AM, Sandbaek G, Slagsvold CE, Sandset PM (2007)
    Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis--the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771)
    Am Heart J, 154 (5), 808-14
    DOI 10.1016/j.ahj.2007.07.010, PubMed 17967583
  9. Fløisand Y, Normann AP, Heim S, Lund-Johansen F, Tjønnfjord GE (2007)
    High expression of CD7 on CD34+ cells is not linked to deletion of derivative chromosome 9 or lack of dendritic cells in chronic myeloid leukaemia
    Scand J Clin Lab Invest, 68 (2), 93-8
    DOI 10.1080/00365510701558477, PubMed 17852828
  10. Frøyland M, Thompson KM, Thorpe SJ, Sahota SS, Gedde-Dahl T, Bogen B (2007)
    A VH4-34+ myeloma protein with weak autoreactivity
    Haematologica, 92 (5), 690-3
    DOI 10.3324/haematol.10850, PubMed 17488696
  11. Ghanima W, Abdelnoor M, Holmen LO, Nielssen BE, Sandset PM (2007)
    The association between the proximal extension of the clot and the severity of pulmonary embolism (PE): a proposal for a new radiological score for PE
    J Intern Med, 261 (1), 74-81
    DOI 10.1111/j.1365-2796.2006.01733.x, PubMed 17222170
  12. Ghanima W, Nielssen BE, Holmen LO, Witwit A, Al-Ashtari A, Sandset PM (2007)
    Multidetector computed tomography (MDCT) in the diagnosis of pulmonary embolism: interobserver agreement among radiologists with varied levels of experience
    Acta Radiol, 48 (2), 165-70
    DOI 10.1080/02841850601100859, PubMed 17354136
  13. Ghanima W, Sandset PM (2007)
    Risk stratification of pulmonary embolism by computed tomography
    J Intern Med, 262 (6), 702
    DOI 10.1111/j.1365-2796.2007.1858.x, PubMed 17944881
  14. Grövdal M, Khan R, Aggerholm A, Antunovic P, Astermark J, Bernell P, Engström LM, Kjeldsen L, Linder O, Nilsson L, Olsson A, Wallvik J, Tangen JM, Oberg G, Jacobsen SE, Hokland P, Porwit A, Hellström-Lindberg E (2007)
    Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome
    Clin Cancer Res, 13 (23), 7107-12
    DOI 10.1158/1078-0432.CCR-07-1193, PubMed 18056190
  15. Holme PA (2007)
    [Deficient thrombosis prophylaxis]
    Tidsskr Nor Laegeforen, 127 (9), 1176
    PubMed 17479132
  16. Jacobsen AF, Skjeldestad FE, Sandset PM (2007)
    Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study
    Am J Obstet Gynecol, 198 (2), 233.e1-7
    DOI 10.1016/j.ajog.2007.08.041, PubMed 17997389
  17. Jensen T, Kierulf P, Sandset PM, Klingenberg O, Joø GB, Godal HC, Skjønsberg OH (2007)
    Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells
    Thromb Haemost, 97 (5), 822-9
    DOI 10.1160/th07-01-0039, PubMed 17479194
  18. Johannessen MK, Skretting G, Ytrehus B, Røed KH (2007)
    Neonatal growth cartilage: equine tissue specific gene expression
    Biochem Biophys Res Commun, 354 (4), 975-80
    DOI 10.1016/j.bbrc.2007.01.074, PubMed 17276390
  19. Jønsson V, Tjønnfjord G, Samuelsen SO, Johannesen T, Olsen J, Sellick G, Houlston R, Yuille M, Catovsky D (2007)
    Birth order pattern in the inheritance of chronic lymphocytic leukaemia and related lymphoproliferative disease
    Leuk Lymphoma, 48 (12), 2387-96
    DOI 10.1080/10428190701686273, PubMed 18067015
  20. Liestøl S, Sandset PM, Mowinckel MC, Wisløff F (2007)
    Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants
    J Thromb Haemost, 5 (11), 2204-10
    DOI 10.1111/j.1538-7836.2007.02734.x, PubMed 17958739
  21. Micci F, Panagopoulos I, Tjønnfjord GE, Kolstad A, Delabie J, Beiske K, Heim S (2007)
    Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies
    Virchows Arch, 450 (5), 559-65
    DOI 10.1007/s00428-007-0407-6, PubMed 17406891
  22. Sioud M, Fløisand Y (2007)
    TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response
    Eur J Immunol, 37 (10), 2834-46
    DOI 10.1002/eji.200737112, PubMed 17853407
  23. Tchaikovski SN, van Vliet HA, Thomassen MC, Bertina RM, Rosendaal FR, Sandset PM, Helmerhorst FM, Tans G, Rosing J (2007)
    Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography
    Thromb Haemost, 98 (6), 1350-6
    DOI 10.1160/TH07-07-0439, PubMed 18064335
  24. Tjønnfjord GE, Gedde-Dahl T, Heldal D, Brinch L (2007)
    Treatment outcome in adults with acute lymphoblastic leukemia: 50% long-term disease-free survival
    Leukemia, 21 (10), 2203-4
    DOI 10.1038/sj.leu.2404751, PubMed 17525727
  25. Tjønnfjord GE, Holme PA (2007)
    Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors
    Vasc Health Risk Manag, 3 (4), 527-31
    PubMed 17969383
  26. Torfoss D, Høiby EA, Tangen JM, Holte H, Bø K, Meyer P, Grøttum K, Weyde K, Lauritzsen GF, Sandstad B, Jacobsen AB, Olsen H, Kvaløy S (2007)
    Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial
    J Antimicrob Chemother, 59 (4), 711-7
    DOI 10.1093/jac/dkm003, PubMed 17327294
  27. van Vliet HA, Bertina RM, Dahm AE, Rosendaal FR, Rosing J, Sandset PM, Helmerhorst FM (2007)
    Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor
    J Thromb Haemost, 6 (2), 346-51
    DOI 10.1111/j.1538-7836.2007.02863.x, PubMed 18067603
  28. Wisløff F (2007)
    [Epoetin in cancer treatment--the end of the game?]
    Tidsskr Nor Laegeforen, 127 (18), 2359
    PubMed 17895937

Publications 2006

  1. Amundsen AL, Khoury J, Sandset PM, Seljeflot I, Ose L, Tonstad S, Henriksen T, Retterstøl K, Iversen PO (2006)
    Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia
    Thromb Res, 120 (1), 21-7
    DOI 10.1016/j.thromres.2006.07.001, PubMed 16914186
  2. Broliden PA, Dahl IM, Hast R, Johansson B, Juvonen E, Kjeldsen L, Porwit-MacDonald A, Sjoo M, Tangen JM, Uggla B, Oberg G, Hellstrom-Lindberg E (2006)
    Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes
    Haematologica, 91 (5), 667-70
    PubMed 16670072
  3. Dahm A, Osterud B, Hjeltnes N, Sandset PM, Iversen PO (2006)
    Opposite circadian rhythms in melatonin and tissue factor pathway inhibitor type 1: does daylight affect coagulation?
    J Thromb Haemost, 4 (8), 1840-2
    DOI 10.1111/j.1538-7836.2006.02048.x, PubMed 16879232
  4. Dahm A, Rosendaal FR, Andersen TO, Sandset PM (2006)
    Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state
    Br J Haematol, 132 (3), 333-8
    DOI 10.1111/j.1365-2141.2005.05876.x, PubMed 16409298
  5. Eilertsen AL, Qvigstad E, Andersen TO, Sandvik L, Sandset PM (2006)
    Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation
    Maturitas, 55 (3), 278-87
    DOI 10.1016/j.maturitas.2006.04.012, PubMed 16713143
  6. Eilertsen AL, Sandvik L, Mowinckel MC, Andersen TO, Qvigstad E, Sandset PM (2006)
    Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis
    Thromb Res, 120 (3), 371-9
    DOI 10.1016/j.thromres.2006.10.013, PubMed 17156824
  7. Enden T, Kløw NE, Sandset PM (2006)
    [Catheter-directed thrombolysis in acute deep venous thrombosis]
    Tidsskr Nor Laegeforen, 126 (13), 1765
    PubMed 16794675
  8. Farkas L, Kvale EO, Lund-Johansen F, Jahnsen FL (2006)
    Plasmacytoid dendritic cells induce a distinct cytokine pattern in virus-specific CD4+ memory T cells that is modulated by CpG oligodeoxynucleotides
    Scand J Immunol, 64 (4), 404-11
    DOI 10.1111/j.1365-3083.2006.01792.x, PubMed 16970682
  9. Ghanima W, Abdelnoor M, Holmen LO, Nielssen BE, Ross S, Sandset PM (2006)
    D-dimer level is associated with the extent of pulmonary embolism
    Thromb Res, 120 (2), 281-8
    DOI 10.1016/j.thromres.2006.08.006, PubMed 17030057
  10. Ghanima W, Abdelnoor M, Mowinckel MC, Sandset PM (2006)
    The performance of STA-Liatest D-dimer assay in out-patients with suspected pulmonary embolism
    Br J Haematol, 132 (2), 210-5
    DOI 10.1111/j.1365-2141.2005.05859.x, PubMed 16398655
  11. Ghanima W, Sandset PM (2006)
    Validation of a new D-dimer microparticle enzyme immunoassay (AxSYM D-Dimer) in patients with suspected pulmonary embolism (PE)
    Thromb Res, 120 (4), 471-6
    DOI 10.1016/j.thromres.2006.11.005, PubMed 17161451
  12. Holm AM, Tjønnfjord G, Yndestad A, Beiske K, Müller F, Aukrust P, Frøland SS (2006)
    Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropenia
    Clin Exp Immunol, 144 (3), 418-24
    DOI 10.1111/j.1365-2249.2006.03086.x, PubMed 16734610
  13. Husted S, Emanuelsson H, Heptinstall S, Sandset PM, Wickens M, Peters G (2006)
    Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin
    Eur Heart J, 27 (9), 1038-47
    DOI 10.1093/eurheartj/ehi754, PubMed 16476694
  14. Jensen T, Retterstøl LJ, Sandset PM, Godal HC, Skjønsberg OH (2006)
    A daily glass of red wine induces a prolonged reduction in plasma viscosity: a randomized controlled trial
    Blood Coagul Fibrinolysis, 17 (6), 471-6
    DOI 10.1097/01.mbc.0000240920.72930.63, PubMed 16905951
  15. Jønsson V (2006)
    [Inheritance and cancer]
    Ugeskr Laeger, 168 (24), 2327
    PubMed 16822411
  16. Jønsson V, Johannesen TB (2006)
    Anticipation in lymphoproliferative disorders
    Leuk Lymphoma, 47 (10), 2015-6
    DOI 10.1080/10428190600774857, PubMed 17071471
  17. Kvale EO, Fløisand Y, Lund-Johansen F, Rollag H, Farkas L, Ghanekar S, Brandtzaeg P, Jahnsen FL, Olweus J (2006)
    Plasmacytoid DCs regulate recall responses by rapid induction of IL-10 in memory T cells
    Blood, 109 (8), 3369-76
    DOI 10.1182/blood-2006-06-031484, PubMed 17158235
  18. Lenhoff S, Hjorth M, Turesson I, Westin J, Gimsing P, Wislöff F, Ahlberg L, Carlson K, Christiansen I, Dahl IM, Forsberg K, Brinch L, Hammerström J, Johnsen HE, Knudsen LM, Linder O, Mellqvist UH, Nesthus I, Nielsen JL, Nordic Myeloma Study Group (2006)
    Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation
    Haematologica, 91 (9), 1228-33
    PubMed 16956822
  19. Liestøl S, Sandset PM, Jacobsen EM, Mowinckel MC, Wisløff F (2006)
    Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants
    Br J Haematol, 136 (1), 131-7
    DOI 10.1111/j.1365-2141.2006.06385.x, PubMed 17092306
  20. Lotfi K, Karlsson K, Fyrberg A, Juliusson G, Jonsson V, Peterson C, Eriksson S, Albertioni F (2006)
    The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia
    Biochem Pharmacol, 71 (6), 882-90
    DOI 10.1016/j.bcp.2005.12.007, PubMed 16436271
  21. Negaard HF, Eilertsen AL, Dahm A, Iversen PO, Østenstad B, Sandset PM (2006)
    Decreased lung cancer survival with hormone-replacement therapy: caused by a decreased tissue factor pathway inhibitor level?
    J Clin Oncol, 24 (17), 2683-4; author reply 2684
    DOI 10.1200/JCO.2006.06.4345, PubMed 16763285
  22. Njaastad AM, Abildgaard U (2006)
    Bleeding in patients with mechanical heart valves on warfarin: impact of target INR and of comorbidity
    J Intern Med, 260 (6), 596
    DOI 10.1111/j.1365-2796.2006.01721.x, PubMed 17116014
  23. Njaastad AM, Abildgaard U, Lassen JF (2006)
    Gains and losses of warfarin therapy as performed in an anticoagulation clinic
    J Intern Med, 259 (3), 296-304
    DOI 10.1111/j.1365-2796.2005.01605.x, PubMed 16476107
  24. O'Donnell MJ, Berge E, Sandset PM (2006)
    Are there patients with acute ischemic stroke and atrial fibrillation that benefit from low molecular weight heparin?
    Stroke, 37 (2), 452-5
    DOI 10.1161/01.STR.0000198887.81948.74, PubMed 16410483
  25. Roed KH, Hasle G, Midthjell V, Skretting G, Leinaas HP (2006)
    Identification and characterization of 17 microsatellite primers for the tick, Ixodes ricinus, using enriched genomic libraries
    Mol. Ecol. Notes, 6 (4), 1165-1167
  26. Sandset PM (2006)
    Hormone replacement therapy and risk of venous thromboembolism--still unresolved questions
    J Thromb Haemost, 4 (1), 68-9
    DOI 10.1111/j.1538-7836.2005.01750.x, PubMed 16409452
  27. Smith A, Wisloff F, Samson D, UK Myeloma Forum, Nordic Myeloma Study Group, British Committee for Standards in Haematology (2006)
    Guidelines on the diagnosis and management of multiple myeloma 2005
    Br J Haematol, 132 (4), 410-51
    DOI 10.1111/j.1365-2141.2005.05867.x, PubMed 16412016
  28. Tjønnfjord GE (2006)
    Surgery in patients with hemophilia and inhibitors: a review of the Norwegian experience with FEIBA
    Semin Hematol, 43 (2 Suppl 4), S18-21
    DOI 10.1053/j.seminhematol.2006.03.003, PubMed 16690372
  29. Wisløff F, Kvam AK, Hjorth M, Lenhoff S (2006)
    Serum calcium is an independent predictor of quality of life in multiple myeloma
    Eur J Haematol, 78 (1), 29-34
    DOI 10.1111/j.0902-4441.2006.t01-1-EJH2887.x, PubMed 17038019
  30. Aamot HV, Tjønnfjord GE, Delabie J, Heim S (2006)
    Molecular cytogenetic analysis of leukemic mantle cell lymphoma with a cryptic t(11;14)
    Cancer Genet Cytogenet, 165 (2), 172-5
    DOI 10.1016/j.cancergencyto.2005.08.012, PubMed 16527613

Publications 2005

  1. Crowther MA, Wisloff F (2005)
    Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis
    Thromb Res, 115 (1-2), 3-8
    DOI 10.1016/j.thromres.2004.06.041, PubMed 15567446
  2. Dahm AE, Andersen TO, Rosendaal F, Sandset PM (2005)
    A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI)
    J Thromb Haemost, 3 (4), 651-8
    DOI 10.1111/j.1538-7836.2005.01237.x, PubMed 15842349
  3. Dahm AE, Iversen PO, Hjeltnes N, Sandset PM (2005)
    Differences in circadian variations of tissue factor pathway inhibitor type 1 between able-bodied and spinal cord injured
    Thromb Res, 118 (2), 281-7
    DOI 10.1016/j.thromres.2005.07.021, PubMed 16139333
  4. de Visser MC, van Hylckama Vlieg A, Tans G, Rosing J, Dahm AE, Sandset PM, Rosendaal FR, Bertina RM (2005)
    Determinants of the APTT- and ETP-based APC sensitivity tests
    J Thromb Haemost, 3 (7), 1488-94
    DOI 10.1111/j.1538-7836.2005.01430.x, PubMed 15978106
  5. Eilertsen AL, Høibraaten E, Os I, Andersen TO, Sandvik L, Sandset PM (2005)
    The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis
    Maturitas, 52 (2), 111-8
    DOI 10.1016/j.maturitas.2005.01.004, PubMed 16186073
  6. Ghanima W, Almaas V, Aballi S, Dörje C, Nielssen BE, Holmen LO, Almaas R, Abdelnoor M, Sandset PM (2005)
    Management of suspected pulmonary embolism (PE) by D-dimer and multi-slice computed tomography in outpatients: an outcome study
    J Thromb Haemost, 3 (9), 1926-32
    DOI 10.1111/j.1538-7836.2005.01544.x, PubMed 16102097
  7. Gruber FX, Lamark T, Anonli A, Sovershaev MA, Olsen M, Gedde-Dahl T, Hjort-Hansen H, Skogen B (2005)
    Selecting and deselecting imatinib-resistant clones: observations made by longitudinal, quantitative monitoring of mutated BCR-ABL
    Leukemia, 19 (12), 2159-65
    DOI 10.1038/sj.leu.2403983, PubMed 16224487
  8. Haram K, Björge L, Sandset PM (2005)
    Successful preconceptional prophylactic treatment with combined acetyl salicylic acid and low-molecular heparin (Fragmin) in a case of antiphospholipid-antibody syndrome with prior life-threatening hemolysis, elevated liver enzymes and low-platelet syndrome: a case report
    Acta Obstet Gynecol Scand, 84 (12), 1213-4
    DOI 10.1111/j.0001-6349.2005.0070e.x, PubMed 16305714
  9. Hippe E, Westin J, Wislöff F (2005)
    Nordic Myeloma Study Group, the first 15 years: scientific collaboration and improvement of patient care
    Eur J Haematol, 74 (3), 185-93
    DOI 10.1111/j.1600-0609.2004.00379.x, PubMed 15693787
  10. Holme PA, Brosstad F, Tjønnfjord GE (2005)
    Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies
    Haemophilia, 11 (5), 510-5
    DOI 10.1111/j.1365-2516.2005.01136.x, PubMed 16128896
  11. Iversen PO, Wiig H (2005)
    Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis
    Clin Cancer Res, 11 (19 Pt 1), 6793-9
    DOI 10.1158/1078-0432.CCR-05-1033, PubMed 16203766
  12. Kvale EØ, Dalgaard J, Lund-Johansen F, Rollag H, Farkas L, Midtvedt K, Jahnsen FL, Brinchmann JE, Olweus J (2005)
    CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection
    Blood, 107 (5), 2022-9
    DOI 10.1182/blood-2005-05-2016, PubMed 16269620
  13. Mishra V, Andresen S, Brinch L, Kvaløy S, Ernst P, Lønset MK, Tangen JM, Wikelund J, Flatum C, Baggerød E, Helle B, Vaaler S, Hagen TP (2005)
    Cost of autologous peripheral blood stem cell transplantation: the Norwegian experience from a multicenter cost study
    Bone Marrow Transplant, 35 (12), 1149-53
    DOI 10.1038/sj.bmt.1704988, PubMed 15880133
  14. Negaard H, Dahm A, Sandset PM, Iversen PO, Østenstad B (2005)
    Angiogenesis and hemostasis in hematological neoplasias
    Curr Drug Targets, 6 (6), 683-99
    DOI 10.2174/1389450054863699, PubMed 16178801
  15. Sandset PM, Francis C, Ginsberg J (2005)
    Thrombosis Research Anno 2005
    Thromb. Res., 115 (1-2), 1
  16. Schulman S, Tjønnfjord GE, Wallensten R, Martinowitz U, Kenet G (2005)
    Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII
    Thromb Haemost, 94 (6), 1177-80
    DOI 10.1160/TH05-05-0342, PubMed 16411390
  17. Sellick GS, Webb EL, Allinson R, Matutes E, Dyer MJ, Jonsson V, Langerak AW, Mauro FR, Fuller S, Wiley J, Lyttelton M, Callea V, Yuille M, Catovsky D, Houlston RS (2005)
    A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci
    Am J Hum Genet, 77 (3), 420-9
    DOI 10.1086/444472, PubMed 16080117
  18. Sigurdardottir K, Digranes A, Harthug S, Nesthus I, Tangen JM, Dybdahl B, Meyer P, Hopen G, Løkeland T, Grøttum K, Vie W, Langeland N (2005)
    A multi-centre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility
    Scand J Infect Dis, 37 (6-7), 455-64
    DOI 10.1080/00365540510038497, PubMed 16012006
  19. Sioud M, Iversen PO (2005)
    Ribozymes, DNAzymes and small interfering RNAs as therapeutics
    Curr Drug Targets, 6 (6), 647-53
    DOI 10.2174/1389450054863653, PubMed 16178798
  20. Tjønnfjord GE (2005)
    [Polycythemia vera]
    Tidsskr Nor Laegeforen, 125 (19), 2649
    PubMed 16273739
  21. Tjønnfjord GE (2005)
    [Anticoagulation therapy and oral surgery]
    Tidsskr Nor Laegeforen, 125 (21), 2999; author reply 2999
    PubMed 16276400
  22. Wisløff F, Gulbrandsen N, Hjorth M, Lenhoff S, Fayers P (2005)
    Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes
    Eur J Haematol, 75 (4), 293-8
    DOI 10.1111/j.1600-0609.2005.00509.x, PubMed 16146535

Publications 2004

  1. Andresen MS, Abildgaard U (2004)
    Coagulation Inhibitor Potential: a study of assay variables
    Thromb Res, 115 (6), 519-26
    DOI 10.1016/j.thromres.2004.11.018, PubMed 15792684
  2. Andresen MS, Abildgaard U, Liestøl S, Sandset PM, Mowinckel MC, Ødegaard OR, Larsen ML, Diep LM (2004)
    The ability of three global plasma assays to recognize thrombophilia
    Thromb Res, 113 (6), 411-7
    DOI 10.1016/j.thromres.2004.05.002, PubMed 15226097
  3. Brodin E, Børvik T, Sandset PM, Bønaa KH, Nordøy A, Hansen JB (2004)
    Coagulation activation in young survivors of myocardial infarction (MI)--a population-based case-control study
    Thromb Haemost, 92 (1), 178-84
    DOI 10.1160/TH03-11-0674, PubMed 15213859
  4. Farkas L, Kvale EO, Johansen FE, Jahnsen FL, Lund-Johansen F (2004)
    Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides
    J Allergy Clin Immunol, 114 (2), 436-43
    DOI 10.1016/j.jaci.2004.04.035, PubMed 15316529
  5. Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE (2004)
    [Treatment of T-cell prolymphocytic leukemia with monoclonal anti- CD52 antibody (alemtuzumab]
    Tidsskr Nor Laegeforen, 124 (6), 768-70
    PubMed 15039804
  6. Ghanima W, Kahrs J, Dahl TG, Tjonnfjord GE (2004)
    Sustained cytogenetic response after discontinuation of imatinib mesylate in a patient with chronic myeloid leukaemia
    Eur J Haematol, 72 (6), 441-3
    DOI 10.1111/j.1600-0609.2004.00257.x, PubMed 15128424
  7. Gulbrandsen N, Hjermstad MJ, Wisløff F, Nordic Myeloma Study Group (2004)
    Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences
    Eur J Haematol, 72 (3), 172-80
    DOI 10.1046/j.0902-4441.2003.00195.x, PubMed 14962235
  8. Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H, Kaasa S (2004)
    A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation
    Bone Marrow Transplant, 34 (3), 257-66
    DOI 10.1038/sj.bmt.1704561, PubMed 15170167
  9. Jacobsen AF, Drolsum A, Klow NE, Dahl GF, Qvigstad E, Sandset PM (2004)
    Deep vein thrombosis after elective cesarean section
    Thromb Res, 113 (5), 283-8
    DOI 10.1016/j.thromres.2004.03.008, PubMed 15183039
  10. Jensen T, Halvorsen S, Godal HC, Sandset PM, Skjønsberg OH (2004)
    The viscosity of fibrinogen subfractions and of EDTA denatured fibrinogen do not differ from that of native fibrinogen
    Thromb Res, 113 (1), 51-6
    DOI 10.1016/j.thromres.2004.01.010, PubMed 15081565
  11. Klar J, Gedde-Dahl T, Larsson M, Pigg M, Carlsson B, Tentler D, Vahlquist A, Dahl N (2004)
    Assignment of the locus for ichthyosis prematurity syndrome to chromosome 9q33.3-34.13
    J Med Genet, 41 (3), 208-12
    DOI 10.1136/jmg.2003.012567, PubMed 14985385
  12. Liestøl S, Wisløff F (2004)
    Effect of subcutaneous administration of dalteparin on lupus anticoagulant assays
    Thromb Res, 115 (6), 509-17
    DOI 10.1016/j.thromres.2004.11.013, PubMed 15792683
  13. Lindahl TL, Egberg N, Hillarp A, Ødegaard OR, Edlund B, Svensson J, Sandset PM, Rånby M (2004)
    INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples
    Thromb Haemost, 91 (6), 1223-31
    DOI 10.1160/TH03-07-0456, PubMed 15175811
  14. Lund MB, Brinch L, Kongerud J, Boe J (2004)
    Lung function 5 yrs after allogeneic bone marrow transplantation conditioned with busulphan and cyclophosphamide
    Eur Respir J, 23 (6), 901-5
    DOI 10.1183/09031936.04.00084804, PubMed 15219005
  15. Rodriguez-Merchan EC, Rocino A, Ewenstein B, Bartha L, Batorova A, Goudemand J, Gringeri A, Joao-Diniz M, Lopaciuk S, Negrier C, Quintana M, Tagariello G, Tjonnfjord GE, Villar VA, Vorlova Z (2004)
    Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement
    Haemophilia, 10 Suppl 2, 50-2
    DOI 10.1111/j.1365-2516.2004.00941.x, PubMed 15385047
  16. Sandset PM, Abildgaard U (2004)
    Tissue factor pathway inhibitor revisited
    J. Thromb. Haemost., 2 (12), 2242-2243
  17. Solberg EE, Ekeberg O, Holen A, Ingjer F, Sandvik L, Standal PA, Vikman A (2004)
    Hemodynamic changes during long meditation
    Appl Psychophysiol Biofeedback, 29 (3), 213-21
    DOI 10.1023/b:apbi.0000039059.20738.39, PubMed 15497620
  18. Tiercy JM, Passweg J, van Biezen A, Zander A, Kröger N, Gratwohl A, Chapuis B, Helg C, Brinch L, Cornelissen J, Oudshoorn M, Ruutu T, Volin L, Niederwieser D, Roosnek E, Chronic Leukemia Working Party of the European Blood and Marrow Transplant Group (EBMT) (2004)
    Isolated HLA-C mismatches in unrelated donor transplantation for CML
    Bone Marrow Transplant, 34 (3), 249-55
    DOI 10.1038/sj.bmt.1704569, PubMed 15195077
  19. Tjønnfjord GE (2004)
    Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience
    Haemophilia, 10 Suppl 2, 41-5
    DOI 10.1111/j.1365-2516.2004.00939.x, PubMed 15385045
  20. Tjønnfjord GE, Brinch L, Gedde-Dahl T, Brosstad FR (2004)
    Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX
    Haemophilia, 10 (2), 174-8
    DOI 10.1046/j.1365-2516.2003.00857.x, PubMed 14962207
  21. Wisløff F (2004)
    [Total survival as quality indicator]
    Tidsskr Nor Laegeforen, 124 (23), 3096; author reply 3096
    PubMed 15586201
  22. Wisløff F, Crowther M (2004)
    Evidence-based treatment of the antiphospholipid syndrome: I. Pregnancy failure
    Thromb Res, 114 (2), 75-81
    DOI 10.1016/j.thromres.2004.05.006, PubMed 15306148
  23. Waage A, Gimsing P, Juliusson G, Turesson I, Gulbrandsen N, Eriksson T, Hjorth M, Nielsen JL, Lenhoff S, Westin J, Wislöff F, Nordic Myeloma Study Group (2004)
    Early response predicts thalidomide efficiency in patients with advanced multiple myeloma
    Br J Haematol, 125 (2), 149-55
    DOI 10.1111/j.1365-2141.2004.04879.x, PubMed 15059136

Publications 2003

  1. Bendz B, Sandset PM (2003)
    Acute hypoxia and activation of coagulation
    Lancet, 362 (9388), 997-8
    DOI 10.1016/S0140-6736(03)14378-4, PubMed 14511938
  2. Bergheim J, Ernst P, Brinch L, Gore DM, Chetty MC, Stewart GW (2003)
    Allogeneic bone marrow transplantation for severe post-splenectomy thrombophilic state in leaky red cell membrane haemolytic anaemia of the stomatocytosis class
    Br J Haematol, 121 (1), 119-22
    DOI 10.1046/j.1365-2141.2003.04262.x, PubMed 12670341
  3. Dahm A, Van Hylckama Vlieg A, Bendz B, Rosendaal F, Bertina RM, Sandset PM (2003)
    Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis
    Blood, 101 (11), 4387-92
    DOI 10.1182/blood-2002-10-3188, PubMed 12560220
  4. Gruber A, Björkholm M, Brinch L, Evensen S, Gustavsson B, Hedenus M, Juliusson G, Löfvenberg E, Nesthus I, Simonsson B, Sjo M, Stenke L, Tangen JM, Tidefelt U, Udén AM, Paul C, Liliemark J (2003)
    A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia
    Leuk Res, 27 (4), 323-8
    DOI 10.1016/s0145-2126(02)00181-9, PubMed 12531223
  5. Haram K, Trovik J, Sandset PM, Hordnes K (2003)
    Severe syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP) in the 18th week of pregnancy associated with the antiphospholipid-antibody syndrome
    Acta Obstet Gynecol Scand, 82 (7), 679-80
    DOI 10.1034/j.1600-0412.2003.00181.x, PubMed 12790854
  6. Heldal D, Brinch L, Tjønnfjord G, Solheim BG, Egeland T, Albrechtsen D, Aamodt G, Evensen SA (2003)
    Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: a 5-year follow-up in a single centre study
    Bone Marrow Transplant, 32 (3), 257-64
    DOI 10.1038/sj.bmt.1704127, PubMed 12858196
  7. Hellström-Lindberg E, Gulbrandsen N, Lindberg G, Ahlgren T, Dahl IM, Dybedal I, Grimfors G, Hesse-Sundin E, Hjorth M, Kanter-Lewensohn L, Linder O, Luthman M, Löfvenberg E, Oberg G, Porwit-MacDonald A, Rådlund A, Samuelsson J, Tangen JM, Winquist I, Wisloff F, Scandinavian MDS Group (2003)
    A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life
    Br J Haematol, 120 (6), 1037-46
    DOI 10.1046/j.1365-2141.2003.04153.x, PubMed 12648074
  8. Hjermstad MJ, Evensen SA, Kvaløy SO, Loge JH, Fayers PM, Kaasa S (2003)
    The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation
    Psychooncology, 12 (8), 803-13
    DOI 10.1002/pon.708, PubMed 14681953
  9. Jacobsen AF, Qvigstad E, Sandset PM (2003)
    Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy
    BJOG, 110 (2), PII S1470-0328(02)02182-1-144
  10. Mishra V, Vaaler S, Brinch L (2003)
    Cost analysis of autologous peripheral blood stem cell transplantation for multiple myeloma
    Clin Lab Haematol, 25 (3), 179-84
    DOI 10.1046/j.1365-2257.2003.00512.x, PubMed 12755795
  11. Normann AP, Egeland T, Madshus IH, Heim S, Tjønnfjord GE (2003)
    CD7 expression by CD34+ cells in CML patients, of prognostic significance?
    Eur J Haematol, 71 (4), 266-75
    DOI 10.1034/j.1600-0609.2003.00133.x, PubMed 12950236
  12. Os I, Høieggen A, Larsen A, Sandset PM, Djurovic S, Berg K, Os A, Birkeland K, Westheim A (2003)
    Smoking and relation to other risk factors in postmenopausal women with coronary artery disease, with particular reference to whole blood viscosity and beta-cell function
    J Intern Med, 253 (2), 232-9
    DOI 10.1046/j.1365-2796.2003.01110.x, PubMed 12542565
  13. Wisløff F (2003)
    [Financing of enzyme treatment in Gaucher disease]
    Tidsskr Nor Laegeforen, 123 (3), 364
    PubMed 12640908

Publications 2002

  1. Andresen MS, Iversen N, Abildgaard U (2002)
    Overall haemostasis potential assays performed in thrombophilic plasma: the effect of preactivating protein C and antithrombin
    Thromb Res, 108 (5-6), 323-8
    DOI 10.1016/s0049-3848(03)00067-7, PubMed 12676193
  2. Bendz B, Sandset PM (2002)
    Air travel and risk of venous thromboembolism
    Thromb Res, 108 (1), 15-7
    DOI 10.1016/s0049-3848(02)00389-4, PubMed 12586126
  3. Ghanima W, Heldal D, Tjønnfjord GE (2002)
    [Hairy cell leukemia treated with cladribine]
    Tidsskr Nor Laegeforen, 122 (11), 1094-7
    PubMed 12043051
  4. Heldal D, Brinch L, Tjønnfjord G, Solheim BG, Egeland T, Gadeholt G, Albrechtsen D, Aamodt G, Evensen SA (2002)
    Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints
    Bone Marrow Transplant, 29 (6), 479-86
    DOI 10.1038/sj.bmt.1703418, PubMed 11960266
  5. Itälä M, Geisler CH, Kimby E, Juvonen E, Tjonnfjord G, Karlsson K, Remes K (2002)
    Standard-dose anti-CD20 antibody rituximab has efficacy in chronic lymphocytic leukaemia: results from a Nordic multicentre study
    Eur J Haematol, 69 (3), 129-34
    DOI 10.1034/j.1600-0609.2002.02786.x, PubMed 12406005
  6. Iversen N, Brandtzaeg P, Sandset PM, Kierulf P, Abildgaard U (2002)
    TFPI fractions in plasma from patients with systemic meningococcal disease
    Thromb Res, 108 (5-6), 347-53
    DOI 10.1016/s0049-3848(03)00065-3, PubMed 12676197
  7. Iversen N, Lindahl AK, Abildgaard U (2002)
    Elevated plasma levels of the factor Xa-TFPI complex in cancer patients
    Thromb Res, 105 (1), 33-6
    DOI 10.1016/s0049-3848(01)00404-2, PubMed 11864704
  8. Iversen PO, De Groot P, Hjeltnes N, Andersen TO, Mowinckel MC, Sandset PM (2002)
    Attenuated diurnal oscillations of pro-thrombotic markers in tetraplegia
  9. Iversen PO, Groot PD, Hjeltnes N, Andersen TO, Mowinckel MC, Sandset PM (2002)
    Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia
    Br J Haematol, 119 (4), 1011-6
    DOI 10.1046/j.1365-2141.2002.03953.x, PubMed 12472582
  10. Jensen T, Halvorsen S, Godal HC, Skjønsberg OH (2002)
    Influence of freeze-drying on the clotting properties of fibrinogen in plasma
    Thromb Res, 105 (6), 499-502
    DOI 10.1016/s0049-3848(02)00057-9, PubMed 12091049
  11. Liestøl S, Jacobsen EM, Wisløff F (2002)
    Dilute prothrombin time-based lupus ratio test. Integrated LA testing with recombinant tissue thromboplastin
    Thromb Res, 105 (2), 177-82
    DOI 10.1016/s0049-3848(01)00420-0, PubMed 11958810
  12. Mishra V, Tjønnfjord GE, Paus AC, Vaaler S (2002)
    Orthopaedic surgery in severe bleeding disorders: a low-volume, high-cost procedure
    Haemophilia, 8 (6), 809-14
    DOI 10.1046/j.1365-2516.2002.00691.x, PubMed 12410652
  13. Müller F, Tjønnfjord GE, Nordøy I, Kvale D, Mellbye OJ, Aukrust P, Frøland SS (2002)
    Immunophenotypic analyses of CD34(+) cell subsets in bone marrow from HIV-infected patients during highly- active antiretroviral therapy
    Eur J Clin Invest, 32 (7), 535-40
    DOI 10.1046/j.1365-2362.2002.00995.x, PubMed 12153555
  14. Sandset PM (2002)
    [Anticoagulant therapy with warfarin--still difficult]
    Tidsskr Nor Laegeforen, 122 (10), 992
    PubMed 12082707
  15. Sandset PM, Abildgaard U (2002)
    Perioperative management of oral anticoagulant therapy
    Thromb Res, 108 (1), 1-2
    DOI 10.1016/s0049-3848(02)00388-2, PubMed 12586124
  16. Standal T, Borset M, Lenhoff S, Wisloff F, Stordal B, Sundan A, Waage A, Seidel C (2002)
    Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor
    Blood, 100 (12), 3925-9
    DOI 10.1182/blood-2002-05-1406, PubMed 12393395
  17. Wisløff F, Jacobsen EM, Liestøl S (2002)
    Laboratory diagnosis of the antiphospholipid syndrome
    Thromb Res, 108 (5-6), 263-71
    DOI 10.1016/s0049-3848(02)00400-0, PubMed 12676184

Publications 2001

  1. Bendz B, Rostrup M, Sevre K, Andersen TO, Sandset PM (2001)
    Hypobaric hypoxia - Reply
    Lancet, 357 (9260), 955-956
  2. Bendz B, Sandset PM (2001)
    Deep-vein thrombosis in long-haul flights
    Lancet, 358 (9284), 837-8; author reply 839
    DOI 10.1016/S0140-6736(01)05978-5, PubMed 11570398
  3. Bendz B, Sevre K, Andersen TO, Sandset PM (2001)
    Low molecular weight heparin prevents activation of coagulation in a hypobaric environment
    Blood Coagul Fibrinolysis, 12 (5), 371-4
    DOI 10.1097/00001721-200107000-00006, PubMed 11505080
  4. Berge E, Fjaertoft H, Indredavik B, Sandset PM (2001)
    Validity and reliability of simple questions in assessing short- and long-term outcome in Norwegian stroke patients
    Cerebrovasc Dis, 11 (4), 305-10
    DOI 10.1159/000047658, PubMed 11385209
  5. Berge E, Friis P, Sandset PM (2001)
    Hemostatic activation in acute ischemic stroke
    Thromb Res, 101 (2), 13-21
    DOI 10.1016/s0049-3848(00)00380-7, PubMed 11342202
  6. Berge E, Nakstad PH, Sandset PM, HAEST Study Group (2001)
    Large middle cerebral artery infarctions and the hyperdense middle cerebral artery sign in patients with atrial fibrillation
    Acta Radiol, 42 (3), 261-8
    DOI 10.1080/028418501127346800, PubMed 11350283
  7. Berge E, Sandset PM (2001)
    Heparin and aspirin in stroke
    Lancet, 357 (9261), 1044-5
    DOI 10.1016/S0140-6736(05)71619-6, PubMed 11293624
  8. Gulbrandsen N, Wisløff F, Brinch L, Carlson K, Dahl IM, Gimsing P, Hippe E, Hjorth M, Knudsen LM, Lamvik J, Lenhoff S, Løfvenberg E, Nesthus I, Nielsen JL, Turesson I, Westin J, Nordic Myeloma Study Group (2001)
    Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support
    Med Oncol, 18 (1), 65-77
    DOI 10.1385/MO:18:1:65, PubMed 11778972
  9. Gulbrandsen N, Wisløff F, Nord E, Lenhoff S, Hjorth M, Westin J, Nordic Myeloma Study Group (2001)
    Cost-utility analysis of high-dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myeloma
    Eur J Haematol, 66 (5), 328-36
    DOI 10.1034/j.1600-0609.2001.066005328.x, PubMed 11422413
  10. Hansen JB, Grimsgaard S, Huseby N, Sandset PM, Bønaa KH (2001)
    Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men
    Thromb Res, 102 (1), 3-13
    DOI 10.1016/s0049-3848(01)00215-8, PubMed 11323009
  11. Høibraaten E, Mowinckel MC, de Ronde H, Bertina RM, Sandset PM (2001)
    Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial
    Br J Haematol, 115 (2), 415-20
    DOI 10.1046/j.1365-2141.2001.03111.x, PubMed 11703344
  12. Høibraaten E, Qvigstad E, Andersen TO, Mowinckel MC, Sandset PM (2001)
    The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial
    Thromb Haemost, 85 (5), 775-81
    PubMed 11372667
  13. Jonkers IJ, de Man FH, van Tilburg NH, van der Laarse A, Sandset PM, Smelt AH, Bertina RM (2001)
    Alterations in the extrinsic pathway in hypertriglyceridemia do not cause a 'procoagulant state': effects of bezafibrate therapy
    Blood Coagul Fibrinolysis, 12 (8), 705-12
    DOI 10.1097/00001721-200112000-00013, PubMed 11734672
  14. Mishra V, Vaaler S, Brinch L (2001)
    A prospective cost evaluation related to allogeneic haemopoietic stem cell transplantation including pretransplant procedures, transplantation and 1 year follow-up procedures
    Bone Marrow Transplant, 28 (12), 1111-6
    DOI 10.1038/sj.bmt.1703310, PubMed 11803351
  15. Wisløff F (2001)
    [Should iron preparations be available only on prescription?]
    Tidsskr Nor Laegeforen, 121 (9), 1155-6
    PubMed 11354901
  16. Wisløff F (2001)
    [Use of blood from patients with hemochromatosis]
    Tidsskr Nor Laegeforen, 121 (12), 1448
    PubMed 11449762

Publications 2000

  1. Bendz B, Andersen TO, Sandset PM (2000)
    A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1
    Thromb Res, 97 (6), 463-72
    DOI 10.1016/s0049-3848(99)00183-8, PubMed 10704656
  2. Bendz B, Andersen TO, Sandset PM (2000)
    Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins
    Blood Coagul Fibrinolysis, 11 (4), 343-8
    DOI 10.1097/00001721-200006000-00005, PubMed 10847421
  3. Bendz B, Rostrup M, Sevre K, Andersen TO, Sandset PM (2000)
    Association between acute hypobaric hypoxia and activation of coagulation in human beings
    Lancet, 356 (9242), 1657-8
    DOI 10.1016/S0140-6736(00)03165-2, PubMed 11089830
  4. Berentsen S, Tjønnfjord GE, Shammas FV, Bergheim J, Hammerstrøm J, Langholm R, Ulvestad E (2000)
    No response to cladribine in five patients with chronic cold agglutinin disease
    Eur J Haematol, 65 (1), 88-90
    DOI 10.1034/j.1600-0609.2000.9l201.x, PubMed 10914950
  5. Berge E, Abdelnoor M, Nakstad PH, Sandset PM (2000)
    Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial
    Lancet, 355 (9211), 1205-10
    DOI 10.1016/s0140-6736(00)02085-7, PubMed 10770301
  6. Berge E, Sandset PM (2000)
    Heparin versus aspirin in ischaemic stroke - Reply
    Lancet, 356 (9228), 505
  7. Bruserud O, Tjønnfjord G, Gjertsen BT, Foss B, Ernst P (2000)
    New strategies in the treatment of acute myelogenous leukemia: mobilization and transplantation of autologous peripheral blood stem cells in adult patients
    Stem Cells, 18 (5), 343-51
    DOI 10.1634/stemcells.19-1-1, PubMed 11007918
  8. Dupuy BM, Gedde-Dahl T, Olaisen B (2000)
    DYS393 and its X chromosome counterpart
    INT CONGR SER (1193), 67-70
  9. Hansen JB, Naalsund T, Sandset PM, Svensson B (2000)
    Rebound activation of coagulation after treatment with unfractionated heparin and not with low molecular weight heparin is associated with partial depletion of tissue factor pathway inhibitor and antithrombin
    Thromb Res, 100 (5), 413-7
    DOI 10.1016/s0049-3848(00)00351-0, PubMed 11150584
  10. Heldal D, Tjønnfjord G, Brinch L, Albrechtsen D, Egeland T, Steen R, Solheim BG, Evensen SA (2000)
    A randomised study of allogeneic transplantation with stem cells from blood or bone marrow
    Bone Marrow Transplant, 25 (11), 1129-36
    DOI 10.1038/sj.bmt.1702422, PubMed 10849524
  11. Hoibraaten E, Os I, Seljeflot I, Andersen TO, Hofstad A, Sandset PM (2000)
    The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study
    Thromb Res, 98 (1), 19-27
    DOI 10.1016/s0049-3848(99)00233-9, PubMed 10706930
  12. Høibraaten E, Qvigstad E, Arnesen H, Larsen S, Wickstrøm E, Sandset PM (2000)
    Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET)
    Thromb Haemost, 84 (6), 961-7
    PubMed 11154141
  13. Iversen N, Strekerud FG, Abildgaard U (2000)
    Tissue factor pathway inhibitor (TFPI) in disseminated intravascular coagulation: low levels of the activated factor X-TFPI complex
    Blood Coagul Fibrinolysis, 11 (7), 591-8
    DOI 10.1097/00001721-200010000-00002, PubMed 11085278
  14. Jacobsen EM, Barna-Cler L, Taylor JM, Triplett DA, Wisløff F (2000)
    The Lupus Ratio test--an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants--ISLA 5
    Thromb Haemost, 83 (5), 704-8
    PubMed 10823266
  15. Lenhoff S, Hjorth M, Holmberg E, Turesson I, Westin J, Nielsen JL, Wislöff F, Brinch L, Carlson K, Carlsson M, Dahl IM, Gimsing P, Hippe E, Johnsen HE, Lamvik J, Löfvenberg E, Nesthus I, Rödjer S (2000)
    Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group
    Blood, 95 (1), 7-11
    PubMed 10607678
  16. Nordbø SA, Skaug K, Holter E, Waage A, Brinch L (2000)
    Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation
    Eur J Haematol, 65 (1), 86-7
    DOI 10.1034/j.1600-0609.2000.9l228.x, PubMed 10914949
  17. Sandset PM, Bendz B, Hansen JB (2000)
    Physiological function of tissue factor pathway inhibitor and interaction with heparins
    Haemostasis, 30 Suppl 2, 48-56
    DOI 10.1159/000054163, PubMed 11251341
  18. Tangen JM (2000)
    [Alexander Pushkin's duel--biographic and medical aspects]
    Tidsskr Nor Laegeforen, 120 (10), 1170-2
    PubMed 10863347
  19. Wisløff F, Gulbrandsen N (2000)
    Health-related quality of life and patients' perceptions in interferon-treated multiple myeloma patients. Nordic Myeloma Study Group
    Acta Oncol, 39 (7), 809-13
    DOI 10.1080/028418600750063550, PubMed 11145438
Page visits: 9164